Price Graph
Price
Yield
These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| (Mark One) | ||
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 | ||
|
OR
|
||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| FOR THE TRANSITION PERIOD FROM TO | ||
|
Delaware
(State or other jurisdiction of incorporation or organization) |
13-4075851
(I.R.S. Employer Identification No.) |
|
|
200 Park Avenue, New York, N.Y.
(Address of principal executive offices) |
10166-0188
(Zip Code) |
|
Large accelerated filer
þ
|
Accelerated filer o | |
|
Non-accelerated filer
o
(Do
not check if a smaller reporting company)
|
Smaller reporting company o |
| Page | ||||||||
| 5 | ||||||||
| 5 | ||||||||
| 6 | ||||||||
| 7 | ||||||||
| 9 | ||||||||
| 10 | ||||||||
| 107 | ||||||||
| 160 | ||||||||
| 168 | ||||||||
| 168 | ||||||||
| 168 | ||||||||
| 170 | ||||||||
| 178 | ||||||||
| 179 | ||||||||
| 180 | ||||||||
| E-1 | ||||||||
| EX-3.6 | ||||||||
| EX-4.2 | ||||||||
| EX-31.1 | ||||||||
| EX-31.2 | ||||||||
| EX-32.1 | ||||||||
| EX-32.2 | ||||||||
| EX-101 INSTANCE DOCUMENT | ||||||||
| EX-101 SCHEMA DOCUMENT | ||||||||
| EX-101 CALCULATION LINKBASE DOCUMENT | ||||||||
| EX-101 LABELS LINKBASE DOCUMENT | ||||||||
| EX-101 PRESENTATION LINKBASE DOCUMENT | ||||||||
| EX-101 DEFINITION LINKBASE DOCUMENT | ||||||||
2
3
| • | should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; | |
| • | have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; | |
| • | may apply standards of materiality in a way that is different from what may be viewed as material to investors; and | |
| • | were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. |
4
| Item 1. | Financial Statements |
|
March 31,
|
December 31,
|
|||||||
| 2011 | 2010 | |||||||
|
Assets
|
||||||||
|
Investments:
|
||||||||
|
Fixed maturity securities
available-for-sale,
at estimated fair value (amortized cost: $327,052 and $317,617,
respectively; includes $3,312 and $3,330, respectively, relating
to variable interest entities)
|
$ | 333,664 | $ | 324,797 | ||||
|
Equity securities
available-for-sale,
at estimated fair value (cost: $3,513 and $3,621, respectively)
|
3,584 | 3,602 | ||||||
|
Trading and other securities, at estimated fair value (includes:
$572 and $463, of actively traded securities, respectively; and
$359 and $387, respectively, relating to variable interest
entities)
|
19,365 | 18,589 | ||||||
|
Mortgage loans:
|
||||||||
|
Held-for-investment,
principally at amortized cost (net of valuation allowances of
$621 and $664, respectively; includes $6,771 and $6,840,
respectively, at estimated fair value, relating to variable
interest entities)
|
59,397 | 58,976 | ||||||
|
Held-for-sale,
principally at estimated fair value
|
2,435 | 3,321 | ||||||
|
Mortgage loans, net
|
61,832 | 62,297 | ||||||
|
Policy loans
|
11,872 | 11,761 | ||||||
|
Real estate and real estate joint ventures (includes $15 and
$10, respectively, relating to variable interest entities)
|
8,042 | 8,030 | ||||||
|
Other limited partnership interests (includes $311 and $298,
respectively, relating to variable interest entities)
|
6,409 | 6,416 | ||||||
|
Short-term investments, principally at estimated fair value
|
8,822 | 9,384 | ||||||
|
Other invested assets, principally at estimated fair value
(includes $103 and $104, respectively, relating to variable
interest entities)
|
13,693 | 15,430 | ||||||
|
Total investments
|
467,283 | 460,306 | ||||||
|
Cash and cash equivalents, principally at estimated fair value
(includes $231 and $69, respectively, relating to variable
interest entities)
|
10,692 | 12,957 | ||||||
|
Accrued investment income (includes $32 and $34, respectively,
relating to variable interest entities)
|
4,478 | 4,328 | ||||||
|
Premiums, reinsurance and other receivables (includes $2 and $2,
respectively, relating to variable interest entities)
|
20,315 | 19,799 | ||||||
|
Deferred policy acquisition costs and value of business acquired
|
27,979 | 27,092 | ||||||
|
Goodwill
|
11,946 | 11,781 | ||||||
|
Other assets (includes $7 and $6, respectively, relating to
variable interest entities)
|
9,321 | 8,174 | ||||||
|
Assets of subsidiaries
held-for-sale
|
3,413 | 3,331 | ||||||
|
Separate account assets
|
195,914 | 183,138 | ||||||
|
Total assets
|
$ | 751,341 | $ | 730,906 | ||||
|
Liabilities and Equity
|
||||||||
|
Liabilities
|
||||||||
|
Future policy benefits
|
$ | 172,987 | $ | 170,912 | ||||
|
Policyholder account balances
|
214,641 | 210,757 | ||||||
|
Other policy-related balances
|
15,641 | 15,750 | ||||||
|
Policyholder dividends payable
|
820 | 830 | ||||||
|
Policyholder dividend obligation
|
793 | 876 | ||||||
|
Payables for collateral under securities loaned and other
transactions
|
28,625 | 27,272 | ||||||
|
Bank deposits
|
9,313 | 10,316 | ||||||
|
Short-term debt
|
572 | 306 | ||||||
|
Long-term debt (includes $6,718 and $6,902, respectively, at
estimated fair value, relating to variable interest entities)
|
27,604 | 27,586 | ||||||
|
Collateral financing arrangements
|
5,297 | 5,297 | ||||||
|
Junior subordinated debt securities
|
3,191 | 3,191 | ||||||
|
Current income tax payable
|
113 | 297 | ||||||
|
Deferred income tax liability
|
2,238 | 1,856 | ||||||
|
Other liabilities (includes $112 and $93, respectively, relating
to variable interest entities)
|
20,037 | 20,366 | ||||||
|
Liabilities of subsidiaries
held-for-sale
|
3,206 | 3,043 | ||||||
|
Separate account liabilities
|
195,914 | 183,138 | ||||||
|
Total liabilities
|
700,992 | 681,793 | ||||||
|
Contingencies, Commitments and Guarantees (Note 8)
|
||||||||
|
Redeemable noncontrolling interests in partially owned
consolidated subsidiaries
|
128 | 117 | ||||||
|
Equity
|
||||||||
|
MetLife, Inc.’s stockholders’ equity:
|
||||||||
|
Preferred stock, par value $0.01 per share;
200,000,000 shares authorized:
|
||||||||
|
Preferred stock, 84,000,000 shares issued and outstanding;
$2,100 aggregate liquidation preference
|
1 | 1 | ||||||
|
Convertible preferred stock, 0 and 6,857,000 shares issued
and outstanding at March 31, 2011 and December 31,
2010, respectively
|
— | — | ||||||
|
Common stock, par value $0.01 per share;
3,000,000,000 shares authorized; 1,059,276,399 and
989,031,704 shares issued at March 31, 2011 and
December 31, 2010, respectively; 1,056,082,512 and
985,837,817 shares outstanding at March 31, 2011 and
December 31, 2010, respectively
|
11 | 10 | ||||||
|
Additional paid-in capital
|
26,668 | 26,423 | ||||||
|
Retained earnings
|
22,193 | 21,363 | ||||||
|
Treasury stock, at cost; 3,193,887 shares at March 31,
2011 and December 31, 2010
|
(172 | ) | (172 | ) | ||||
|
Accumulated other comprehensive income (loss)
|
1,115 | 1,000 | ||||||
|
Total MetLife, Inc.’s stockholders’ equity
|
49,816 | 48,625 | ||||||
|
Noncontrolling interests
|
405 | 371 | ||||||
|
Total equity
|
50,221 | 48,996 | ||||||
|
Total liabilities and equity
|
$ | 751,341 | $ | 730,906 | ||||
5
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
|
Revenues
|
||||||||
|
Premiums
|
$ | 8,554 | $ | 6,788 | ||||
|
Universal life and investment-type product policy fees
|
1,889 | 1,405 | ||||||
|
Net investment income
|
5,317 | 4,321 | ||||||
|
Other revenues
|
566 | 513 | ||||||
|
Net investment gains (losses):
|
||||||||
|
Other-than-temporary
impairments on fixed maturity securities
|
(132 | ) | (151 | ) | ||||
|
Other-than-temporary
impairments on fixed maturity securities transferred to other
comprehensive income (loss)
|
9 | 59 | ||||||
|
Other net investment gains (losses)
|
24 | 124 | ||||||
|
Total net investment gains (losses)
|
(99 | ) | 32 | |||||
|
Net derivative gains (losses)
|
(315 | ) | 41 | |||||
|
Total revenues
|
15,912 | 13,100 | ||||||
|
Expenses
|
||||||||
|
Policyholder benefits and claims
|
8,231 | 7,464 | ||||||
|
Interest credited to policyholder account balances
|
1,924 | 1,142 | ||||||
|
Policyholder dividends
|
372 | 377 | ||||||
|
Other expenses
|
3,902 | 2,932 | ||||||
|
Total expenses
|
14,429 | 11,915 | ||||||
|
Income (loss) from continuing operations before provision for
income tax
|
1,483 | 1,185 | ||||||
|
Provision for income tax expense (benefit)
|
428 | 356 | ||||||
|
Income (loss) from continuing operations, net of income tax
|
1,055 | 829 | ||||||
|
Income (loss) from discontinued operations, net of income tax
|
(42 | ) | 5 | |||||
|
Net income (loss)
|
1,013 | 834 | ||||||
|
Less: Net income (loss) attributable to noncontrolling interests
|
7 | (1 | ) | |||||
|
Net income (loss) attributable to MetLife, Inc.
|
1,006 | 835 | ||||||
|
Less: Preferred stock dividends
|
30 | 30 | ||||||
|
Preferred stock redemption premium
|
146 | — | ||||||
|
Net income (loss) available to MetLife, Inc.’s common
shareholders
|
$ | 830 | $ | 805 | ||||
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.’s common shareholders per common
share:
|
||||||||
|
Basic
|
$ | 0.82 | $ | 0.97 | ||||
|
Diluted
|
$ | 0.82 | $ | 0.96 | ||||
|
Net income (loss) available to MetLife, Inc.’s common
shareholders per common share:
|
||||||||
|
Basic
|
$ | 0.78 | $ | 0.98 | ||||
|
Diluted
|
$ | 0.78 | $ | 0.97 | ||||
6
| Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net
|
Foreign
|
Defined
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
Convertible
|
Additional
|
Treasury
|
Unrealized
|
Other-Than-
|
Currency
|
Benefit
|
MetLife, Inc.’s
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Preferred
|
Preferred
|
Common
|
Paid-in
|
Retained
|
Stock
|
Investment
|
Temporary
|
Translation
|
Plans
|
Stockholders’
|
Noncontrolling
|
Total
|
||||||||||||||||||||||||||||||||||||||||
| Stock | Stock | Stock | Capital | Earnings | at Cost | Gains (Losses) | Impairments | Adjustments | Adjustment | Equity | Interests (1) | Equity | ||||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2010
|
$ | 1 | $ | — | $ | 10 | $ | 26,423 | $ | 21,363 | $ | (172 | ) | $ | 3,356 | $ | (366 | ) | $ | (541 | ) | $ | (1,449 | ) | $ | 48,625 | $ | 371 | $ | 48,996 | ||||||||||||||||||||||
|
Redemption of convertible preferred stock
|
— | (2,805 | ) | (2,805 | ) | (2,805 | ) | |||||||||||||||||||||||||||||||||||||||||||||
|
Preferred stock redemption premium
|
(146 | ) | (146 | ) | (146 | ) | ||||||||||||||||||||||||||||||||||||||||||||||
|
Common stock issuance — newly issued shares
|
1 | 2,949 | 2,950 | 2,950 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Stock-based compensation
|
101 | — | 101 | 101 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Dividends on preferred stock
|
(30 | ) | (30 | ) | (30 | ) | ||||||||||||||||||||||||||||||||||||||||||||||
|
Change in equity of noncontrolling interests
|
36 | 36 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Comprehensive income (loss):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net income (loss)
|
1,006 | 1,006 | (3 | ) | 1,003 | |||||||||||||||||||||||||||||||||||||||||||||||
|
Other comprehensive income (loss):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
(116 | ) | (116 | ) | (116 | ) | ||||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
(240 | ) | 27 | (213 | ) | — | (213 | ) | ||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation adjustments, net of income tax
|
425 | 425 | 1 | 426 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Defined benefit plans adjustment, net of income tax
|
19 | 19 | 19 | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
115 | 1 | 116 | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Comprehensive income (loss)
|
1,121 | (2 | ) | 1,119 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Balance at March 31, 2011
|
$ | 1 | $ | — | $ | 11 | $ | 26,668 | $ | 22,193 | $ | (172 | ) | $ | 3,000 | $ | (339 | ) | $ | (116 | ) | $ | (1,430 | ) | $ | 49,816 | $ | 405 | $ | 50,221 | ||||||||||||||||||||||
| (1) | Net income (loss) attributable to noncontrolling interests excludes gains (losses) of redeemable noncontrolling interests in partially owned consolidated subsidiaries of $10 million. |
7
| Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Net
|
Foreign
|
Defined
|
Total
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Additional
|
Treasury
|
Unrealized
|
Other-Than-
|
Currency
|
Benefit
|
MetLife, Inc.’s
|
||||||||||||||||||||||||||||||||||||||||||
|
Preferred
|
Common
|
Paid-in
|
Retained
|
Stock
|
Investment
|
Temporary
|
Translation
|
Plans
|
Stockholders’
|
Noncontrolling
|
Total
|
|||||||||||||||||||||||||||||||||||||
| Stock | Stock | Capital | Earnings | at Cost | Gains (Losses) | Impairments | Adjustments | Adjustment | Equity | Interests | Equity | |||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2009
|
$ | 1 | $ | 8 | $ | 16,859 | $ | 19,501 | $ | (190 | ) | $ | (817 | ) | $ | (513 | ) | $ | (183 | ) | $ | (1,545 | ) | $ | 33,121 | $ | 377 | $ | 33,498 | |||||||||||||||||||
|
Cumulative effect of change in accounting principle, net of
income tax
|
(12 | ) | 31 | 11 | 30 | 30 | ||||||||||||||||||||||||||||||||||||||||||
|
Balance at January 1, 2010
|
1 | 8 | 16,859 | 19,489 | (190 | ) | (786 | ) | (502 | ) | (183 | ) | (1,545 | ) | 33,151 | 377 | 33,528 | |||||||||||||||||||||||||||||||
|
Stock-based compensation
|
12 | 18 | 30 | 30 | ||||||||||||||||||||||||||||||||||||||||||||
|
Dividends on preferred stock
|
(30 | ) | (30 | ) | (30 | ) | ||||||||||||||||||||||||||||||||||||||||||
|
Change in equity of noncontrolling interests
|
(14 | ) | (14 | ) | ||||||||||||||||||||||||||||||||||||||||||||
|
Comprehensive income (loss):
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Net income (loss)
|
835 | 835 | (1 | ) | 834 | |||||||||||||||||||||||||||||||||||||||||||
|
Other comprehensive income (loss):
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized gains (losses) on derivative instruments, net of
income tax
|
78 | 78 | 78 | |||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized investment gains (losses), net of related offsets and
income tax
|
1,696 | (29 | ) | 1,667 | (1 | ) | 1,666 | |||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation adjustments, net of income tax
|
61 | 61 | 7 | 68 | ||||||||||||||||||||||||||||||||||||||||||||
|
Defined benefit plans adjustment, net of income tax
|
19 | 19 | 19 | |||||||||||||||||||||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
1,825 | 6 | 1,831 | |||||||||||||||||||||||||||||||||||||||||||||
|
Comprehensive income (loss)
|
2,660 | 5 | 2,665 | |||||||||||||||||||||||||||||||||||||||||||||
|
Balance at March 31, 2010
|
$ | 1 | $ | 8 | $ | 16,871 | $ | 20,294 | $ | (172 | ) | $ | 988 | $ | (531 | ) | $ | (122 | ) | $ | (1,526 | ) | $ | 35,811 | $ | 368 | $ | 36,179 | ||||||||||||||||||||
8
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
|
Net cash provided by operating activities
|
$ | 3,501 | $ | 2,871 | ||||
|
Cash flows from investing activities
|
||||||||
|
Sales, maturities and repayments of:
|
||||||||
|
Fixed maturity securities
|
25,149 | 14,896 | ||||||
|
Equity securities
|
473 | 255 | ||||||
|
Mortgage loans
|
2,411 | 1,152 | ||||||
|
Real estate and real estate joint ventures
|
106 | 18 | ||||||
|
Other limited partnership interests
|
320 | 97 | ||||||
|
Purchases of:
|
||||||||
|
Fixed maturity securities
|
(32,954 | ) | (22,518 | ) | ||||
|
Equity securities
|
(271 | ) | (134 | ) | ||||
|
Mortgage loans
|
(2,678 | ) | (1,156 | ) | ||||
|
Real estate and real estate joint ventures
|
(159 | ) | (176 | ) | ||||
|
Other limited partnership interests
|
(211 | ) | (166 | ) | ||||
|
Cash received in connection with freestanding derivatives
|
1,070 | 465 | ||||||
|
Cash paid in connection with freestanding derivatives
|
(1,916 | ) | (725 | ) | ||||
|
Net change in policy loans
|
(87 | ) | (85 | ) | ||||
|
Net change in short-term investments
|
774 | 386 | ||||||
|
Net change in other invested assets
|
(68 | ) | 128 | |||||
|
Other, net
|
(53 | ) | (35 | ) | ||||
|
Net cash used in investing activities
|
(8,094 | ) | (7,598 | ) | ||||
|
Cash flows from financing activities
|
||||||||
|
Policyholder account balances:
|
||||||||
|
Deposits
|
25,042 | 17,321 | ||||||
|
Withdrawals
|
(23,363 | ) | (14,194 | ) | ||||
|
Net change in payables for collateral under securities loaned
and other transactions
|
1,353 | 1,786 | ||||||
|
Net change in bank deposits
|
(1,027 | ) | (218 | ) | ||||
|
Net change in short-term debt
|
266 | (594 | ) | |||||
|
Long-term debt issued
|
280 | 163 | ||||||
|
Long-term debt repaid
|
(249 | ) | (322 | ) | ||||
|
Common stock issued, net of issuance costs
|
2,997 | — | ||||||
|
Redemption of convertible preferred stock
|
(2,805 | ) | — | |||||
|
Preferred stock redemption premium
|
(146 | ) | — | |||||
|
Dividends on preferred stock
|
(30 | ) | (30 | ) | ||||
|
Other, net
|
(56 | ) | (67 | ) | ||||
|
Net cash provided by financing activities
|
2,262 | 3,845 | ||||||
|
Effect of change in foreign currency exchange rates on cash and
cash equivalents balances
|
93 | (28 | ) | |||||
|
Change in cash and cash equivalents
|
(2,238 | ) | (910 | ) | ||||
|
Cash and cash equivalents, beginning of period
|
13,046 | 10,112 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 10,808 | $ | 9,202 | ||||
|
Cash and cash equivalents, subsidiaries
held-for-sale,
beginning of period
|
$ | 89 | $ | 88 | ||||
|
Cash and cash equivalents, subsidiaries
held-for-sale,
end of period
|
$ | 116 | $ | 85 | ||||
|
Cash and cash equivalents, from continuing operations, beginning
of period
|
$ | 12,957 | $ | 10,024 | ||||
|
Cash and cash equivalents, from continuing operations, end of
period
|
$ | 10,692 | $ | 9,117 | ||||
|
Supplemental disclosures of cash flow information:
|
||||||||
|
Net cash paid during the period for:
|
||||||||
|
Interest
|
$ | 333 | $ | 258 | ||||
|
Income tax
|
$ | 415 | $ | (88 | ) | |||
|
Non-cash transactions during the period:
|
||||||||
|
Real estate and real estate joint ventures acquired in
satisfaction of debt
|
$ | — | $ | 8 | ||||
9
| 1. | Business, Basis of Presentation and Summary of Significant Accounting Policies |
| • | Reclassification from other net investment gains (losses) of $41 million to net derivative gains (losses) in the consolidated statements of operations for the three months ended March 31, 2010; |
10
| • | Realignment that affected assets, liabilities and results of operations on a segment basis with no impact to the consolidated results. See Note 13; | |
| • | Reclassifications related to operating revenues and expenses that affected results of operations on a segment and consolidated basis. See Note 13; and | |
| • | Reclassifications related to discontinued operations. See Note 14. |
11
| 2. | Acquisitions and Dispositions |
12
13
| 3. | Investments |
| March 31, 2011 | ||||||||||||||||||||||||
|
Cost or
|
Gross Unrealized |
Estimated
|
||||||||||||||||||||||
|
Amortized
|
Temporary
|
OTTI
|
Fair
|
% of
|
||||||||||||||||||||
| Cost | Gains | Losses | Losses | Value | Total | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Fixed Maturity Securities:
|
||||||||||||||||||||||||
|
U.S. corporate securities
|
$ | 90,810 | $ | 4,277 | $ | 1,538 | $ | — | $ | 93,549 | 28.0 | % | ||||||||||||
|
Foreign corporate securities (1)
|
66,414 | 3,289 | 1,007 | (1 | ) | 68,697 | 20.6 | |||||||||||||||||
|
Foreign government securities
|
44,288 | 1,584 | 683 | — | 45,189 | 13.6 | ||||||||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
44,627 | 1,542 | 703 | 459 | 45,007 | 13.5 | ||||||||||||||||||
|
U.S. Treasury and agency securities
|
35,158 | 1,179 | 858 | — | 35,479 | 10.6 | ||||||||||||||||||
|
Commercial mortgage-backed securities (“CMBS”) (1)
|
19,135 | 838 | 196 | (8 | ) | 19,785 | 5.9 | |||||||||||||||||
|
Asset-backed securities (“ABS”)
|
15,308 | 306 | 524 | 100 | 14,990 | 4.5 | ||||||||||||||||||
|
State and political subdivision securities
|
11,306 | 192 | 537 | — | 10,961 | 3.3 | ||||||||||||||||||
|
Other fixed maturity securities
|
6 | 1 | — | — | 7 | — | ||||||||||||||||||
|
Total fixed maturity securities (2),(3)
|
$ | 327,052 | $ | 13,208 | $ | 6,046 | $ | 550 | $ | 333,664 | 100.0 | % | ||||||||||||
|
Equity Securities:
|
||||||||||||||||||||||||
|
Common stock
|
$ | 1,939 | $ | 193 | $ | 20 | $ | — | $ | 2,112 | 58.9 | % | ||||||||||||
|
Non-redeemable preferred stock (2)
|
1,574 | 90 | 192 | — | 1,472 | 41.1 | ||||||||||||||||||
|
Total equity securities
|
$ | 3,513 | $ | 283 | $ | 212 | $ | — | $ | 3,584 | 100.0 | % | ||||||||||||
14
| December 31, 2010 | ||||||||||||||||||||||||
|
Cost or
|
Gross Unrealized |
Estimated
|
||||||||||||||||||||||
|
Amortized
|
Temporary
|
OTTI
|
Fair
|
% of
|
||||||||||||||||||||
| Cost | Gains | Losses | Losses | Value | Total | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Fixed Maturity Securities:
|
||||||||||||||||||||||||
|
U.S. corporate securities
|
$ | 88,905 | $ | 4,469 | $ | 1,602 | $ | — | $ | 91,772 | 28.3 | % | ||||||||||||
|
Foreign corporate securities
|
65,487 | 3,326 | 925 | — | 67,888 | 20.9 | ||||||||||||||||||
|
Foreign government securities
|
40,871 | 1,733 | 602 | — | 42,002 | 12.9 | ||||||||||||||||||
|
RMBS
|
44,468 | 1,652 | 917 | 470 | 44,733 | 13.8 | ||||||||||||||||||
|
U.S. Treasury and agency securities
|
32,469 | 1,394 | 559 | — | 33,304 | 10.2 | ||||||||||||||||||
|
CMBS
|
20,213 | 740 | 266 | 12 | 20,675 | 6.4 | ||||||||||||||||||
|
ABS
|
14,722 | 274 | 590 | 119 | 14,287 | 4.4 | ||||||||||||||||||
|
State and political subdivision securities
|
10,476 | 171 | 518 | — | 10,129 | 3.1 | ||||||||||||||||||
|
Other fixed maturity securities
|
6 | 1 | — | — | 7 | — | ||||||||||||||||||
|
Total fixed maturity securities (2),(3)
|
$ | 317,617 | $ | 13,760 | $ | 5,979 | $ | 601 | $ | 324,797 | 100.0 | % | ||||||||||||
|
Equity Securities:
|
||||||||||||||||||||||||
|
Common stock
|
$ | 2,059 | $ | 146 | $ | 12 | $ | — | $ | 2,193 | 60.9 | % | ||||||||||||
|
Non-redeemable preferred stock (2)
|
1,562 | 76 | 229 | — | 1,409 | 39.1 | ||||||||||||||||||
|
Total equity securities
|
$ | 3,621 | $ | 222 | $ | 241 | $ | — | $ | 3,602 | 100.0 | % | ||||||||||||
| (1) | OTTI losses as presented above represents the noncredit portion of OTTI losses that is included in accumulated other comprehensive income (loss). OTTI losses include both the initial recognition of noncredit losses, and the effects of subsequent increases and decreases in estimated fair value for those fixed maturity securities that were previously noncredit loss impaired. The noncredit loss component of OTTI losses for foreign corporate securities and CMBS were in an unrealized gain (loss) position of $1 million and $8 million, respectively, at March 31, 2011, due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “Net Unrealized Investment Gains (Losses)”. | |
| (2) | Upon acquisition, the Company classifies perpetual securities that have attributes of both debt and equity as fixed maturity securities if the security has an interest rate step-up feature which, when combined with other qualitative factors, indicates that the security has more debt-like characteristics; while those with more equity-like characteristics, are classified as equity securities within non-redeemable preferred stock. Many of such securities have been issued by non-U.S. financial institutions that are accorded Tier 1 and Upper Tier 2 capital treatment by their respective regulatory bodies and are commonly referred to as “perpetual hybrid securities.” The following table presents the perpetual hybrid securities held by the Company at: |
| March 31, 2011 | December 31, 2010 | |||||||||||
|
Estimated
|
Estimated
|
|||||||||||
| Classification |
Fair
|
Fair
|
||||||||||
| Consolidated Balance Sheets | Sector Table | Primary Issuers | Value | Value | ||||||||
| (In millions) | ||||||||||||
|
Equity securities
|
Non-redeemable preferred stock | Non-U.S. financial institutions | $ | 1,105 | $ | 1,043 | ||||||
|
Equity securities
|
Non-redeemable preferred stock | U.S. financial institutions | $ | 226 | $ | 236 | ||||||
|
Fixed maturity securities
|
Foreign corporate securities | Non-U.S. financial institutions | $ | 1,782 | $ | 2,008 | ||||||
|
Fixed maturity securities
|
U.S. corporate securities | U.S. financial institutions | $ | 75 | $ | 83 | ||||||
| (3) | The Company’s holdings in redeemable preferred stock with stated maturity dates, commonly referred to as “capital securities”, were primarily issued by U.S. financial institutions and have cumulative interest deferral features. The Company held $2.2 billion and $2.7 billion at estimated fair value of such securities at March 31, 2011 and December 31, 2010, respectively, which are included in the U.S. and foreign corporate securities sectors within fixed maturity securities. |
15
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Below investment grade or non-rated fixed maturity securities:
|
||||||||
|
Estimated fair value
|
$ | 25,139 | $ | 24,870 | ||||
|
Net unrealized gains (losses)
|
$ | (218 | ) | $ | (696 | ) | ||
|
Non-income producing fixed maturity securities:
|
||||||||
|
Estimated fair value
|
$ | 148 | $ | 130 | ||||
|
Net unrealized gains (losses)
|
$ | (20 | ) | $ | (23 | ) | ||
| March 31, 2011 | December 31, 2010 | |||||||
| Carrying Value (1) | ||||||||
| (In millions) | ||||||||
|
Government and agency fixed maturity securities:
|
||||||||
|
United States
|
$ | 35,479 | $ | 33,304 | ||||
|
Japan
|
$ | 16,596 | $ | 15,591 | ||||
|
Mexico
|
$ | 5,306 | $ | 5,050 | ||||
|
U.S. Treasury and agency fixed-income securities included in:
|
||||||||
|
Short-term investments
|
$ | 4,026 | $ | 4,048 | ||||
|
Cash equivalents
|
$ | 4,300 | $ | 5,762 | ||||
16
| (1) | Represents estimated fair value for fixed maturity securities; amortized cost, which approximates estimated fair value or estimated fair value, if available, for short-term investments; and amortized cost, which approximates estimated fair value for cash equivalents. |
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||
|
Fair
|
% of
|
Fair
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Corporate fixed maturity securities — by sector:
|
||||||||||||||||
|
Foreign corporate fixed maturity securities (1)
|
$ | 68,697 | 42.3 | % | $ | 67,888 | 42.5 | % | ||||||||
|
U.S. corporate fixed maturity securities — by industry:
|
||||||||||||||||
|
Industrial
|
22,437 | 13.8 | 22,070 | 13.8 | ||||||||||||
|
Consumer
|
22,344 | 13.8 | 21,482 | 13.5 | ||||||||||||
|
Finance
|
20,317 | 12.5 | 20,785 | 13.0 | ||||||||||||
|
Utility
|
17,668 | 10.9 | 16,902 | 10.6 | ||||||||||||
|
Communications
|
7,607 | 4.7 | 7,335 | 4.6 | ||||||||||||
|
Other
|
3,176 | 2.0 | 3,198 | 2.0 | ||||||||||||
|
Total
|
$ | 162,246 | 100.0 | % | $ | 159,660 | 100.0 | % | ||||||||
| (1) | Includes U.S. dollar-denominated debt obligations of foreign obligors and other foreign fixed maturity securities. |
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||
|
Fair
|
% of Total
|
Fair
|
% of Total
|
|||||||||||||
| Value | Investments | Value | Investments | |||||||||||||
| (In millions) | ||||||||||||||||
|
Concentrations within corporate fixed maturity securities:
|
||||||||||||||||
|
Largest exposure to a single issuer
|
$ | 2,189 | 0.5 | % | $ | 2,291 | 0.5 | % | ||||||||
|
Holdings in ten issuers with the largest exposures
|
$ | 13,463 | 2.9 | % | $ | 14,247 | 3.1 | % | ||||||||
17
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||
|
Fair
|
% of
|
Fair
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
By security type:
|
||||||||||||||||
|
Pass-through securities
|
$ | 23,275 | 51.7 | % | $ | 22,430 | 50.1 | % | ||||||||
|
Collateralized mortgage obligations
|
21,732 | 48.3 | 22,303 | 49.9 | ||||||||||||
|
Total RMBS
|
$ | 45,007 | 100.0 | % | $ | 44,733 | 100.0 | % | ||||||||
|
By risk profile:
|
||||||||||||||||
|
Agency
|
$ | 34,856 | 77.5 | % | $ | 34,254 | 76.6 | % | ||||||||
|
Prime
|
5,900 | 13.1 | 6,258 | 14.0 | ||||||||||||
|
Alternative residential mortgage loans
|
4,251 | 9.4 | 4,221 | 9.4 | ||||||||||||
|
Total RMBS
|
$ | 45,007 | 100.0 | % | $ | 44,733 | 100.0 | % | ||||||||
|
Rated Aaa/AAA
|
$ | 36,550 | 81.2 | % | $ | 36,085 | 80.7 | % | ||||||||
|
Rated NAIC 1
|
$ | 39,482 | 87.7 | % | $ | 38,984 | 87.1 | % | ||||||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||
|
Fair
|
% of
|
Fair
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Vintage Year:
|
||||||||||||||||
|
2004 & Prior
|
$ | 91 | 2.1 | % | $ | 93 | 2.2 | % | ||||||||
|
2005
|
1,519 | 35.7 | 1,483 | 35.1 | ||||||||||||
|
2006
|
1,019 | 24.0 | 1,013 | 24.0 | ||||||||||||
|
2007
|
943 | 22.2 | 922 | 21.8 | ||||||||||||
|
2008
|
6 | 0.1 | 7 | 0.2 | ||||||||||||
|
2009 (1)
|
641 | 15.1 | 671 | 15.9 | ||||||||||||
|
2010 (1)
|
32 | 0.8 | 32 | 0.8 | ||||||||||||
|
Total
|
$ | 4,251 | 100.0 | % | $ | 4,221 | 100.0 | % | ||||||||
| (1) | All of the Company’s Alt-A RMBS holdings in the 2009 and 2010 vintage years are resecuritization of real estate mortgage investment conduit (“Re-REMIC”) Alt-A RMBS that were purchased in 2009 and 2010 and are comprised of original issue vintage year 2005 through 2007 Alt-A RMBS. All of the Company’s Re-REMIC Alt-A RMBS holdings are NAIC 1 rated. |
18
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
% of
|
% of
|
|||||||||||||||
| Amount | Total | Amount | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Net unrealized gains (losses)
|
$ | (577 | ) | $ | (670 | ) | ||||||||||
|
Rated Aa/AA or better
|
14.7 | % | 15.9 | % | ||||||||||||
|
Rated NAIC 1
|
41.2 | % | 39.5 | % | ||||||||||||
|
Distribution of holdings — at estimated fair
value — by collateral type:
|
||||||||||||||||
|
Fixed rate mortgage loans collateral
|
90.8 | % | 90.7 | % | ||||||||||||
|
Hybrid adjustable rate mortgage loans collateral
|
9.2 | 9.3 | ||||||||||||||
|
Total Alt-A RMBS
|
100.0 | % | 100.0 | % | ||||||||||||
| March 31, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Below
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Investment
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Aaa | Aa | A | Baa | Grade | Total | |||||||||||||||||||||||||||||||||||||||||||
|
Estimated
|
Estimated
|
Estimated
|
Estimated
|
Estimated
|
Estimated
|
|||||||||||||||||||||||||||||||||||||||||||
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
|||||||||||||||||||||||||||||||||||||
| Cost | Value | Cost | Value | Cost | Value | Cost | Value | Cost | Value | Cost | Value | |||||||||||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
2003 & Prior
|
$ | 6,851 | $ | 7,032 | $ | 229 | $ | 231 | $ | 155 | $ | 154 | $ | 74 | $ | 72 | $ | 21 | $ | 19 | $ | 7,330 | $ | 7,508 | ||||||||||||||||||||||||
|
2004
|
3,452 | 3,579 | 508 | 517 | 106 | 104 | 103 | 103 | 91 | 73 | 4,260 | 4,376 | ||||||||||||||||||||||||||||||||||||
|
2005
|
2,904 | 3,091 | 400 | 430 | 315 | 336 | 201 | 207 | 46 | 42 | 3,866 | 4,106 | ||||||||||||||||||||||||||||||||||||
|
2006
|
1,454 | 1,536 | 164 | 168 | 88 | 94 | 166 | 178 | 175 | 192 | 2,047 | 2,168 | ||||||||||||||||||||||||||||||||||||
|
2007
|
676 | 689 | 414 | 385 | 173 | 166 | 51 | 53 | 96 | 106 | 1,410 | 1,399 | ||||||||||||||||||||||||||||||||||||
|
2008
|
— | — | 28 | 35 | — | — | — | — | — | — | 28 | 35 | ||||||||||||||||||||||||||||||||||||
|
2009
|
2 | 2 | — | — | — | — | — | — | — | — | 2 | 2 | ||||||||||||||||||||||||||||||||||||
|
2010
|
3 | 3 | 56 | 55 | — | — | — | — | — | — | 59 | 58 | ||||||||||||||||||||||||||||||||||||
|
2011
|
133 | 133 | — | — | — | — | — | — | — | — | 133 | 133 | ||||||||||||||||||||||||||||||||||||
|
Total
|
$ | 15,475 | $ | 16,065 | $ | 1,799 | $ | 1,821 | $ | 837 | $ | 854 | $ | 595 | $ | 613 | $ | 429 | $ | 432 | $ | 19,135 | $ | 19,785 | ||||||||||||||||||||||||
|
Ratings Distribution
|
81.2 | % | 9.2 | % | 4.3 | % | 3.1 | % | 2.2 | % | 100.0 | % | ||||||||||||||||||||||||||||||||||||
| December 31, 2010 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Below
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Investment
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Aaa | Aa | A | Baa | Grade | Total | |||||||||||||||||||||||||||||||||||||||||||
|
Estimated
|
Estimated
|
Estimated
|
Estimated
|
Estimated
|
Estimated
|
|||||||||||||||||||||||||||||||||||||||||||
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
Amortized
|
Fair
|
|||||||||||||||||||||||||||||||||||||
| Cost | Value | Cost | Value | Cost | Value | Cost | Value | Cost | Value | Cost | Value | |||||||||||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
2003 & Prior
|
$ | 7,411 | $ | 7,640 | $ | 282 | $ | 282 | $ | 228 | $ | 227 | $ | 74 | $ | 71 | $ | 28 | $ | 24 | $ | 8,023 | $ | 8,244 | ||||||||||||||||||||||||
|
2004
|
3,489 | 3,620 | 277 | 273 | 216 | 209 | 181 | 175 | 91 | 68 | 4,254 | 4,345 | ||||||||||||||||||||||||||||||||||||
|
2005
|
3,113 | 3,292 | 322 | 324 | 286 | 280 | 263 | 255 | 73 | 66 | 4,057 | 4,217 | ||||||||||||||||||||||||||||||||||||
|
2006
|
1,463 | 1,545 | 159 | 160 | 168 | 168 | 385 | 398 | 166 | 156 | 2,341 | 2,427 | ||||||||||||||||||||||||||||||||||||
|
2007
|
840 | 791 | 344 | 298 | 96 | 95 | 119 | 108 | 122 | 133 | 1,521 | 1,425 | ||||||||||||||||||||||||||||||||||||
|
2008
|
2 | 2 | — | — | — | — | — | — | — | — | 2 | 2 | ||||||||||||||||||||||||||||||||||||
|
2009
|
3 | 3 | — | — | — | — | — | — | — | — | 3 | 3 | ||||||||||||||||||||||||||||||||||||
|
2010
|
8 | 8 | — | — | 4 | 4 | — | — | — | — | 12 | 12 | ||||||||||||||||||||||||||||||||||||
|
Total
|
$ | 16,329 | $ | 16,901 | $ | 1,384 | $ | 1,337 | $ | 998 | $ | 983 | $ | 1,022 | $ | 1,007 | $ | 480 | $ | 447 | $ | 20,213 | $ | 20,675 | ||||||||||||||||||||||||
|
Ratings Distribution
|
81.7 | % | 6.4 | % | 4.8 | % | 4.9 | % | 2.2 | % | 100.0 | % | ||||||||||||||||||||||||||||||||||||
19
| March 31, 2011 | December 31, 2010 | |||||||
|
NAIC 1
|
93.9 | % | 93.7 | % | ||||
|
NAIC 2
|
3.3 | % | 3.2 | % | ||||
|
NAIC 3
|
1.4 | % | 1.8 | % | ||||
|
NAIC 4
|
1.1 | % | 1.0 | % | ||||
|
NAIC 5
|
0.3 | % | 0.3 | % | ||||
|
NAIC 6
|
— | % | — | % | ||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||
|
Fair
|
% of
|
Fair
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
By collateral type:
|
||||||||||||||||
|
Credit card loans
|
$ | 5,879 | 39.2 | % | $ | 6,027 | 42.2 | % | ||||||||
|
Student loans
|
2,648 | 17.7 | 2,416 | 16.9 | ||||||||||||
|
Collateralized debt obligations
|
1,949 | 13.0 | 1,798 | 12.6 | ||||||||||||
|
RMBS backed by
sub-prime
mortgage loans
|
1,113 | 7.4 | 1,119 | 7.8 | ||||||||||||
|
Automobile loans
|
776 | 5.2 | 605 | 4.2 | ||||||||||||
|
Other loans
|
2,625 | 17.5 | 2,322 | 16.3 | ||||||||||||
|
Total
|
$ | 14,990 | 100.0 | % | $ | 14,287 | 100.0 | % | ||||||||
|
Rated Aaa/AAA
|
$ | 10,486 | 70.0 | % | $ | 10,411 | 72.9 | % | ||||||||
|
Rated NAIC 1
|
$ | 13,805 | 92.1 | % | $ | 13,133 | 91.9 | % | ||||||||
20
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||
|
Amortized
|
Fair
|
Amortized
|
Fair
|
|||||||||||||
| Cost | Value | Cost | Value | |||||||||||||
| (In millions) | ||||||||||||||||
|
Due in one year or less
|
$ | 10,343 | $ | 10,487 | $ | 8,580 | $ | 8,702 | ||||||||
|
Due after one year through five years
|
66,913 | 68,596 | 65,143 | 66,796 | ||||||||||||
|
Due after five years through ten years
|
79,908 | 82,766 | 76,508 | 79,571 | ||||||||||||
|
Due after ten years
|
90,818 | 92,033 | 87,983 | 90,033 | ||||||||||||
|
Subtotal
|
247,982 | 253,882 | 238,214 | 245,102 | ||||||||||||
|
RMBS, CMBS and ABS
|
79,070 | 79,782 | 79,403 | 79,695 | ||||||||||||
|
Total fixed maturity securities
|
$ | 327,052 | $ | 333,664 | $ | 317,617 | $ | 324,797 | ||||||||
21
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Fixed maturity securities
|
$ | 7,189 | $ | 7,817 | ||||
|
Fixed maturity securities with noncredit OTTI losses in
accumulated other comprehensive income (loss)
|
(550 | ) | (601 | ) | ||||
|
Total fixed maturity securities
|
6,639 | 7,216 | ||||||
|
Equity securities
|
99 | (3 | ) | |||||
|
Derivatives
|
(237 | ) | (59 | ) | ||||
|
Other
|
4 | 42 | ||||||
|
Subtotal
|
6,505 | 7,196 | ||||||
|
Amounts allocated from:
|
||||||||
|
Insurance liability loss recognition
|
(569 | ) | (672 | ) | ||||
|
DAC and VOBA related to noncredit OTTI losses recognized in
accumulated other comprehensive income (loss)
|
31 | 38 | ||||||
|
DAC and VOBA
|
(1,187 | ) | (1,205 | ) | ||||
|
Policyholder dividend obligation
|
(793 | ) | (876 | ) | ||||
|
Subtotal
|
(2,518 | ) | (2,715 | ) | ||||
|
Deferred income tax benefit (expense) related to noncredit OTTI
losses recognized in accumulated other comprehensive income
(loss)
|
180 | 197 | ||||||
|
Deferred income tax benefit (expense)
|
(1,510 | ) | (1,692 | ) | ||||
|
Net unrealized investment gains (losses)
|
2,657 | 2,986 | ||||||
|
Net unrealized investment gains (losses) attributable to
noncontrolling interests
|
4 | 4 | ||||||
|
Net unrealized investment gains (losses) attributable to
MetLife, Inc.
|
$ | 2,661 | $ | 2,990 | ||||
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Balance, beginning of period
|
$ | (601 | ) | $ | (859 | ) | ||
|
Noncredit OTTI losses recognized (1)
|
(9 | ) | (212 | ) | ||||
|
Transferred to retained earnings (2)
|
— | 16 | ||||||
|
Securities sold with previous noncredit OTTI loss
|
37 | 137 | ||||||
|
Subsequent increases in estimated fair value
|
23 | 317 | ||||||
|
Balance, end of period
|
$ | (550 | ) | $ | (601 | ) | ||
| (1) | Noncredit OTTI losses recognized, net of deferred policy acquisition costs (“DAC”), were ($13) million and ($202) million for the periods ended March 31, 2011 and December 31, 2010, respectively. | |
| (2) | Amounts transferred to retained earnings were in connection with the adoption of guidance related to the consolidation of VIEs as described in Note 1 of the Notes to the Consolidated Financial Statements included in the 2010 Annual Report. |
22
|
Three Months
|
||||
|
Ended
|
||||
| March 31, 2011 | ||||
| (In millions) | ||||
|
Balance, beginning of period
|
$ | 2,990 | ||
|
Fixed maturity securities on which noncredit OTTI losses have
been recognized
|
51 | |||
|
Unrealized investment gains (losses) during the period
|
(742 | ) | ||
|
Unrealized investment gains (losses) relating to:
|
||||
|
Insurance liability gain (loss) recognition
|
103 | |||
|
DAC and VOBA related to noncredit OTTI losses recognized in
accumulated other comprehensive income (loss)
|
(7 | ) | ||
|
DAC and VOBA
|
18 | |||
|
Policyholder dividend obligation
|
83 | |||
|
Deferred income tax benefit (expense) related to noncredit OTTI
losses recognized in accumulated other comprehensive income
(loss)
|
(17 | ) | ||
|
Deferred income tax benefit (expense)
|
182 | |||
|
Net unrealized investment gains (losses)
|
2,661 | |||
|
Net unrealized investment gains (losses) attributable to
noncontrolling interests
|
— | |||
|
Balance, end of period
|
$ | 2,661 | ||
|
Change in net unrealized investment gains (losses)
|
$ | (329 | ) | |
|
Change in net unrealized investment gains (losses) attributable
to noncontrolling interests
|
— | |||
|
Change in net unrealized investment gains (losses) attributable
to MetLife, Inc.
|
$ | (329 | ) | |
23
| March 31, 2011 | ||||||||||||||||||||||||
|
Equal to or Greater
|
||||||||||||||||||||||||
| Less than 12 Months | than 12 Months | Total | ||||||||||||||||||||||
|
Estimated
|
Gross
|
Estimated
|
Gross
|
Estimated
|
Gross
|
|||||||||||||||||||
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
|||||||||||||||||||
| Value | Losses | Value | Losses | Value | Losses | |||||||||||||||||||
| (In millions, except number of securities) | ||||||||||||||||||||||||
|
Fixed Maturity Securities:
|
||||||||||||||||||||||||
|
U.S. corporate securities
|
$ | 22,680 | $ | 580 | $ | 7,608 | $ | 958 | $ | 30,288 | $ | 1,538 | ||||||||||||
|
Foreign corporate securities
|
23,018 | 635 | 3,320 | 371 | 26,338 | 1,006 | ||||||||||||||||||
|
Foreign government securities
|
26,529 | 670 | 172 | 13 | 26,701 | 683 | ||||||||||||||||||
|
RMBS
|
9,396 | 257 | 5,873 | 905 | 15,269 | 1,162 | ||||||||||||||||||
|
U.S. Treasury and agency securities
|
14,313 | 827 | 110 | 31 | 14,423 | 858 | ||||||||||||||||||
|
CMBS
|
3,187 | 52 | 1,061 | 136 | 4,248 | 188 | ||||||||||||||||||
|
ABS
|
2,999 | 35 | 2,767 | 589 | 5,766 | 624 | ||||||||||||||||||
|
State and political subdivision securities
|
5,036 | 251 | 968 | 286 | 6,004 | 537 | ||||||||||||||||||
|
Other fixed maturity securities
|
1 | — | — | — | 1 | — | ||||||||||||||||||
|
Total fixed maturity securities
|
$ | 107,159 | $ | 3,307 | $ | 21,879 | $ | 3,289 | $ | 129,038 | $ | 6,596 | ||||||||||||
|
Equity Securities:
|
||||||||||||||||||||||||
|
Common stock
|
$ | 97 | $ | 20 | $ | — | $ | — | $ | 97 | $ | 20 | ||||||||||||
|
Non-redeemable preferred stock
|
173 | 11 | 828 | 181 | 1,001 | 192 | ||||||||||||||||||
|
Total equity securities
|
$ | 270 | $ | 31 | $ | 828 | $ | 181 | $ | 1,098 | $ | 212 | ||||||||||||
|
Total number of securities in an unrealized loss position
|
5,882 | 1,533 | ||||||||||||||||||||||
| December 31, 2010 | ||||||||||||||||||||||||
|
Equal to or Greater
|
||||||||||||||||||||||||
| Less than 12 Months | than 12 Months | Total | ||||||||||||||||||||||
|
Estimated
|
Gross
|
Estimated
|
Gross
|
Estimated
|
Gross
|
|||||||||||||||||||
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
Fair
|
Unrealized
|
|||||||||||||||||||
| Value | Losses | Value | Losses | Value | Losses | |||||||||||||||||||
| (In millions, except number of securities) | ||||||||||||||||||||||||
|
Fixed Maturity Securities:
|
||||||||||||||||||||||||
|
U.S. corporate securities
|
$ | 22,954 | $ | 447 | $ | 8,319 | $ | 1,155 | $ | 31,273 | $ | 1,602 | ||||||||||||
|
Foreign corporate securities
|
22,415 | 410 | 3,976 | 515 | 26,391 | 925 | ||||||||||||||||||
|
Foreign government securities
|
26,659 | 585 | 189 | 17 | 26,848 | 602 | ||||||||||||||||||
|
RMBS
|
7,588 | 212 | 6,700 | 1,175 | 14,288 | 1,387 | ||||||||||||||||||
|
U.S. Treasury and agency securities
|
13,401 | 530 | 118 | 29 | 13,519 | 559 | ||||||||||||||||||
|
CMBS
|
3,787 | 29 | 1,363 | 249 | 5,150 | 278 | ||||||||||||||||||
|
ABS
|
2,713 | 42 | 3,026 | 667 | 5,739 | 709 | ||||||||||||||||||
|
State and political subdivision securities
|
5,061 | 246 | 988 | 272 | 6,049 | 518 | ||||||||||||||||||
|
Other fixed maturity securities
|
1 | — | — | — | 1 | — | ||||||||||||||||||
|
Total fixed maturity securities
|
$ | 104,579 | $ | 2,501 | $ | 24,679 | $ | 4,079 | $ | 129,258 | $ | 6,580 | ||||||||||||
|
Equity Securities:
|
||||||||||||||||||||||||
|
Common stock
|
$ | 89 | $ | 12 | $ | 1 | $ | — | $ | 90 | $ | 12 | ||||||||||||
|
Non-redeemable preferred stock
|
191 | 9 | 824 | 220 | 1,015 | 229 | ||||||||||||||||||
|
Total equity securities
|
$ | 280 | $ | 21 | $ | 825 | $ | 220 | $ | 1,105 | $ | 241 | ||||||||||||
|
Total number of securities in an unrealized loss position
|
5,609 | 1,704 | ||||||||||||||||||||||
24
| March 31, 2011 | ||||||||||||||||||||||||
| Cost or Amortized Cost | Gross Unrealized Losses | Number of Securities | ||||||||||||||||||||||
|
Less than
|
20% or
|
Less than
|
20% or
|
Less than
|
20% or
|
|||||||||||||||||||
| 20% | more | 20% | more | 20% | more | |||||||||||||||||||
| (In millions, except number of securities) | ||||||||||||||||||||||||
|
Fixed Maturity Securities:
|
||||||||||||||||||||||||
|
Less than six months
|
$ | 106,912 | $ | 1,821 | $ | 2,990 | $ | 446 | 5,432 | 123 | ||||||||||||||
|
Six months or greater but less than nine months
|
2,300 | 186 | 156 | 63 | 291 | 13 | ||||||||||||||||||
|
Nine months or greater but less than twelve months
|
740 | 159 | 20 | 53 | 59 | 11 | ||||||||||||||||||
|
Twelve months or greater
|
19,740 | 3,776 | 1,640 | 1,228 | 1,171 | 227 | ||||||||||||||||||
|
Total
|
$ | 129,692 | $ | 5,942 | $ | 4,806 | $ | 1,790 | ||||||||||||||||
|
Percentage of amortized cost
|
4 | % | 30 | % | ||||||||||||||||||||
|
Equity Securities:
|
||||||||||||||||||||||||
|
Less than six months
|
$ | 245 | $ | 43 | $ | 12 | $ | 18 | 96 | 21 | ||||||||||||||
|
Six months or greater but less than nine months
|
3 | 1 | — | 1 | 4 | 5 | ||||||||||||||||||
|
Nine months or greater but less than twelve months
|
28 | — | 4 | — | 2 | — | ||||||||||||||||||
|
Twelve months or greater
|
604 | 386 | 58 | 119 | 39 | 15 | ||||||||||||||||||
|
Total
|
$ | 880 | $ | 430 | $ | 74 | $ | 138 | ||||||||||||||||
|
Percentage of cost
|
8 | % | 32 | % | ||||||||||||||||||||
25
| December 31, 2010 | ||||||||||||||||||||||||
| Cost or Amortized Cost | Gross Unrealized Losses | Number of Securities | ||||||||||||||||||||||
|
Less than
|
20% or
|
Less than
|
20% or
|
Less than
|
20% or
|
|||||||||||||||||||
| 20% | more | 20% | more | 20% | more | |||||||||||||||||||
| (In millions, except number of securities) | ||||||||||||||||||||||||
|
Fixed Maturity Securities:
|
||||||||||||||||||||||||
|
Less than six months
|
$ | 105,301 | $ | 1,403 | $ | 2,348 | $ | 368 | 5,320 | 121 | ||||||||||||||
|
Six months or greater but less than nine months
|
1,125 | 376 | 29 | 102 | 104 | 29 | ||||||||||||||||||
|
Nine months or greater but less than twelve months
|
371 | 89 | 28 | 27 | 50 | 9 | ||||||||||||||||||
|
Twelve months or greater
|
21,627 | 5,546 | 1,863 | 1,815 | 1,245 | 311 | ||||||||||||||||||
|
Total
|
$ | 128,424 | $ | 7,414 | $ | 4,268 | $ | 2,312 | ||||||||||||||||
|
Percentage of amortized cost
|
3 | % | 31 | % | ||||||||||||||||||||
|
Equity Securities:
|
||||||||||||||||||||||||
|
Less than six months
|
$ | 247 | $ | 94 | $ | 10 | $ | 22 | 106 | 33 | ||||||||||||||
|
Six months or greater but less than nine months
|
29 | 65 | 5 | 16 | 3 | 2 | ||||||||||||||||||
|
Nine months or greater but less than twelve months
|
6 | 47 | — | 16 | 3 | 2 | ||||||||||||||||||
|
Twelve months or greater
|
518 | 340 | 56 | 116 | 35 | 14 | ||||||||||||||||||
|
Total
|
$ | 800 | $ | 546 | $ | 71 | $ | 170 | ||||||||||||||||
|
Percentage of cost
|
9 | % | 31 | % | ||||||||||||||||||||
26
| March 31, 2011 | December 31, 2010 | |||||||
|
Sector:
|
||||||||
|
U.S. corporate securities
|
23 | % | 23 | % | ||||
|
RMBS
|
17 | 20 | ||||||
|
Foreign corporate securities
|
15 | 14 | ||||||
|
U.S. Treasury and agency securities
|
13 | 8 | ||||||
|
Foreign government securities
|
10 | 9 | ||||||
|
ABS
|
9 | 10 | ||||||
|
State and political subdivision securities
|
8 | 8 | ||||||
|
CMBS
|
3 | 4 | ||||||
|
Other
|
2 | 4 | ||||||
|
Total
|
100 | % | 100 | % | ||||
|
Industry:
|
||||||||
|
Mortgage-backed
|
20 | % | 24 | % | ||||
|
Finance
|
17 | 21 | ||||||
|
U.S. Treasury and agency securities
|
13 | 8 | ||||||
|
Foreign government securities
|
10 | 9 | ||||||
|
Asset-backed
|
9 | 10 | ||||||
|
State and political subdivision securities
|
8 | 8 | ||||||
|
Utility
|
6 | 5 | ||||||
|
Consumer
|
6 | 4 | ||||||
|
Communications
|
2 | 2 | ||||||
|
Industrial
|
1 | 2 | ||||||
|
Other
|
8 | 7 | ||||||
|
Total
|
100 | % | 100 | % | ||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Fixed Maturity
|
Equity
|
Fixed Maturity
|
Equity
|
|||||||||||||
| Securities | Securities | Securities | Securities | |||||||||||||
| (In millions, except number of securities) | ||||||||||||||||
|
Number of securities
|
97 | 6 | 107 | 6 | ||||||||||||
|
Total gross unrealized losses
|
$ | 1,885 | $ | 93 | $ | 2,014 | $ | 103 | ||||||||
|
Percentage of total gross unrealized losses
|
29 | % | 44 | % | 31 | % | 43 | % | ||||||||
27
| Non-Redeemable Preferred Stock | ||||||||||||||||||||||||||||||||
|
All Types of
|
||||||||||||||||||||||||||||||||
|
All Equity
|
Non-Redeemable
|
Investment Grade | ||||||||||||||||||||||||||||||
| Securities | Preferred Stock | All Industries | Financial Services Industry | |||||||||||||||||||||||||||||
|
Gross
|
Gross
|
% of All
|
Gross
|
% of All
|
Gross
|
% A
|
||||||||||||||||||||||||||
|
Unrealized
|
Unrealized
|
Equity
|
Unrealized
|
Non-Redeemable
|
Unrealized
|
% of All
|
Rated or
|
|||||||||||||||||||||||||
| Losses | Losses | Securities | Losses | Preferred Stock | Losses | Industries | Better | |||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
|
Less than six months
|
$ | 18 | $ | 5 | 28 | % | $ | 5 | 100 | % | $ | 5 | 100 | % | 100 | % | ||||||||||||||||
|
Six months or greater but less than twelve months
|
1 | — | — | % | — | — | % | — | — | % | — | % | ||||||||||||||||||||
|
Twelve months or greater
|
119 | 119 | 100 | % | 118 | 99 | % | 118 | 100 | % | 80 | % | ||||||||||||||||||||
|
All equity securities with
gross unrealized losses of 20% or more |
$ | 138 | $ | 124 | 90 | % | $ | 123 | 99 | % | $ | 123 | 100 | % | 80 | % | ||||||||||||||||
28
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Total gains (losses) on fixed maturity securities:
|
||||||||
|
Total OTTI losses recognized
|
$ | (132 | ) | $ | (151 | ) | ||
|
Less: Noncredit portion of OTTI losses transferred to and
recognized in other comprehensive income (loss)
|
9 | 59 | ||||||
|
Net OTTI losses on fixed maturity securities recognized in
earnings
|
(123 | ) | (92 | ) | ||||
|
Fixed maturity securities — net gains (losses) on
sales and disposals
|
(40 | ) | 26 | |||||
|
Total gains (losses) on fixed maturity securities
|
(163 | ) | (66 | ) | ||||
|
Other net investment gains (losses):
|
||||||||
|
Equity securities
|
36 | 27 | ||||||
|
Mortgage loans
|
47 | (28 | ) | |||||
|
Real estate and real estate joint ventures
|
1 | (22 | ) | |||||
|
Other limited partnership interests
|
3 | (1 | ) | |||||
|
Other investment portfolio gains (losses)
|
4 | 58 | ||||||
|
Subtotal — investment portfolio gains (losses)
|
(72 | ) | (32 | ) | ||||
|
Fair value option (“FVO”) consolidated securitization
entities — changes in estimated fair value included in
net investment gains (losses):
|
||||||||
|
Commercial mortgage loans
|
18 | 481 | ||||||
|
Securities
|
(40 | ) | (4 | ) | ||||
|
Long-term debt — related to commercial mortgage loans
|
— | (479 | ) | |||||
|
Long-term debt — related to securities
|
47 | 12 | ||||||
|
Other gains (losses) (1)
|
(52 | ) | 54 | |||||
|
Subtotal FVO consolidated securitization entities and other
gains (losses)
|
(27 | ) | 64 | |||||
|
Total net investment gains (losses)
|
$ | (99 | ) | $ | 32 | |||
| (1) | Other gains (losses) for the three months ended March 31, 2011 includes a loss of $80 million related to the sale of the Company’s investment in MSI MetLife. See Note 2. |
29
| Three Months Ended March 31, | ||||||||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | 2011 | 2010 | |||||||||||||||||||
| Fixed Maturity Securities | Equity Securities | Total | ||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Proceeds
|
$ | 16,532 | $ | 8,372 | $ | 316 | $ | 145 | $ | 16,848 | $ | 8,517 | ||||||||||||
|
Gross investment gains
|
$ | 193 | $ | 164 | $ | 48 | $ | 31 | $ | 241 | $ | 195 | ||||||||||||
|
Gross investment losses
|
(233 | ) | (138 | ) | (6 | ) | (3 | ) | (239 | ) | (141 | ) | ||||||||||||
|
Total OTTI losses recognized in earnings:
|
||||||||||||||||||||||||
|
Credit-related
|
(43 | ) | (86 | ) | — | — | (43 | ) | (86 | ) | ||||||||||||||
|
Other (1)
|
(80 | ) | (6 | ) | (6 | ) | (1 | ) | (86 | ) | (7 | ) | ||||||||||||
|
Total OTTI losses recognized in earnings
|
(123 | ) | (92 | ) | (6 | ) | (1 | ) | (129 | ) | (93 | ) | ||||||||||||
|
Net investment gains (losses)
|
$ | (163 | ) | $ | (66 | ) | $ | 36 | $ | 27 | $ | (127 | ) | $ | (39 | ) | ||||||||
| (1) | Other OTTI losses recognized in earnings include impairments on equity securities, impairments on perpetual hybrid securities classified within fixed maturity securities where the primary reason for the impairment was the severity and/or the duration of an unrealized loss position and fixed maturity securities where there is an intent to sell or it is more likely than not that the Company will be required to sell the security before recovery of the decline in estimated fair value. |
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Sector:
|
||||||||
|
U.S. and foreign corporate securities — by industry:
|
||||||||
|
Communications
|
$ | 13 | $ | 3 | ||||
|
Consumer
|
2 | 22 | ||||||
|
Utility
|
1 | — | ||||||
|
Finance
|
1 | 8 | ||||||
|
Total U.S. and foreign corporate securities
|
17 | 33 | ||||||
|
Foreign government securities
|
76 | — | ||||||
|
RMBS
|
18 | 30 | ||||||
|
ABS
|
9 | 19 | ||||||
|
CMBS
|
3 | 10 | ||||||
|
Total
|
$ | 123 | $ | 92 | ||||
30
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Sector:
|
||||||||
|
Common stock
|
$ | 6 | $ | 1 | ||||
|
Industry:
|
||||||||
|
Other industries
|
$ | 6 | $ | 1 | ||||
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Balance, beginning of period
|
$ | 443 | $ | 581 | ||||
|
Additions:
|
||||||||
|
Initial impairments — credit loss OTTI recognized on
securities not previously impaired
|
8 | 19 | ||||||
|
Additional impairments — credit loss OTTI recognized
on securities previously impaired
|
16 | 31 | ||||||
|
Reductions:
|
||||||||
|
Due to sales (maturities, pay downs or prepayments) during the
period of securities previously credit loss OTTI impaired
|
(29 | ) | (104 | ) | ||||
|
Due to securities de-recognized in connection with the adoption
of new guidance related to the consolidation of VIEs
|
— | (100 | ) | |||||
|
Due to securities impaired to net present value of expected
future cash flows
|
(44 | ) | — | |||||
|
Due to increases in cash flows — accretion of previous
credit loss OTTI
|
(5 | ) | (3 | ) | ||||
|
Balance, end of period
|
$ | 389 | $ | 424 | ||||
31
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Investment income:
|
||||||||
|
Fixed maturity securities
|
$ | 3,683 | $ | 3,053 | ||||
|
Equity securities
|
30 | 25 | ||||||
|
Trading and other securities — Actively Traded
Securities and FVO general account securities (1)
|
28 | 15 | ||||||
|
Mortgage loans
|
759 | 673 | ||||||
|
Policy loans
|
160 | 176 | ||||||
|
Real estate and real estate joint ventures
|
156 | 46 | ||||||
|
Other limited partnership interests
|
243 | 265 | ||||||
|
Cash, cash equivalents and short-term investments
|
46 | 18 | ||||||
|
International joint ventures (2)
|
(19 | ) | 17 | |||||
|
Other
|
(32 | ) | 86 | |||||
|
Subtotal
|
5,054 | 4,374 | ||||||
|
Less: Investment expenses
|
252 | 226 | ||||||
|
Subtotal, net
|
4,802 | 4,148 | ||||||
|
Trading and other securities — FVO
contractholder-directed unit-linked investments (1)
|
419 | 64 | ||||||
|
FVO consolidated securitization entities:
|
||||||||
|
Commercial mortgage loans
|
95 | 105 | ||||||
|
Securities
|
1 | 4 | ||||||
|
Subtotal
|
515 | 173 | ||||||
|
Net investment income
|
$ | 5,317 | $ | 4,321 | ||||
| (1) | Changes in estimated fair value subsequent to purchase included in net investment income: |
|
Trading and other securities — Actively Traded
Securities and FVO general account securities
|
$ | 21 | $ | 7 | ||||
|
Trading and other securities— FVO
contractholder-directed unit-linked investments
|
$ | 316 | $ | 57 |
| (2) | Amounts are presented net of changes in estimated fair value of derivatives related to economic hedges of the Company’s investment in these equity method international joint venture investments that do not qualify for hedge accounting of ($23) million and ($32) million for the three months ended March 31, 2011 and 2010, respectively. |
32
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Securities on loan:
|
||||||||
|
Amortized cost
|
$ | 25,689 | $ | 23,715 | ||||
|
Estimated fair value
|
$ | 25,893 | $ | 24,230 | ||||
|
Aging of cash collateral liability:
|
||||||||
|
Open (1)
|
$ | 3,672 | $ | 2,752 | ||||
|
Less than thirty days
|
9,736 | 12,301 | ||||||
|
Thirty days or greater but less than sixty days
|
6,496 | 4,399 | ||||||
|
Sixty days or greater but less than ninety days
|
4,215 | 2,291 | ||||||
|
Ninety days or greater
|
2,346 | 2,904 | ||||||
|
Total cash collateral liability
|
$ | 26,465 | $ | 24,647 | ||||
|
Security collateral on deposit from counterparties
|
$ | 11 | $ | — | ||||
|
Reinvestment portfolio — estimated fair value
|
$ | 26,188 | $ | 24,177 | ||||
| (1) | Open — meaning that the related loaned security could be returned to the Company on the next business day requiring the Company to immediately return the cash collateral. |
33
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Invested assets on deposit:
|
||||||||
|
Regulatory agencies
|
$ | 2,085 | $ | 2,110 | ||||
|
Invested assets held in trust:
|
||||||||
|
Collateral financing arrangements
|
5,550 | 5,340 | ||||||
|
Reinsurance arrangements
|
2,206 | 3,090 | ||||||
|
Invested assets pledged as collateral:
|
||||||||
|
Funding agreements and advances — Federal Home Loan
Bank (“FHLB”) of New York
|
20,878 | 21,975 | ||||||
|
Funding agreements — FHLB of Boston
|
600 | 211 | ||||||
|
Funding agreements — FHLB of Des Moines
|
859 | — | ||||||
|
Funding agreements — Federal Agricultural Mortgage
Corporation
|
3,160 | 3,159 | ||||||
|
Federal Reserve Bank of New York
|
1,633 | 1,822 | ||||||
|
Collateral financing arrangements
|
50 | 112 | ||||||
|
Derivative transactions
|
1,296 | 1,726 | ||||||
|
Short sale agreements
|
575 | 465 | ||||||
|
Total invested assets on deposit, held in trust and pledged as
collateral
|
$ | 38,892 | $ | 40,010 | ||||
34
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Actively Traded Securities
|
$ | 572 | $ | 463 | ||||
|
FVO general account securities
|
173 | 131 | ||||||
|
FVO contractholder-directed unit-linked investments
|
18,459 | 17,794 | ||||||
|
FVO securities held by consolidated securitization entities
|
161 | 201 | ||||||
|
Total trading and other securities — at estimated fair
value
|
$ | 19,365 | $ | 18,589 | ||||
|
Actively Traded Securities — at estimated fair value
|
$ | 572 | $ | 463 | ||||
|
Short sale agreement liabilities — at estimated fair
value
|
(47 | ) | (46 | ) | ||||
|
Net long/short position — at estimated fair value
|
$ | 525 | $ | 417 | ||||
|
Investments pledged to secure short sale agreement liabilities
|
$ | 575 | $ | 465 | ||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Carrying
|
% of
|
Carrying
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Mortgage loans
held-for-investment:
|
||||||||||||||||
|
Commercial
|
$ | 38,087 | 61.6 | % | $ | 37,818 | 60.7 | % | ||||||||
|
Agricultural
|
12,761 | 20.6 | 12,751 | 20.4 | ||||||||||||
|
Residential
|
2,399 | 3.9 | 2,231 | 3.7 | ||||||||||||
|
Subtotal
|
53,247 | 86.1 | 52,800 | 84.8 | ||||||||||||
|
Valuation allowances
|
(621 | ) | (1.0 | ) | (664 | ) | (1.1 | ) | ||||||||
|
Subtotal mortgage loans
held-for-investment,
net
|
52,626 | 85.1 | 52,136 | 83.7 | ||||||||||||
|
Commercial mortgage loans held by consolidated securitization
entities — FVO
|
6,771 | 11.0 | 6,840 | 11.0 | ||||||||||||
|
Total mortgage loans
held-for-investment,
net
|
59,397 | 96.1 | 58,976 | 94.7 | ||||||||||||
|
Mortgage loans
held-for-sale:
|
||||||||||||||||
|
Residential — FVO
|
1,571 | 2.5 | 2,510 | 4.0 | ||||||||||||
|
Agricultural and residential mortgage loans — lower of
amortized cost or estimated fair value
|
864 | 1.4 | 811 | 1.3 | ||||||||||||
|
Total mortgage loans
held-for-sale
|
2,435 | 3.9 | 3,321 | 5.3 | ||||||||||||
|
Total mortgage loans, net
|
$ | 61,832 | 100.0 | % | $ | 62,297 | 100.0 | % | ||||||||
35
| Commercial | Agricultural | Residential | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
March 31, 2011:
|
||||||||||||||||
|
Mortgage loans:
|
||||||||||||||||
|
Evaluated individually for credit losses
|
$ | 160 | $ | 105 | $ | 18 | $ | 283 | ||||||||
|
Evaluated collectively for credit losses
|
37,927 | 12,656 | 2,381 | 52,964 | ||||||||||||
|
Total mortgage loans
|
38,087 | 12,761 | 2,399 | 53,247 | ||||||||||||
|
Valuation allowances:
|
||||||||||||||||
|
Specific credit losses
|
41 | 39 | 1 | 81 | ||||||||||||
|
Non-specifically identified credit losses
|
491 | 37 | 12 | 540 | ||||||||||||
|
Total valuation allowances
|
532 | 76 | 13 | 621 | ||||||||||||
|
Mortgage loans, net of valuation allowance
|
$ | 37,555 | $ | 12,685 | $ | 2,386 | $ | 52,626 | ||||||||
|
December 31, 2010:
|
||||||||||||||||
|
Mortgage loans:
|
||||||||||||||||
|
Evaluated individually for credit losses
|
$ | 120 | $ | 146 | $ | 13 | $ | 279 | ||||||||
|
Evaluated collectively for credit losses
|
37,698 | 12,605 | 2,218 | 52,521 | ||||||||||||
|
Total mortgage loans
|
37,818 | 12,751 | 2,231 | 52,800 | ||||||||||||
|
Valuation allowances:
|
||||||||||||||||
|
Specific credit losses
|
36 | 52 | — | 88 | ||||||||||||
|
Non-specifically identified credit losses
|
526 | 36 | 14 | 576 | ||||||||||||
|
Total valuation allowances
|
562 | 88 | 14 | 664 | ||||||||||||
|
Mortgage loans, net of valuation allowance
|
$ | 37,256 | $ | 12,663 | $ | 2,217 | $ | 52,136 | ||||||||
36
| Mortgage Loan Valuation Allowances | ||||||||||||||||
| Commercial | Agricultural | Residential | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Balance at January 1, 2010
|
$ | 589 | $ | 115 | $ | 17 | $ | 721 | ||||||||
|
Provision (release)
|
35 | 6 | — | 41 | ||||||||||||
|
Charge-offs, net of recoveries
|
— | (11 | ) | — | (11 | ) | ||||||||||
|
Balance at March 31, 2010
|
$ | 624 | $ | 110 | $ | 17 | $ | 751 | ||||||||
|
Balance at January 1, 2011
|
$ | 562 | $ | 88 | $ | 14 | $ | 664 | ||||||||
|
Provision (release)
|
(30 | ) | (9 | ) | — | (39 | ) | |||||||||
|
Charge-offs, net of recoveries
|
— | (3 | ) | (1 | ) | (4 | ) | |||||||||
|
Balance at March 31, 2011
|
$ | 532 | $ | 76 | $ | 13 | $ | 621 | ||||||||
| Recorded Investment | ||||||||||||||||||||||||||||
| Debt Service Coverage Ratios |
Estimated
|
|||||||||||||||||||||||||||
| > 1.20x | 1.00x - 1.20x | < 1.00x | Total | % of Total | Fair Value | % of Total | ||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||||
|
March 31, 2011:
|
||||||||||||||||||||||||||||
|
Loan-to-value
ratios:
|
||||||||||||||||||||||||||||
|
Less than 65%
|
$ | 17,994 | $ | 182 | $ | 338 | $ | 18,514 | 48.6 | % | $ | 19,604 | 49.9 | % | ||||||||||||||
|
65% to 75%
|
9,700 | 554 | 598 | 10,852 | 28.5 | 11,276 | 28.7 | |||||||||||||||||||||
|
76% to 80%
|
2,763 | 321 | 109 | 3,193 | 8.4 | 3,268 | 8.3 | |||||||||||||||||||||
|
Greater than 80%
|
3,858 | 984 | 686 | 5,528 | 14.5 | 5,124 | 13.1 | |||||||||||||||||||||
|
Total
|
$ | 34,315 | $ | 2,041 | $ | 1,731 | $ | 38,087 | 100.0 | % | $ | 39,272 | 100.0 | % | ||||||||||||||
|
December 31, 2010:
|
||||||||||||||||||||||||||||
|
Loan-to-value
ratios:
|
||||||||||||||||||||||||||||
|
Less than 65%
|
$ | 16,663 | $ | 125 | $ | 483 | $ | 17,271 | 45.7 | % | $ | 18,183 | 46.9 | % | ||||||||||||||
|
65% to 75%
|
9,022 | 765 | 513 | 10,300 | 27.2 | 10,685 | 27.6 | |||||||||||||||||||||
|
76% to 80%
|
3,033 | 304 | 135 | 3,472 | 9.2 | 3,535 | 9.1 | |||||||||||||||||||||
|
Greater than 80%
|
4,155 | 1,813 | 807 | 6,775 | 17.9 | 6,374 | 16.4 | |||||||||||||||||||||
|
Total
|
$ | 32,873 | $ | 3,007 | $ | 1,938 | $ | 37,818 | 100.0 | % | $ | 38,777 | 100.0 | % | ||||||||||||||
37
| Agricultural | ||||||||||||||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||
| Recorded Investment | % of Total | Recorded Investment | % of Total | |||||||||||||
| (In millions) | (In millions) | |||||||||||||||
|
Loan-to-value
ratios:
|
||||||||||||||||
|
Less than 65%
|
$ | 11,318 | 88.7 | % | $ | 11,483 | 90.1 | % | ||||||||
|
65% to 75%
|
933 | 7.3 | 885 | 6.9 | ||||||||||||
|
76% to 80%
|
79 | 0.6 | 48 | 0.4 | ||||||||||||
|
Greater than 80%
|
431 | 3.4 | 335 | 2.6 | ||||||||||||
|
Total
|
$ | 12,761 | 100.0 | % | $ | 12,751 | 100.0 | % | ||||||||
| Residential | ||||||||||||||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||
| Recorded Investment | % of Total | Recorded Investment | % of Total | |||||||||||||
| (In millions) | (In millions) | |||||||||||||||
|
Performance indicators:
|
||||||||||||||||
|
Performing
|
$ | 2,360 | 98.4 | % | $ | 2,149 | 96.3 | % | ||||||||
|
Nonperforming
|
39 | 1.6 | 82 | 3.7 | ||||||||||||
|
Total
|
$ | 2,399 | 100.0 | % | $ | 2,231 | 100.0 | % | ||||||||
|
Greater than 90 Days Past Due
|
||||||||||||||||||||||||
| Past Due | Still Accruing Interest | Nonaccrual Status | ||||||||||||||||||||||
| March 31, 2011 | December 31, 2010 | March 31, 2011 | December 31, 2010 | March 31, 2011 | December 31, 2010 | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Commercial
|
$ | 1 | $ | 58 | $ | 1 | $ | 1 | $ | — | $ | 7 | ||||||||||||
|
Agricultural
|
159 | 159 | 38 | 13 | 150 | 177 | ||||||||||||||||||
|
Residential
|
36 | 79 | 17 | 11 | 17 | 25 | ||||||||||||||||||
|
Total
|
$ | 196 | $ | 296 | $ | 56 | $ | 25 | $ | 167 | $ | 209 | ||||||||||||
38
| Impaired Mortgage Loans | ||||||||||||||||||||||||||||||||
|
Loans without
|
||||||||||||||||||||||||||||||||
| Loans with a Valuation Allowance | a Valuation Allowance | All Impaired Loans | ||||||||||||||||||||||||||||||
|
Unpaid
|
Unpaid
|
Unpaid
|
||||||||||||||||||||||||||||||
|
Principal
|
Recorded
|
Valuation
|
Carrying
|
Principal
|
Recorded
|
Principal
|
Carrying
|
|||||||||||||||||||||||||
| Balance | Investment | Allowances | Value | Balance | Investment | Balance | Value | |||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
|
March 31, 2011:
|
||||||||||||||||||||||||||||||||
|
Commercial
|
$ | 160 | $ | 160 | $ | 41 | $ | 119 | $ | 215 | $ | 204 | $ | 375 | $ | 323 | ||||||||||||||||
|
Agricultural
|
105 | 105 | 39 | 66 | 181 | 177 | 286 | 243 | ||||||||||||||||||||||||
|
Residential
|
18 | 18 | 1 | 17 | 20 | 20 | 38 | 37 | ||||||||||||||||||||||||
|
Total
|
$ | 283 | $ | 283 | $ | 81 | $ | 202 | $ | 416 | $ | 401 | $ | 699 | $ | 603 | ||||||||||||||||
|
December 31, 2010:
|
||||||||||||||||||||||||||||||||
|
Commercial
|
$ | 120 | $ | 120 | $ | 36 | $ | 84 | $ | 99 | $ | 87 | $ | 219 | $ | 171 | ||||||||||||||||
|
Agricultural
|
146 | 146 | 52 | 94 | 123 | 119 | 269 | 213 | ||||||||||||||||||||||||
|
Residential
|
3 | 3 | — | 3 | 16 | 16 | 19 | 19 | ||||||||||||||||||||||||
|
Total
|
$ | 269 | $ | 269 | $ | 88 | $ | 181 | $ | 238 | $ | 222 | $ | 507 | $ | 403 | ||||||||||||||||
| Impaired Mortgage Loans | ||||||||||||
| Average Investment | Interest Income Recognized | |||||||||||
| Cash Basis | Accrual Basis | |||||||||||
| (In millions) | ||||||||||||
|
For the Three Months Ended March 31, 2011:
|
||||||||||||
|
Commercial
|
$ | 242 | $ | 3 | $ | 1 | ||||||
|
Agricultural
|
278 | 2 | — | |||||||||
|
Residential
|
19 | — | — | |||||||||
|
Total
|
$ | 539 | $ | 5 | $ | 1 | ||||||
|
For the Three Months Ended March 31, 2010:
|
||||||||||||
|
Commercial
|
$ | 93 | $ | 2 | $ | 1 | ||||||
|
Agricultural
|
280 | 1 | — | |||||||||
|
Residential
|
5 | — | — | |||||||||
|
Total
|
$ | 378 | $ | 3 | $ | 1 | ||||||
39
| March 31, 2011 | December 31, 2010 | |||||||||||||||
| Fixed Maturity Securities | Mortgage Loans | Fixed Maturity Securities | Mortgage Loans | |||||||||||||
| (In millions) | ||||||||||||||||
|
Outstanding principal and interest balance (1)
|
$ | 1,783 | $ | 513 | $ | 1,548 | $ | 504 | ||||||||
|
Carrying value (2)
|
$ | 1,235 | $ | 204 | $ | 1,050 | $ | 195 | ||||||||
| (1) | Represents the contractually required payments which is the sum of contractual principal, whether or not currently due, and accrued interest. | |
| (2) | Estimated fair value plus accrued interest for fixed maturity securities and amortized cost, plus accrued interest, less any valuation allowances for mortgage loans. |
| Three Months Ended March 31, | ||||||||||||||||
| 2011 | 2010 | |||||||||||||||
| Fixed Maturity Securities | Mortgage Loans | Fixed Maturity Securities | Mortgage Loans | |||||||||||||
| (In millions) | ||||||||||||||||
|
Contractually required payments (including interest)
|
$ | 399 | $ | — | $ | 177 | $ | — | ||||||||
|
Cash flows expected to be collected (1)
|
$ | 368 | $ | — | $ | 171 | $ | — | ||||||||
|
Fair value of investments acquired
|
$ | 236 | $ | — | $ | 100 | $ | — | ||||||||
| (1) | Represents undiscounted principal and interest cash flow expectations at the date of acquisition. |
| Three Months Ended March 31, | ||||||||||||||||
| 2011 | 2010 | |||||||||||||||
| Fixed Maturity Securities | Mortgage Loans | Fixed Maturity Securities | Mortgage Loans | |||||||||||||
| (In millions) | ||||||||||||||||
|
Accretable yield, beginning of period
|
$ | 541 | $ | 170 | $ | — | $ | — | ||||||||
|
Investments purchased
|
132 | — | 71 | — | ||||||||||||
|
Accretion recognized in net investment income
|
(17 | ) | (12 | ) | (1 | ) | — | |||||||||
|
Disposals
|
(51 | ) | — | — | — | |||||||||||
|
Reclassification (to) from nonaccretable difference
|
103 | 18 | — | — | ||||||||||||
|
Accretable yield, end of period
|
$ | 708 | $ | 176 | $ | 70 | $ | — | ||||||||
40
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Total
|
Total
|
Total
|
Total
|
|||||||||||||
| Assets | Liabilities | Assets | Liabilities | |||||||||||||
| (In millions) | ||||||||||||||||
|
Consolidated securitization entities (1)
|
$ | 7,023 | $ | 6,774 | $ | 7,114 | $ | 6,892 | ||||||||
|
MRSC collateral financing arrangement (2)
|
3,464 | — | 3,333 | — | ||||||||||||
|
Other limited partnership interests
|
333 | 38 | 319 | 85 | ||||||||||||
|
Trading and other securities
|
198 | — | 186 | — | ||||||||||||
|
Other invested assets
|
108 | 1 | 108 | 1 | ||||||||||||
|
Real estate joint ventures
|
17 | 17 | 20 | 17 | ||||||||||||
|
Total
|
$ | 11,143 | $ | 6,830 | $ | 11,080 | $ | 6,995 | ||||||||
| (1) | The Company consolidated former qualified special purpose entities (“QSPEs”) that are structured as CMBS and former QSPEs that are structured as collateralized debt obligations. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company or any of its subsidiaries or affiliates liable for any principal or interest shortfalls should any arise. The Company’s exposure is limited to that of its remaining investment in the former QSPEs of $222 million and $201 million at estimated fair value at March 31, 2011 and December 31, 2010, respectively. The long-term debt referred to below bears interest at primarily fixed rates ranging from 2.25% to 5.57%, payable primarily on a monthly basis and is expected to be repaid over the next 7 years. Interest expense related to these obligations, included in other expenses, was $92 million and $106 million for the three months ended March 31, 2011 and 2010, respectively. The assets and liabilities of these CSEs were as follows at: |
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Total
|
Total
|
Total
|
Total
|
|||||||||||||
| Assets | Liabilities | Assets | Liabilities | |||||||||||||
| (In millions) | ||||||||||||||||
|
Mortgage loans
held-for-investment
(commercial mortgage loans)
|
$ | 6,771 | $ | — | $ | 6,840 | $ | — | ||||||||
|
Trading and other securities
|
161 | — | 201 | — | ||||||||||||
|
Cash and cash equivalents
|
59 | — | 39 | — | ||||||||||||
|
Accrued investment income
|
32 | — | 34 | — | ||||||||||||
|
Long-term debt
|
— | 6,684 | — | 6,820 | ||||||||||||
|
Other liabilities
|
— | 90 | — | 72 | ||||||||||||
|
Total
|
$ | 7,023 | $ | 6,774 | $ | 7,114 | $ | 6,892 | ||||||||
41
| (2) | See Note 12 of the Notes to the Consolidated Financial Statements included in the 2010 Annual Report for a description of the MetLife Reinsurance Company of South Carolina (“MRSC”) collateral financing arrangement. These assets consist of the following, at estimated fair value at: |
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Fixed maturity securities
available-for-sale:
|
||||||||
|
ABS
|
$ | 1,470 | $ | 1,333 | ||||
|
U.S. corporate securities
|
657 | 893 | ||||||
|
RMBS
|
489 | 547 | ||||||
|
CMBS
|
450 | 383 | ||||||
|
Foreign corporate securities
|
201 | 139 | ||||||
|
U.S. Treasury and agency securities
|
15 | — | ||||||
|
State and political subdivision securities
|
30 | 30 | ||||||
|
Foreign government securities
|
— | 5 | ||||||
|
Cash and cash equivalents
|
152 | 3 | ||||||
|
Total
|
$ | 3,464 | $ | 3,333 | ||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Maximum
|
Maximum
|
|||||||||||||||
|
Carrying
|
Exposure
|
Carrying
|
Exposure
|
|||||||||||||
| Amount | to Loss (1) | Amount | to Loss (1) | |||||||||||||
| (In millions) | ||||||||||||||||
|
Fixed maturity securities
available-for-sale:
|
||||||||||||||||
|
RMBS (2)
|
$ | 45,007 | $ | 45,007 | $ | 44,733 | $ | 44,733 | ||||||||
|
CMBS (2)
|
19,785 | 19,785 | 20,675 | 20,675 | ||||||||||||
|
ABS (2)
|
14,990 | 14,990 | 14,287 | 14,287 | ||||||||||||
|
Foreign corporate securities
|
3,158 | 3,158 | 2,950 | 2,950 | ||||||||||||
|
U.S. corporate securities
|
2,658 | 2,658 | 2,435 | 2,435 | ||||||||||||
|
Other limited partnership interests
|
4,394 | 6,370 | 4,383 | 6,479 | ||||||||||||
|
Trading and other securities
|
793 | 793 | 789 | 789 | ||||||||||||
|
Other invested assets
|
542 | 759 | 576 | 773 | ||||||||||||
|
Mortgage loans
|
422 | 422 | 350 | 350 | ||||||||||||
|
Real estate joint ventures
|
58 | 106 | 40 | 108 | ||||||||||||
|
Equity securities
available-for-sale:
|
||||||||||||||||
|
Non-redeemable preferred stock
|
34 | 34 | — | — | ||||||||||||
|
Total
|
$ | 91,841 | $ | 94,082 | $ | 91,218 | $ | 93,579 | ||||||||
| (1) | The maximum exposure to loss relating to the fixed maturity, equity and trading and other securities is equal to the carrying amounts or carrying amounts of retained interests. The maximum exposure to loss relating to the other limited partnership interests and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments of the Company. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee. The maximum exposure to loss relating to the mortgage loans is equal to the carrying amounts plus any unfunded commitments of the Company. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by a creditworthy third-party. For such investments, the |
42
| maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by amounts guaranteed by third parties of $234 million and $231 million at March 31, 2011 and December 31, 2010, respectively. | ||
| (2) | For these variable interests, the Company’s involvement is limited to that of a passive investor. |
| 4. | Derivative Financial Instruments |
43
44
45
| March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||||
|
Estimated Fair
|
Estimated Fair
|
|||||||||||||||||||||||||
|
Primary Underlying
|
Notional
|
Value (1) |
Notional
|
Value (1) | ||||||||||||||||||||||
| Risk Exposure | Instrument Type | Amount | Assets | Liabilities | Amount | Assets | Liabilities | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
|
Interest rate
|
Interest rate swaps | $ | 60,526 | $ | 2,287 | $ | 1,557 | $ | 54,803 | $ | 2,654 | $ | 1,516 | |||||||||||||
| Interest rate floors | 23,866 | 492 | 54 | 23,866 | 630 | 66 | ||||||||||||||||||||
| Interest rate caps | 36,726 | 232 | — | 35,412 | 176 | 1 | ||||||||||||||||||||
| Interest rate futures | 10,697 | 8 | 5 | 9,385 | 43 | 17 | ||||||||||||||||||||
| Interest rate options | 8,391 | 121 | 28 | 8,761 | 144 | 23 | ||||||||||||||||||||
| Interest rate forwards | 7,742 | 22 | 142 | 10,374 | 106 | 135 | ||||||||||||||||||||
| Synthetic GICs | 4,365 | — | — | 4,397 | — | — | ||||||||||||||||||||
|
Foreign currency
|
Foreign currency swaps | 17,194 | 1,341 | 1,334 | 17,626 | 1,616 | 1,282 | |||||||||||||||||||
| Foreign currency forwards | 10,830 | 61 | 173 | 10,443 | 119 | 91 | ||||||||||||||||||||
| Currency futures | 476 | — | — | 493 | 2 | — | ||||||||||||||||||||
| Currency options | 2,346 | 33 | 5 | 5,426 | 50 | — | ||||||||||||||||||||
| Non-derivative hedging instruments (2) | — | — | — | 169 | — | 185 | ||||||||||||||||||||
|
Credit
|
Credit default swaps | 12,013 | 146 | 116 | 10,957 | 173 | 104 | |||||||||||||||||||
| Credit forwards | 120 | 1 | 6 | 90 | 2 | 3 | ||||||||||||||||||||
|
Equity market
|
Equity futures | 5,761 | 3 | 37 | 8,794 | 21 | 9 | |||||||||||||||||||
| Equity options | 14,920 | 1,447 | 352 | 33,688 | 1,843 | 1,197 | ||||||||||||||||||||
| Variance swaps | 17,635 | 150 | 155 | 18,022 | 198 | 118 | ||||||||||||||||||||
| Total rate of return swaps | 1,694 | — | 3 | 1,547 | — | — | ||||||||||||||||||||
|
Total
|
$ | 235,302 | $ | 6,344 | $ | 3,967 | $ | 254,253 | $ | 7,777 | $ | 4,747 | ||||||||||||||
| (1) | The estimated fair value of all derivatives in an asset position is reported within other invested assets in the consolidated balance sheets and the estimated fair value of all derivatives in a liability position is reported within other liabilities in the consolidated balance sheets. | |
| (2) | The estimated fair value of non-derivative hedging instruments represents the amortized cost of the instruments, as adjusted for foreign currency transaction gains or losses. Non-derivative hedging instruments are reported within policyholder account balances in the consolidated balance sheets. |
46
47
48
49
| March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||
|
Notional
|
Estimated Fair Value |
Notional
|
Estimated Fair Value | |||||||||||||||||||||
| Derivatives Designated as Hedging Instruments | Amount | Assets | Liabilities | Amount | Assets | Liabilities | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Fair value hedges:
|
||||||||||||||||||||||||
|
Foreign currency swaps
|
$ | 3,658 | $ | 871 | $ | 73 | $ | 4,524 | $ | 907 | $ | 145 | ||||||||||||
|
Interest rate swaps
|
5,292 | 765 | 179 | 5,108 | 823 | 169 | ||||||||||||||||||
|
Subtotal
|
8,950 | 1,636 | 252 | 9,632 | 1,730 | 314 | ||||||||||||||||||
|
Cash flow hedges:
|
||||||||||||||||||||||||
|
Foreign currency swaps
|
6,062 | 164 | 382 | 5,556 | 213 | 347 | ||||||||||||||||||
|
Interest rate swaps
|
5,017 | 63 | 140 | 3,562 | 102 | 116 | ||||||||||||||||||
|
Interest rate forwards
|
1,140 | — | 120 | 1,140 | — | 107 | ||||||||||||||||||
|
Credit forwards
|
120 | 1 | 6 | 90 | 2 | 3 | ||||||||||||||||||
|
Subtotal
|
12,339 | 228 | 648 | 10,348 | 317 | 573 | ||||||||||||||||||
|
Foreign operations hedges:
|
||||||||||||||||||||||||
|
Foreign currency forwards
|
1,832 | 2 | 37 | 1,935 | 9 | 26 | ||||||||||||||||||
|
Non-derivative hedging instruments
|
— | — | — | 169 | — | 185 | ||||||||||||||||||
|
Subtotal
|
1,832 | 2 | 37 | 2,104 | 9 | 211 | ||||||||||||||||||
|
Total qualifying hedges
|
$ | 23,121 | $ | 1,866 | $ | 937 | $ | 22,084 | $ | 2,056 | $ | 1,098 | ||||||||||||
| March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||
|
Derivatives Not Designated or Not
|
Notional
|
Estimated Fair Value |
Notional
|
Estimated Fair Value | ||||||||||||||||||||
| Qualifying as Hedging Instruments | Amount | Assets | Liabilities | Amount | Assets | Liabilities | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Interest rate swaps
|
$ | 50,217 | $ | 1,459 | $ | 1,238 | $ | 46,133 | $ | 1,729 | $ | 1,231 | ||||||||||||
|
Interest rate floors
|
23,866 | 492 | 54 | 23,866 | 630 | 66 | ||||||||||||||||||
|
Interest rate caps
|
36,726 | 232 | — | 35,412 | 176 | 1 | ||||||||||||||||||
|
Interest rate futures
|
10,697 | 8 | 5 | 9,385 | 43 | 17 | ||||||||||||||||||
|
Interest rate options
|
8,391 | 121 | 28 | 8,761 | 144 | 23 | ||||||||||||||||||
|
Interest rate forwards
|
6,602 | 22 | 22 | 9,234 | 106 | 28 | ||||||||||||||||||
|
Synthetic GICs
|
4,365 | — | — | 4,397 | — | — | ||||||||||||||||||
|
Foreign currency swaps
|
7,474 | 306 | 879 | 7,546 | 496 | 790 | ||||||||||||||||||
|
Foreign currency forwards
|
8,998 | 59 | 136 | 8,508 | 110 | 65 | ||||||||||||||||||
|
Currency futures
|
476 | — | — | 493 | 2 | — | ||||||||||||||||||
|
Currency options
|
2,346 | 33 | 5 | 5,426 | 50 | — | ||||||||||||||||||
|
Credit default swaps
|
12,013 | 146 | 116 | 10,957 | 173 | 104 | ||||||||||||||||||
|
Equity futures
|
5,761 | 3 | 37 | 8,794 | 21 | 9 | ||||||||||||||||||
|
Equity options
|
14,920 | 1,447 | 352 | 33,688 | 1,843 | 1,197 | ||||||||||||||||||
|
Variance swaps
|
17,635 | 150 | 155 | 18,022 | 198 | 118 | ||||||||||||||||||
|
Total rate of return swaps
|
1,694 | — | 3 | 1,547 | — | — | ||||||||||||||||||
|
Total non-designated or non-qualifying derivatives
|
$ | 212,181 | $ | 4,478 | $ | 3,030 | $ | 232,169 | $ | 5,721 | $ | 3,649 | ||||||||||||
50
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Derivatives and hedging gains (losses) (1)
|
$ | (1,258 | ) | $ | (481 | ) | ||
|
Embedded derivatives
|
943 | 522 | ||||||
|
Total net derivative gains (losses)
|
$ | (315 | ) | $ | 41 | |||
| (1) | Includes foreign currency transaction gains (losses) on hedged items in cash flow and non-qualifying hedge relationships, which are not presented elsewhere in this note. |
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Qualifying hedges:
|
||||||||
|
Net investment income
|
$ | 22 | $ | 23 | ||||
|
Interest credited to policyholder account balances
|
61 | 61 | ||||||
|
Other expenses
|
(1 | ) | (2 | ) | ||||
|
Non-qualifying hedges:
|
||||||||
|
Net investment income
|
(1 | ) | — | |||||
|
Net derivative gains (losses)
|
(27 | ) | 30 | |||||
|
Other revenues
|
15 | 29 | ||||||
|
Policyholder benefits and claims
|
2 | — | ||||||
|
Total
|
$ | 71 | $ | 141 | ||||
51
|
Net Derivative
|
Net Derivative
|
Ineffectiveness
|
||||||||||||
|
Gains (Losses)
|
Gains (Losses)
|
Recognized in
|
||||||||||||
|
Derivatives in Fair Value
|
Hedged Items in Fair Value
|
Recognized
|
Recognized for
|
Net Derivative
|
||||||||||
| Hedging Relationships | Hedging Relationships | for Derivatives | Hedged Items | Gains (Losses) | ||||||||||
| (In millions) | ||||||||||||||
|
For the Three Months Ended March 31, 2011:
|
||||||||||||||
|
Interest rate swaps:
|
Fixed maturity securities | $ | 11 | $ | (10 | ) | $ | 1 | ||||||
| Policyholder account balances (1) | (114 | ) | 116 | 2 | ||||||||||
|
Foreign currency swaps:
|
Foreign-denominated fixed maturity securities | (1 | ) | 1 | — | |||||||||
| Foreign-denominated policyholder account balances (2) | 77 | (87 | ) | (10 | ) | |||||||||
|
Total
|
$ | (27 | ) | $ | 20 | $ | (7 | ) | ||||||
|
For the Three Months Ended March 31, 2010:
|
||||||||||||||
|
Interest rate swaps:
|
Fixed maturity securities | $ | (5 | ) | $ | 6 | $ | 1 | ||||||
| Policyholder account balances (1) | 33 | (33 | ) | — | ||||||||||
|
Foreign currency swaps:
|
Foreign-denominated fixed maturity securities | 11 | (11 | ) | — | |||||||||
| Foreign-denominated policyholder account balances (2) | (159 | ) | 149 | (10 | ) | |||||||||
|
Total
|
$ | (120 | ) | $ | 111 | $ | (9 | ) | ||||||
| (1) | Fixed rate liabilities | |
| (2) | Fixed rate or floating rate liabilities |
52
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Accumulated other comprehensive income (loss), balance at
beginning of period
|
$ | (59 | ) | $ | (76 | ) | ||
|
Gains (losses) deferred in other comprehensive income (loss) on
the effective portion of cash flow hedges
|
(185 | ) | 51 | |||||
|
Amounts reclassified to net derivative gains (losses)
|
4 | 68 | ||||||
|
Amounts reclassified to net investment income
|
1 | 1 | ||||||
|
Amounts reclassified to other expenses
|
2 | — | ||||||
|
Accumulated other comprehensive income (loss), balance at end of
period
|
$ | (237 | ) | $ | 44 | |||
|
Amount of Gains
|
Amount and Location
|
|||||||||||||||||||||||
|
(Losses) Deferred
|
of Gains (Losses)
|
Amount and Location
|
||||||||||||||||||||||
|
in Accumulated Other
|
Reclassified from
|
of Gains (Losses)
|
||||||||||||||||||||||
|
Derivatives in Cash Flow
|
Comprehensive Income
|
Accumulated Other Comprehensive
|
Recognized in Income (Loss)
|
|||||||||||||||||||||
| Hedging Relationships | (Loss) on Derivatives | Income (Loss) into Income (Loss) | on Derivatives | |||||||||||||||||||||
|
(Ineffective Portion and
|
||||||||||||||||||||||||
|
Amount Excluded from
|
||||||||||||||||||||||||
| (Effective Portion) | (Effective Portion) | Effectiveness Testing) | ||||||||||||||||||||||
|
Net Derivative
|
Net Investment
|
Other
|
Net Derivative
|
Net Investment
|
||||||||||||||||||||
| Gains (Losses) | Income | Expenses | Gains (Losses) | Income | ||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
For the Three Months Ended March 31, 2011:
|
||||||||||||||||||||||||
|
Interest rate swaps
|
$ | (63 | ) | $ | — | $ | — | $ | (2 | ) | $ | — | $ | — | ||||||||||
|
Foreign currency swaps
|
(104 | ) | (4 | ) | (2 | ) | — | (1 | ) | — | ||||||||||||||
|
Interest rate forwards
|
(15 | ) | — | 1 | — | 2 | — | |||||||||||||||||
|
Credit forwards
|
(3 | ) | — | — | — | — | — | |||||||||||||||||
|
Total
|
$ | (185 | ) | $ | (4 | ) | $ | (1 | ) | $ | (2 | ) | $ | 1 | $ | — | ||||||||
|
For the Three Months Ended March 31, 2010:
|
||||||||||||||||||||||||
|
Interest rate swaps
|
$ | 1 | $ | — | $ | — | $ | — | $ | 2 | $ | — | ||||||||||||
|
Foreign currency swaps
|
47 | (68 | ) | (2 | ) | — | 1 | — | ||||||||||||||||
|
Interest rate forwards
|
— | — | 1 | — | — | — | ||||||||||||||||||
|
Credit forwards
|
3 | — | — | — | — | — | ||||||||||||||||||
|
Total
|
$ | 51 | $ | (68 | ) | $ | (1 | ) | $ | — | $ | 3 | $ | — | ||||||||||
53
|
Amount and Location
|
||||||||
|
of Gains (Losses)
|
||||||||
|
Reclassified From Accumulated Other
|
||||||||
|
Amount of Gains (Losses)
|
Comprehensive Income
|
|||||||
|
Deferred in Accumulated
|
(Loss) into Income (Loss)
|
|||||||
|
Derivatives and Non-Derivative Hedging Instruments in Net
|
Other Comprehensive Income (Loss)
|
(Effective Portion) | ||||||
| Investment Hedging Relationships (1),(2) | (Effective Portion) | Net Investment Gains (Losses) | ||||||
| (In millions) | ||||||||
|
For the Three Months Ended March 31, 2011:
|
||||||||
|
Foreign currency forwards
|
$ | (56 | ) | $ | — | |||
|
Non-derivative hedging instruments
|
6 | — | ||||||
|
Total
|
$ | (50 | ) | $ | — | |||
|
For the Three Months Ended March 31, 2010:
|
||||||||
|
Foreign currency forwards
|
$ | (10 | ) | $ | — | |||
|
Non-derivative hedging instruments
|
— | — | ||||||
|
Total
|
$ | (10 | ) | $ | — | |||
| (1) | There were no sales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from accumulated other comprehensive income (loss) into earnings during the periods presented. | |
| (2) | There was no ineffectiveness recognized for the Company’s hedges of net investments in foreign operations. |
54
|
Net
|
Net
|
Policyholder
|
||||||||||||||||||
|
Derivative
|
Investment
|
Benefits and
|
Other
|
Other
|
||||||||||||||||
| Gains (Losses) | Income (1) | Claims (2) | Revenues (3) | Expenses (4) | ||||||||||||||||
| (In millions) | ||||||||||||||||||||
|
For the Three Months Ended March 31, 2011:
|
||||||||||||||||||||
|
Interest rate swaps
|
$ | (270 | ) | $ | (1 | ) | $ | — | $ | (48 | ) | $ | — | |||||||
|
Interest rate floors
|
(125 | ) | — | — | — | — | ||||||||||||||
|
Interest rate caps
|
(9 | ) | — | — | — | — | ||||||||||||||
|
Interest rate futures
|
(2 | ) | 1 | — | — | — | ||||||||||||||
|
Equity futures
|
54 | (7 | ) | (102 | ) | — | — | |||||||||||||
|
Foreign currency swaps
|
(121 | ) | — | — | — | — | ||||||||||||||
|
Foreign currency forwards
|
(169 | ) | (9 | ) | — | — | — | |||||||||||||
|
Currency futures
|
9 | — | — | — | — | |||||||||||||||
|
Currency options
|
(32 | ) | — | — | — | — | ||||||||||||||
|
Equity options
|
(419 | ) | (7 | ) | — | — | — | |||||||||||||
|
Interest rate options
|
(27 | ) | — | — | (9 | ) | — | |||||||||||||
|
Interest rate forwards
|
— | — | — | (8 | ) | — | ||||||||||||||
|
Variance swaps
|
(77 | ) | (3 | ) | — | — | — | |||||||||||||
|
Credit default swaps
|
(45 | ) | — | — | — | — | ||||||||||||||
|
Total rate of return swaps
|
(2 | ) | — | — | — | — | ||||||||||||||
|
Total
|
$ | (1,235 | ) | $ | (26 | ) | $ | (102 | ) | $ | (65 | ) | $ | — | ||||||
|
For the Three Months Ended March 31, 2010:
|
||||||||||||||||||||
|
Interest rate swaps
|
$ | 81 | $ | (1 | ) | $ | 3 | $ | 57 | $ | — | |||||||||
|
Interest rate floors
|
(7 | ) | — | — | — | — | ||||||||||||||
|
Interest rate caps
|
(113 | ) | — | — | — | — | ||||||||||||||
|
Interest rate futures
|
(20 | ) | (5 | ) | — | — | — | |||||||||||||
|
Equity futures
|
(82 | ) | (11 | ) | (88 | ) | — | — | ||||||||||||
|
Foreign currency swaps
|
58 | — | — | — | — | |||||||||||||||
|
Foreign currency forwards
|
59 | 8 | — | — | — | |||||||||||||||
|
Currency options
|
3 | (1 | ) | — | — | (4 | ) | |||||||||||||
|
Equity options
|
(382 | ) | (22 | ) | — | — | — | |||||||||||||
|
Interest rate options
|
— | — | — | (2 | ) | — | ||||||||||||||
|
Interest rate forwards
|
8 | — | — | (33 | ) | — | ||||||||||||||
|
Variance swaps
|
(120 | ) | (3 | ) | — | — | — | |||||||||||||
|
Credit default swaps
|
3 | — | — | — | — | |||||||||||||||
|
Total rate of return swaps
|
12 | — | — | — | — | |||||||||||||||
|
Total
|
$ | (500 | ) | $ | (35 | ) | $ | (85 | ) | $ | 22 | $ | (4 | ) | ||||||
| (1) | Changes in estimated fair value related to economic hedges of equity method investments in joint ventures, and changes in estimated fair value related to derivatives held in relation to trading portfolios. | |
| (2) | Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits. |
55
| (3) | Changes in estimated fair value related to derivatives held in connection with the Company’s mortgage banking activities. | |
| (4) | Changes in estimated fair value related to economic hedges of foreign currency exposure associated with the Company’s international subsidiaries. |
| March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||
|
Maximum
|
Maximum
|
|||||||||||||||||||||||
|
Estimated
|
Amount
|
Estimated
|
Amount of
|
|||||||||||||||||||||
|
Fair Value
|
of Future
|
Weighted
|
Fair Value
|
Future
|
Weighted
|
|||||||||||||||||||
|
of Credit
|
Payments under
|
Average
|
of Credit
|
Payments under
|
Average
|
|||||||||||||||||||
|
Rating Agency Designation of Referenced
|
Default
|
Credit Default
|
Years to
|
Default
|
Credit Default
|
Years to
|
||||||||||||||||||
| Credit Obligations (1) | Swaps | Swaps (2) | Maturity (3) | Swaps | Swaps (2) | Maturity (3) | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Aaa/Aa/A
|
||||||||||||||||||||||||
|
Single name credit default swaps (corporate)
|
$ | 7 | $ | 575 | 3.8 | $ | 5 | $ | 470 | 3.8 | ||||||||||||||
|
Credit default swaps referencing indices
|
48 | 3,128 | 3.6 | 45 | 2,928 | 3.7 | ||||||||||||||||||
|
Subtotal
|
55 | 3,703 | 3.6 | 50 | 3,398 | 3.7 | ||||||||||||||||||
|
Baa
|
||||||||||||||||||||||||
|
Single name credit default swaps (corporate)
|
5 | 860 | 4.3 | 5 | 735 | 4.3 | ||||||||||||||||||
|
Credit default swaps referencing indices
|
11 | 1,496 | 4.8 | 7 | 931 | 5.0 | ||||||||||||||||||
|
Subtotal
|
16 | 2,356 | 4.6 | 12 | 1,666 | 4.7 | ||||||||||||||||||
|
Ba
|
||||||||||||||||||||||||
|
Single name credit default swaps (corporate)
|
— | 40 | 4.5 | — | 25 | 4.4 | ||||||||||||||||||
|
Credit default swaps referencing indices
|
— | — | — | — | — | — | ||||||||||||||||||
|
Subtotal
|
— | 40 | 4.5 | — | 25 | 4.4 | ||||||||||||||||||
|
Total
|
$ | 71 | $ | 6,099 | 4.0 | $ | 62 | $ | 5,089 | 4.1 | ||||||||||||||
| (1) | The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s, S&P and Fitch. If no rating is available from a rating agency, then an internally developed rating is used. | |
| (2) | Assumes the value of the referenced credit obligations is zero. |
56
| (3) | The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts. |
57
|
Estimated Fair Value of
|
Fair Value of Incremental
|
|||||||||||||||||||
| Collateral Provided: | Collateral Provided Upon: | |||||||||||||||||||
|
Downgrade in the
|
||||||||||||||||||||
|
One Notch
|
Company’s Credit Rating
|
|||||||||||||||||||
|
Downgrade
|
to a Level that Triggers
|
|||||||||||||||||||
|
Estimated
|
in the
|
Full Overnight
|
||||||||||||||||||
|
Fair Value (1) of
|
Company’s
|
Collateralization or
|
||||||||||||||||||
|
Derivatives in Net
|
Fixed Maturity
|
Credit
|
Termination of
|
|||||||||||||||||
| Liability Position | Securities (2) | Cash (3) | Rating | the Derivative Position | ||||||||||||||||
| (In millions) | ||||||||||||||||||||
|
March 31, 2011:
|
||||||||||||||||||||
|
Derivatives subject to credit- contingent provisions
|
$ | 954 | $ | 690 | $ | — | $ | 114 | $ | 291 | ||||||||||
|
Derivatives not subject to credit- contingent provisions
|
3 | — | 20 | — | — | |||||||||||||||
|
Total
|
$ | 957 | $ | 690 | $ | 20 | $ | 114 | $ | 291 | ||||||||||
|
December 31, 2010:
|
||||||||||||||||||||
|
Derivatives subject to credit- contingent provisions
|
$ | 1,167 | $ | 1,024 | $ | — | $ | 99 | $ | 231 | ||||||||||
|
Derivatives not subject to credit- contingent provisions
|
22 | — | 43 | — | — | |||||||||||||||
|
Total
|
$ | 1,189 | $ | 1,024 | $ | 43 | $ | 99 | $ | 231 | ||||||||||
| (1) | After taking into consideration the existence of netting agreements. | |
| (2) | Included in fixed maturity securities in the consolidated balance sheets. The counterparties are permitted by contract to sell or repledge this collateral. | |
| (3) | Included in premiums, reinsurance and other receivables in the consolidated balance sheets. |
58
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Net embedded derivatives within asset host contracts:
|
||||||||
|
Ceded guaranteed minimum benefits
|
$ | 162 | $ | 185 | ||||
|
Options embedded in debt or equity securities
|
(75 | ) | (57 | ) | ||||
|
Net embedded derivatives within asset host contracts
|
$ | 87 | $ | 128 | ||||
|
Net embedded derivatives within liability host contracts:
|
||||||||
|
Direct guaranteed minimum benefits
|
$ | 1,636 | $ | 2,556 | ||||
|
Other
|
75 | 78 | ||||||
|
Net embedded derivatives within liability host contracts
|
$ | 1,711 | $ | 2,634 | ||||
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Net derivative gains (losses) (1)
|
$ | 943 | $ | 522 | ||||
|
Policyholder benefits and claims
|
$ | (18 | ) | $ | (21 | ) | ||
| (1) | The valuation of guaranteed minimum benefits includes an adjustment for nonperformance risk. Included in net derivative gains (losses), in connection with this adjustment, were gains (losses) of ($74) million and ($86) million for the three months ended March 31, 2011 and 2010, respectively. |
| 5. | Fair Value |
59
| March 31, 2011 | ||||||||||||||||
| Fair Value Measurements at Reporting Date Using | ||||||||||||||||
|
Quoted Prices in
|
||||||||||||||||
|
Active Markets for
|
Significant
|
Total
|
||||||||||||||
|
Identical Assets
|
Significant Other
|
Unobservable
|
Estimated
|
|||||||||||||
|
and Liabilities
|
Observable Inputs
|
Inputs
|
Fair
|
|||||||||||||
| (Level 1) | (Level 2) | (Level 3) | Value | |||||||||||||
| (In millions) | ||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturity securities:
|
||||||||||||||||
|
U.S. corporate securities
|
$ | — | $ | 86,688 | $ | 6,861 | $ | 93,549 | ||||||||
|
Foreign corporate securities
|
— | 63,163 | 5,534 | 68,697 | ||||||||||||
|
Foreign government securities
|
87 | 41,916 | 3,186 | 45,189 | ||||||||||||
|
RMBS
|
— | 44,736 | 271 | 45,007 | ||||||||||||
|
U.S. Treasury and agency securities
|
16,581 | 18,822 | 76 | 35,479 | ||||||||||||
|
CMBS
|
— | 18,994 | 791 | 19,785 | ||||||||||||
|
ABS
|
— | 10,484 | 4,506 | 14,990 | ||||||||||||
|
State and political subdivision securities
|
— | 10,915 | 46 | 10,961 | ||||||||||||
|
Other fixed maturity securities
|
— | 3 | 4 | 7 | ||||||||||||
|
Total fixed maturity securities
|
16,668 | 295,721 | 21,275 | 333,664 | ||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common stock
|
632 | 1,121 | 359 | 2,112 | ||||||||||||
|
Non-redeemable preferred stock
|
— | 526 | 946 | 1,472 | ||||||||||||
|
Total equity securities
|
632 | 1,647 | 1,305 | 3,584 | ||||||||||||
|
Trading and other securities:
|
||||||||||||||||
|
Actively Traded Securities
|
— | 532 | 40 | 572 | ||||||||||||
|
FVO general account securities
|
— | 111 | 62 | 173 | ||||||||||||
|
FVO contractholder-directed unit-linked investments
|
7,085 | 10,808 | 566 | 18,459 | ||||||||||||
|
FVO securities held by consolidated securitization entities
|
— | 161 | — | 161 | ||||||||||||
|
Total trading and other securities
|
7,085 | 11,612 | 668 | 19,365 | ||||||||||||
|
Short-term investments (1)
|
3,089 | 4,160 | 742 | 7,991 | ||||||||||||
|
Mortgage loans:
|
||||||||||||||||
|
Mortgage loans held by consolidated securitization entities
|
— | 6,771 | — | 6,771 | ||||||||||||
|
Mortgage loans
held-for-sale
(2)
|
— | 1,546 | 25 | 1,571 | ||||||||||||
|
Total mortgage loans
|
— | 8,317 | 25 | 8,342 | ||||||||||||
|
Other invested assets:
|
||||||||||||||||
|
MSRs
|
— | — | 1,029 | 1,029 | ||||||||||||
|
Investment funds
|
297 | 107 | — | 404 | ||||||||||||
|
Derivative assets: (3)
|
||||||||||||||||
|
Interest rate contracts
|
14 | 3,111 | 37 | 3,162 | ||||||||||||
|
Foreign currency contracts
|
— | 1,396 | 39 | 1,435 | ||||||||||||
|
Credit contracts
|
— | 94 | 53 | 147 | ||||||||||||
|
Equity market contracts
|
3 | 1,427 | 170 | 1,600 | ||||||||||||
|
Total derivative assets
|
17 | 6,028 | 299 | 6,344 | ||||||||||||
|
Net embedded derivatives within asset host contracts (4)
|
— | — | 162 | 162 | ||||||||||||
|
Separate account assets (5)
|
27,771 | 166,139 | 2,004 | 195,914 | ||||||||||||
|
Total assets
|
$ | 55,559 | $ | 493,731 | $ | 27,509 | $ | 576,799 | ||||||||
|
Liabilities:
|
||||||||||||||||
|
Derivative liabilities: (3)
|
||||||||||||||||
|
Interest rate contracts
|
$ | 25 | $ | 1,635 | $ | 126 | $ | 1,786 | ||||||||
|
Foreign currency contracts
|
— | 1,512 | — | 1,512 | ||||||||||||
|
Credit contracts
|
— | 112 | 10 | 122 | ||||||||||||
|
Equity market contracts
|
37 | 324 | 186 | 547 | ||||||||||||
|
Total derivative liabilities
|
62 | 3,583 | 322 | 3,967 | ||||||||||||
|
Net embedded derivatives within liability host contracts (4)
|
— | 11 | 1,700 | 1,711 | ||||||||||||
|
Long-term debt of consolidated securitization entities
|
— | 6,546 | 138 | 6,684 | ||||||||||||
|
Trading liabilities (6)
|
47 | — | — | 47 | ||||||||||||
|
Total liabilities
|
$ | 109 | $ | 10,140 | $ | 2,160 | $ | 12,409 | ||||||||
60
| December 31, 2010 | ||||||||||||||||
| Fair Value Measurements at Reporting Date Using | ||||||||||||||||
|
Quoted Prices in
|
||||||||||||||||
|
Active Markets for
|
Significant
|
Total
|
||||||||||||||
|
Identical Assets
|
Significant Other
|
Unobservable
|
Estimated
|
|||||||||||||
|
and Liabilities
|
Observable Inputs
|
Inputs
|
Fair
|
|||||||||||||
| (Level 1) | (Level 2) | (Level 3) | Value | |||||||||||||
| (In millions) | ||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturity securities:
|
||||||||||||||||
|
U.S. corporate securities
|
$ | — | $ | 84,623 | $ | 7,149 | $ | 91,772 | ||||||||
|
Foreign corporate securities
|
— | 62,162 | 5,726 | 67,888 | ||||||||||||
|
Foreign government securities
|
149 | 38,719 | 3,134 | 42,002 | ||||||||||||
|
RMBS
|
274 | 43,037 | 1,422 | 44,733 | ||||||||||||
|
U.S. Treasury and agency securities
|
14,602 | 18,623 | 79 | 33,304 | ||||||||||||
|
CMBS
|
— | 19,664 | 1,011 | 20,675 | ||||||||||||
|
ABS
|
— | 10,142 | 4,145 | 14,287 | ||||||||||||
|
State and political subdivision securities
|
— | 10,083 | 46 | 10,129 | ||||||||||||
|
Other fixed maturity securities
|
— | 3 | 4 | 7 | ||||||||||||
|
Total fixed maturity securities
|
15,025 | 287,056 | 22,716 | 324,797 | ||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common stock
|
831 | 1,094 | 268 | 2,193 | ||||||||||||
|
Non-redeemable preferred stock
|
— | 504 | 905 | 1,409 | ||||||||||||
|
Total equity securities
|
831 | 1,598 | 1,173 | 3,602 | ||||||||||||
|
Trading and other securities:
|
||||||||||||||||
|
Actively Traded Securities
|
— | 453 | 10 | 463 | ||||||||||||
|
FVO general account securities
|
— | 54 | 77 | 131 | ||||||||||||
|
FVO contractholder-directed unit-linked investments
|
6,270 | 10,789 | 735 | 17,794 | ||||||||||||
|
FVO securities held by consolidated securitization entities
|
— | 201 | — | 201 | ||||||||||||
|
Total trading and other securities
|
6,270 | 11,497 | 822 | 18,589 | ||||||||||||
|
Short-term investments (1)
|
3,026 | 4,681 | 858 | 8,565 | ||||||||||||
|
Mortgage loans:
|
||||||||||||||||
|
Mortgage loans held by consolidated securitization entities
|
— | 6,840 | — | 6,840 | ||||||||||||
|
Mortgage loans
held-for-sale
(2)
|
— | 2,486 | 24 | 2,510 | ||||||||||||
|
Total mortgage loans
|
— | 9,326 | 24 | 9,350 | ||||||||||||
|
Other invested assets:
|
||||||||||||||||
|
MSRs
|
— | — | 950 | 950 | ||||||||||||
|
Investment funds
|
373 | 121 | — | 494 | ||||||||||||
|
Derivative assets: (3)
|
||||||||||||||||
|
Interest rate contracts
|
131 | 3,583 | 39 | 3,753 | ||||||||||||
|
Foreign currency contracts
|
2 | 1,711 | 74 | 1,787 | ||||||||||||
|
Credit contracts
|
— | 125 | 50 | 175 | ||||||||||||
|
Equity market contracts
|
23 | 1,757 | 282 | 2,062 | ||||||||||||
|
Total derivative assets
|
156 | 7,176 | 445 | 7,777 | ||||||||||||
|
Net embedded derivatives within asset host contracts(4)
|
— | — | 185 | 185 | ||||||||||||
|
Separate account assets (5)
|
25,566 | 155,589 | 1,983 | 183,138 | ||||||||||||
|
Total assets
|
$ | 51,247 | $ | 477,044 | $ | 29,156 | $ | 557,447 | ||||||||
|
Liabilities:
|
||||||||||||||||
|
Derivative liabilities: (3)
|
||||||||||||||||
|
Interest rate contracts
|
$ | 35 | $ | 1,598 | $ | 125 | $ | 1,758 | ||||||||
|
Foreign currency contracts
|
— | 1,372 | 1 | 1,373 | ||||||||||||
|
Credit contracts
|
— | 101 | 6 | 107 | ||||||||||||
|
Equity market contracts
|
10 | 1,174 | 140 | 1,324 | ||||||||||||
|
Total derivative liabilities
|
45 | 4,245 | 272 | 4,562 | ||||||||||||
|
Net embedded derivatives within liability host contracts (4)
|
— | 11 | 2,623 | 2,634 | ||||||||||||
|
Long-term debt of consolidated securitization entities
|
— | 6,636 | 184 | 6,820 | ||||||||||||
|
Trading liabilities (6)
|
46 | — | — | 46 | ||||||||||||
|
Total liabilities
|
$ | 91 | $ | 10,892 | $ | 3,079 | $ | 14,062 | ||||||||
| (1) | Short-term investments as presented in the tables above differ from the amounts presented in the consolidated balance sheets because certain short-term investments are not measured at estimated fair value (e.g., time deposits, etc.), and therefore are excluded from the tables presented above. |
61
| (2) | Mortgage loans held-for-sale as presented in the tables above differ from the amount presented in the consolidated balance sheets as these tables only include residential mortgage loans held-for-sale measured at estimated fair value on a recurring basis. | |
| (3) | Derivative liabilities are presented within other liabilities in the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation in the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables which follow. At March 31, 2011 and December 31, 2010, certain non-derivative hedging instruments of $0 and $185 million, respectively, which are carried at amortized cost, are included with the liabilities total in Note 4 but excluded from derivative liabilities in the tables above as they are not derivative instruments. | |
| (4) | Net embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables in the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented primarily within policyholder account balances in the consolidated balance sheets. At March 31, 2011, fixed maturity securities and equity securities also included embedded derivatives of $7 million and ($82) million, respectively. At December 31, 2010, fixed maturity securities and equity securities included embedded derivatives of $5 million and ($62) million, respectively. | |
| (5) | Separate account assets are measured at estimated fair value. Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. | |
| (6) | Trading liabilities are presented within other liabilities in the consolidated balance sheets. |
62
63
64
65
66
67
68
69
70
71
72
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||||||||||||||||
| Fixed Maturity Securities: | ||||||||||||||||||||||||||||||||||||
|
U.S.
|
State and
|
Other
|
||||||||||||||||||||||||||||||||||
|
U.S.
|
Foreign
|
Foreign
|
Treasury
|
Political
|
Fixed
|
|||||||||||||||||||||||||||||||
|
Corporate
|
Corporate
|
Government
|
and Agency
|
Subdivision
|
Maturity
|
|||||||||||||||||||||||||||||||
| Securities | Securities | Securities | RMBS | Securities | CMBS | ABS | Securities | Securities | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||
|
Three Months Ended March 31, 2011:
|
||||||||||||||||||||||||||||||||||||
|
Balance, beginning of period
|
$ | 7,149 | $ | 5,726 | $ | 3,134 | $ | 1,422 | $ | 79 | $ | 1,011 | $ | 4,145 | $ | 46 | $ | 4 | ||||||||||||||||||
|
Total realized/unrealized gains (losses) included in:
|
||||||||||||||||||||||||||||||||||||
|
Earnings: (1),(2)
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
3 | 6 | 6 | — | — | (6 | ) | 14 | — | — | ||||||||||||||||||||||||||
|
Net investment gains (losses)
|
— | 13 | (14 | ) | — | — | 45 | (14 | ) | — | — | |||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
48 | 74 | 86 | 3 | — | 99 | 112 | — | — | |||||||||||||||||||||||||||
|
Purchases (3)
|
588 | 621 | 469 | 126 | 1 | 142 | 495 | 4 | — | |||||||||||||||||||||||||||
|
Sales (3)
|
(317 | ) | (646 | ) | (213 | ) | (33 | ) | (3 | ) | (497 | ) | (206 | ) | — | — | ||||||||||||||||||||
|
Transfers into Level 3 (4)
|
88 | 3 | 13 | — | — | 92 | — | — | — | |||||||||||||||||||||||||||
|
Transfers out of Level 3 (4)
|
(698 | ) | (263 | ) | (295 | ) | (1,247 | ) | (1 | ) | (95 | ) | (40 | ) | (4 | ) | — | |||||||||||||||||||
|
Balance, end of period
|
$ | 6,861 | $ | 5,534 | $ | 3,186 | $ | 271 | $ | 76 | $ | 791 | $ | 4,506 | $ | 46 | $ | 4 | ||||||||||||||||||
|
Changes in unrealized gains (losses) relating to assets still
held at March 31, 2011 included in earnings:
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
$ | 3 | $ | 6 | $ | 7 | $ | — | $ | — | $ | (7 | ) | $ | 14 | $ | — | $ | — | |||||||||||||||||
|
Net investment gains (losses)
|
$ | (2 | ) | $ | — | $ | (15 | ) | $ | — | $ | — | $ | 45 | $ | (9 | ) | $ | — | $ | — | |||||||||||||||
73
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||||||||||||||||
| Equity Securities: | Trading and Other Securities: | |||||||||||||||||||||||||||||||||||
|
FVO
|
||||||||||||||||||||||||||||||||||||
|
Non-
|
FVO
|
Contractholder —
|
||||||||||||||||||||||||||||||||||
|
Redeemable
|
Actively
|
General
|
Directed
|
Mortgage
|
Separate
|
|||||||||||||||||||||||||||||||
|
Common
|
Preferred
|
Traded
|
Account
|
Unit-linked
|
Short-term
|
Loans Held-
|
MSRs
|
Account
|
||||||||||||||||||||||||||||
| Stock | Stock | Securities | Securities | Investments | Investments | for-Sale | (5),(6) | Assets (7) | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||
|
Three Months Ended March 31, 2011:
|
||||||||||||||||||||||||||||||||||||
|
Balance, beginning of period
|
$ | 268 | $ | 905 | $ | 10 | $ | 77 | $ | 735 | $ | 858 | $ | 24 | $ | 950 | $ | 1,983 | ||||||||||||||||||
|
Total realized/unrealized gains (losses) included in:
|
||||||||||||||||||||||||||||||||||||
|
Earnings: (1),(2)
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
— | — | 1 | 5 | 30 | 2 | — | — | — | |||||||||||||||||||||||||||
|
Net investment gains (losses)
|
3 | — | — | — | — | (1 | ) | — | — | 50 | ||||||||||||||||||||||||||
|
Other revenues
|
— | — | — | — | — | — | (2 | ) | 58 | — | ||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
18 | 37 | — | — | — | 7 | — | — | — | |||||||||||||||||||||||||||
|
Purchases (3)
|
41 | 1 | 22 | — | 62 | 371 | — | — | 375 | |||||||||||||||||||||||||||
|
Sales (3)
|
(35 | ) | (8 | ) | — | (20 | ) | (248 | ) | (492 | ) | — | — | (227 | ) | |||||||||||||||||||||
|
Issuances (3)
|
— | — | — | — | — | — | — | 54 | — | |||||||||||||||||||||||||||
|
Settlements (3)
|
— | — | — | — | — | — | — | (33 | ) | (1 | ) | |||||||||||||||||||||||||
|
Transfers into Level 3 (4)
|
71 | 11 | 7 | — | 129 | 5 | 5 | — | 20 | |||||||||||||||||||||||||||
|
Transfers out of Level 3 (4)
|
(7 | ) | — | — | — | (142 | ) | (8 | ) | (2 | ) | — | (196 | ) | ||||||||||||||||||||||
|
Balance, end of period
|
$ | 359 | $ | 946 | $ | 40 | $ | 62 | $ | 566 | $ | 742 | $ | 25 | $ | 1,029 | $ | 2,004 | ||||||||||||||||||
|
Changes in unrealized gains (losses) relating to assets still
held at March 31, 2011 included in earnings:
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
$ | — | $ | — | $ | 1 | $ | 8 | $ | (10 | ) | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
|
Net investment gains (losses)
|
$ | 1 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||||
|
Other revenues
|
$ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (2 | ) | $ | 57 | $ | — | |||||||||||||||||
74
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||||
| Net Derivatives: (8) | ||||||||||||||||||||||||
|
Long-term Debt
|
||||||||||||||||||||||||
|
Interest
|
Foreign
|
Equity
|
Net
|
of Consolidated
|
||||||||||||||||||||
|
Rate
|
Currency
|
Credit
|
Market
|
Embedded
|
Securitization
|
|||||||||||||||||||
| Contracts | Contracts | Contracts | Contracts | Derivatives (9) | Entities | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Three Months Ended March 31, 2011:
|
||||||||||||||||||||||||
|
Balance, beginning of period
|
$ | (86 | ) | $ | 73 | $ | 44 | $ | 142 | $ | (2,438 | ) | $ | (184 | ) | |||||||||
|
Total realized/unrealized gains (losses) included in:
|
||||||||||||||||||||||||
|
Earnings: (1),(2)
|
||||||||||||||||||||||||
|
Net investment income
|
— | — | — | (3 | ) | — | — | |||||||||||||||||
|
Net investment gains (losses)
|
— | — | — | — | — | 46 | ||||||||||||||||||
|
Net derivative gains (losses)
|
8 | (8 | ) | 6 | (92 | ) | 975 | — | ||||||||||||||||
|
Other revenues
|
9 | — | — | — | — | — | ||||||||||||||||||
|
Policyholder benefits and claims
|
— | — | — | — | (18 | ) | — | |||||||||||||||||
|
Other expenses
|
— | — | — | — | — | — | ||||||||||||||||||
|
Other comprehensive income (loss)
|
(13 | ) | — | (3 | ) | (1 | ) | 48 | — | |||||||||||||||
|
Purchases (3)
|
— | — | — | 18 | — | — | ||||||||||||||||||
|
Sales (3)
|
— | — | — | — | — | — | ||||||||||||||||||
|
Issuances (3)
|
— | — | (4 | ) | — | — | — | |||||||||||||||||
|
Settlements (3)
|
— | — | — | (5 | ) | (105 | ) | — | ||||||||||||||||
|
Transfers into Level 3 (4)
|
— | — | — | — | — | — | ||||||||||||||||||
|
Transfers out of Level 3 (4)
|
(7 | ) | (26 | ) | — | (75 | ) | — | — | |||||||||||||||
|
Balance, end of period
|
$ | (89 | ) | $ | 39 | $ | 43 | $ | (16 | ) | $ | (1,538 | ) | $ | (138 | ) | ||||||||
|
Changes in unrealized gains (losses) relating to assets and
liabilities still held at March 31, 2011 included in
earnings:
|
||||||||||||||||||||||||
|
Net investment gains (losses)
|
$ | — | $ | — | $ | — | $ | — | $ | — | $ | 46 | ||||||||||||
|
Net derivative gains (losses)
|
$ | 7 | $ | (8 | ) | $ | 6 | $ | (92 | ) | $ | 968 | $ | — | ||||||||||
|
Other revenues
|
$ | 14 | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||
|
Policyholder benefits and claims
|
$ | — | $ | — | $ | — | $ | — | $ | (18 | ) | $ | — | |||||||||||
|
Other expenses
|
$ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||
75
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||||||||||||||||
| Fixed Maturity Securities: | ||||||||||||||||||||||||||||||||||||
|
U.S.
|
State and
|
Other
|
||||||||||||||||||||||||||||||||||
|
U.S.
|
Foreign
|
Foreign
|
Treasury
|
Political
|
Fixed
|
|||||||||||||||||||||||||||||||
|
Corporate
|
Corporate
|
Government
|
and Agency
|
Subdivision
|
Maturity
|
|||||||||||||||||||||||||||||||
| Securities | Securities | Securities | RMBS | Securities | CMBS | ABS | Securities | Securities | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||
|
Three Months Ended March 31, 2010:
|
||||||||||||||||||||||||||||||||||||
|
Balance, beginning of period
|
$ | 6,694 | $ | 5,244 | $ | 378 | $ | 1,840 | $ | 37 | $ | 139 | $ | 2,703 | $ | 69 | $ | 6 | ||||||||||||||||||
|
Total realized/unrealized gains (losses) included in:
|
||||||||||||||||||||||||||||||||||||
|
Earnings: (1),(2)
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
5 | 1 | (3 | ) | 14 | — | — | 10 | — | — | ||||||||||||||||||||||||||
|
Net investment gains (losses)
|
5 | 5 | (1 | ) | — | — | (5 | ) | (19 | ) | — | — | ||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
216 | 216 | 3 | 17 | 1 | 15 | 143 | 7 | — | |||||||||||||||||||||||||||
|
Purchases, sales, issuances and settlements (3)
|
(547 | ) | 36 | (42 | ) | 192 | (2 | ) | 3 | 178 | 25 | — | ||||||||||||||||||||||||
|
Transfers into Level 3 (4)
|
84 | 58 | — | 24 | — | 100 | 10 | — | — | |||||||||||||||||||||||||||
|
Transfers out of Level 3 (4)
|
(118 | ) | (230 | ) | (136 | ) | (160 | ) | — | (27 | ) | (212 | ) | — | — | |||||||||||||||||||||
|
Balance, end of period
|
$ | 6,339 | $ | 5,330 | $ | 199 | $ | 1,927 | $ | 36 | $ | 225 | $ | 2,813 | $ | 101 | $ | 6 | ||||||||||||||||||
|
Changes in unrealized gains (losses) relating to assets still
held at March 31, 2010 included in earnings:
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
$ | 4 | $ | 1 | $ | (3 | ) | $ | 14 | $ | — | $ | — | $ | 10 | $ | — | $ | — | |||||||||||||||||
|
Net investment gains (losses)
|
$ | (14 | ) | $ | (8 | ) | $ | — | $ | — | $ | — | $ | (5 | ) | $ | (19 | ) | $ | — | $ | — | ||||||||||||||
76
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||||||||||||||||
| Equity Securities: | Trading and Other Securities: | |||||||||||||||||||||||||||||||||||
|
FVO
|
||||||||||||||||||||||||||||||||||||
|
Non-
|
FVO
|
Contractholder -
|
||||||||||||||||||||||||||||||||||
|
Redeemable
|
Actively
|
General
|
Directed
|
Mortgage
|
Separate
|
|||||||||||||||||||||||||||||||
|
Common
|
Preferred
|
Traded
|
Account
|
Unit-linked
|
Short-term
|
Loans Held-
|
MSRs
|
Account
|
||||||||||||||||||||||||||||
| Stock | Stock | Securities | Securities | Investments | Investments | for-Sale | (5),(6) | Assets (7) | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||
|
Three Months Ended March 31, 2010:
|
||||||||||||||||||||||||||||||||||||
|
Balance, beginning of period
|
$ | 136 | $ | 1,102 | $ | 32 | $ | 51 | $ | — | $ | 18 | $ | 25 | $ | 878 | $ | 1,797 | ||||||||||||||||||
|
Total realized/unrealized gains (losses) included in:
|
||||||||||||||||||||||||||||||||||||
|
Earnings: (1),(2)
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
— | — | — | (1 | ) | — | — | — | — | — | ||||||||||||||||||||||||||
|
Net investment gains (losses)
|
— | 1 | — | — | — | — | — | — | 40 | |||||||||||||||||||||||||||
|
Other revenues
|
— | — | — | — | — | — | — | (55 | ) | — | ||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
4 | 18 | — | — | — | — | — | — | — | |||||||||||||||||||||||||||
|
Purchases, sales, issuances and settlements (3)
|
21 | (113 | ) | (24 | ) | — | — | 28 | — | 36 | — | |||||||||||||||||||||||||
|
Transfers into Level 3 (4)
|
— | — | — | — | — | 48 | 6 | — | 21 | |||||||||||||||||||||||||||
|
Transfers out of Level 3 (4)
|
(2 | ) | (3 | ) | — | (18 | ) | — | (2 | ) | (3 | ) | — | (156 | ) | |||||||||||||||||||||
|
Balance, end of period
|
$ | 159 | $ | 1,005 | $ | 8 | $ | 32 | $ | — | $ | 92 | $ | 28 | $ | 859 | $ | 1,702 | ||||||||||||||||||
|
Changes in unrealized gains (losses) relating to assets still
held at March 31, 2010 included in earnings:
|
||||||||||||||||||||||||||||||||||||
|
Net investment income
|
$ | — | $ | — | $ | — | $ | (1 | ) | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
|
Net investment gain (losses)
|
$ | (1 | ) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
|
Other revenues
|
$ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (54 | ) | $ | — | |||||||||||||||||
77
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||||||||||||||||||||||
| Net Derivatives: (8) | ||||||||||||||||||||||||
|
Long-term Debt
|
||||||||||||||||||||||||
|
Interest
|
Foreign
|
Equity
|
Net
|
of Consolidated
|
||||||||||||||||||||
|
Rate
|
Currency
|
Credit
|
Market
|
Embedded
|
Securitization
|
|||||||||||||||||||
| Contracts | Contracts | Contracts | Contracts | Derivatives (9) | Entities (10) | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Three Months Ended March 31, 2010:
|
||||||||||||||||||||||||
|
Balance, beginning of period
|
$ | 7 | $ | 108 | $ | 42 | $ | 199 | $ | (1,455 | ) | $ | — | |||||||||||
|
Total realized/unrealized gains (losses) included in:
|
||||||||||||||||||||||||
|
Earnings: (1),(2)
|
||||||||||||||||||||||||
|
Net investment income
|
— | — | — | (4 | ) | — | — | |||||||||||||||||
|
Net investment gains (losses)
|
— | — | — | — | — | 12 | ||||||||||||||||||
|
Net derivative gains (losses)
|
13 | (17 | ) | — | (121 | ) | 540 | — | ||||||||||||||||
|
Other revenues
|
14 | — | — | — | — | — | ||||||||||||||||||
|
Policyholder benefits and claims
|
— | — | — | — | (21 | ) | — | |||||||||||||||||
|
Other expenses
|
— | (4 | ) | — | — | — | — | |||||||||||||||||
|
Other comprehensive income (loss)
|
— | (1 | ) | 3 | 1 | 10 | — | |||||||||||||||||
|
Purchases, sales, issuances and settlements (3)
|
— | (12 | ) | 2 | 5 | (68 | ) | (232 | ) | |||||||||||||||
|
Transfers into Level 3 (4)
|
— | — | — | — | — | — | ||||||||||||||||||
|
Transfers out of Level 3 (4)
|
— | — | — | — | — | — | ||||||||||||||||||
|
Balance, end of period
|
$ | 34 | $ | 74 | $ | 47 | $ | 80 | $ | (994 | ) | $ | (220 | ) | ||||||||||
|
Changes in unrealized gains (losses) relating to assets and
liabilities still held at March 31, 2010 included in
earnings:
|
||||||||||||||||||||||||
|
Net investment income
|
$ | — | $ | — | $ | — | $ | 4 | $ | — | $ | — | ||||||||||||
|
Net investment gains (losses)
|
$ | — | $ | — | $ | — | $ | — | $ | — | $ | 12 | ||||||||||||
|
Net derivative gains (losses)
|
$ | 13 | $ | (16 | ) | $ | — | $ | (115 | ) | $ | 536 | $ | — | ||||||||||
|
Other revenues
|
$ | 19 | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||
|
Policyholder benefits and claims
|
$ | — | $ | — | $ | — | $ | — | $ | (21 | ) | $ | — | |||||||||||
|
Other expenses
|
$ | — | $ | (3 | ) | $ | — | $ | — | $ | — | $ | — | |||||||||||
| (1) | Amortization of premium/discount is included within net investment income. Impairments charged to earnings on securities and certain mortgage loans are included within net investment gains (losses) while changes in estimated fair value of certain mortgage loans and MSRs are recorded in other revenues. Lapses associated with embedded derivatives are included within the earnings caption of total gains (losses). | |
| (2) | Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. | |
| (3) | The amount reported within purchases, sales, issuances and settlements is the purchase or issuance price and the sales or settlement proceeds based upon the actual date purchased or issued and sold or settled, respectively. Items purchased/issued and sold/settled in the same period are excluded from the rollforward. For the three months ended March 31, 2011, fees attributed to embedded derivatives are |
78
| included within settlements. For the three months ended March 31, 2010, fees attributed to embedded derivatives are included within purchases, sales, issuances and settlements. | ||
| (4) | Total gains and losses (in earnings and other comprehensive income (loss)) are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and out of Level 3 in the same period are excluded from the rollforward. | |
| (5) | The additions for purchases, originations and issuances and the reductions for loan payments, sales and settlements, affecting MSRs were $54 million and ($33) million, respectively, for the three months ended March 31, 2011 and $59 million and ($23) million, respectively, for the three months ended March 31, 2010. | |
| (6) | The changes in estimated fair value due to changes in valuation model inputs or assumptions and other changes in estimated fair value affecting MSRs were $58 million and ($55) million for the three months ended March 31, 2011 and 2010, respectively. | |
| (7) | Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses). | |
| (8) | Freestanding derivative assets and liabilities are presented net for purposes of the rollforward. | |
| (9) | Embedded derivative assets and liabilities are presented net for purposes of the rollforward. | |
| (10) | The long-term debt of the CSEs at January 1, 2010 is reported within the purchases, sales, issuances and settlements caption of the rollforward. |
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Unpaid principal balance
|
$ | 1,524 | $ | 2,473 | ||||
|
Excess of estimated fair value over unpaid principal balance
|
47 | 37 | ||||||
|
Carrying value at estimated fair value
|
$ | 1,571 | $ | 2,510 | ||||
|
Loans in non-accrual status
|
$ | 2 | $ | 2 | ||||
|
Loans more than 90 days past due
|
$ | 3 | $ | 3 | ||||
|
Loans in non-accrual status or more than 90 days past due,
or both — difference between aggregate estimated fair
value and unpaid principal balance
|
$ | (1 | ) | $ | (1 | ) | ||
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Instrument-specific credit risk based on changes in credit
spreads for non-agency loans and adjustments in individual loan
quality
|
$ | (1 | ) | $ | — | |||
|
Other changes in estimated fair value
|
63 | 110 | ||||||
|
Total gains (losses) recognized in other revenues
|
$ | 62 | $ | 110 | ||||
79
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Unpaid principal balance
|
$ | 6,550 | $ | 6,636 | ||||
|
Excess of estimated fair value over unpaid principal balance
|
221 | 204 | ||||||
|
Carrying value at estimated fair value
|
$ | 6,771 | $ | 6,840 | ||||
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Contractual principal balance
|
$ | 6,487 | $ | 6,619 | ||||
|
Excess of estimated fair value over contractual principal balance
|
197 | 201 | ||||||
|
Carrying value at estimated fair value
|
$ | 6,684 | $ | 6,820 | ||||
| Three Months Ended March 31, | ||||||||||||||||||||||||
| 2011 | 2010 | |||||||||||||||||||||||
|
Estimated
|
Net
|
Estimated
|
Net
|
|||||||||||||||||||||
|
Carrying
|
Fair
|
Investment
|
Carrying
|
Fair
|
Investment
|
|||||||||||||||||||
|
Value Prior to
|
Value After
|
Gains
|
Value Prior to
|
Value After
|
Gains
|
|||||||||||||||||||
| Measurement | Measurement | (Losses) | Measurement | Measurement | (Losses) | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Mortgage loans: (1)
|
||||||||||||||||||||||||
|
Held-for-investment
|
$ | 176 | $ | 184 | $ | 8 | $ | 165 | $ | 141 | $ | (24 | ) | |||||||||||
|
Held-for-sale
|
43 | 43 | — | 13 | 13 | — | ||||||||||||||||||
|
Mortgage loans, net
|
$ | 219 | $ | 227 | $ | 8 | $ | 178 | $ | 154 | $ | (24 | ) | |||||||||||
|
Real estate joint ventures (2)
|
$ | — | $ | — | $ | — | $ | 26 | $ | 5 | $ | (21 | ) | |||||||||||
| (1) | Mortgage loans — The impaired mortgage loans presented above were written down to their estimated fair values at the date the impairments were recognized and are reported as losses above. Subsequent improvements in estimated fair value on previously impaired loans recorded through a reduction in the previously established valuation allowance are reported as gains above. Estimated fair values for impaired mortgage loans are based on observable market prices or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, on the estimated fair value of the underlying collateral, or the present value of the expected future cash flows. Impairments to estimated fair value and decreases in previous impairments from subsequent |
80
| improvements in estimated fair value represent non-recurring fair value measurements that have been categorized as Level 3 due to the lack of price transparency inherent in the limited markets for such mortgage loans. | ||
| (2) | Real estate joint ventures — The impaired investments presented above were accounted for using the cost method. Impairments on these cost method investments were recognized at estimated fair value determined from information provided in the financial statements of the underlying entities in the period in which the impairment was incurred. These impairments to estimated fair value represent non-recurring fair value measurements that have been classified as Level 3 due to the limited activity and price transparency inherent in the market for such investments. This category includes several real estate funds that typically invest primarily in commercial real estate. The estimated fair values of these investments have been determined using the NAV of the Company’s ownership interest in the partners’ capital. Distributions from these investments will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next 2 to 10 years. There were no unfunded commitments for these investments at March 31, 2011. Unfunded commitments for these investments were $13 million at March 31, 2010. |
81
| March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||||||||||
|
Notional
|
Carrying
|
Fair
|
Notional
|
Carrying
|
Fair
|
|||||||||||||||||||
| Amount | Value | Value | Amount | Value | Value | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||
|
Assets:
|
||||||||||||||||||||||||
|
Mortgage loans: (1)
|
||||||||||||||||||||||||
|
Held-for-investment
|
$ | 52,626 | $ | 54,616 | $ | 52,136 | $ | 53,927 | ||||||||||||||||
|
Held-for-sale
|
864 | 864 | 811 | 811 | ||||||||||||||||||||
|
Mortgage loans, net
|
$ | 53,490 | $ | 55,480 | $ | 52,947 | $ | 54,738 | ||||||||||||||||
|
Policy loans
|
$ | 11,872 | $ | 13,247 | $ | 11,761 | $ | 13,253 | ||||||||||||||||
|
Real estate joint ventures (2)
|
$ | 458 | $ | 489 | $ | 451 | $ | 482 | ||||||||||||||||
|
Other limited partnership interests (2)
|
$ | 1,486 | $ | 1,658 | $ | 1,539 | $ | 1,619 | ||||||||||||||||
|
Short-term investments (3)
|
$ | 831 | $ | 831 | $ | 819 | $ | 819 | ||||||||||||||||
|
Other invested assets (2)
|
$ | 1,509 | $ | 1,509 | $ | 1,490 | $ | 1,490 | ||||||||||||||||
|
Cash and cash equivalents
|
$ | 10,692 | $ | 10,692 | $ | 12,957 | $ | 12,957 | ||||||||||||||||
|
Accrued investment income
|
$ | 4,478 | $ | 4,478 | $ | 4,328 | $ | 4,328 | ||||||||||||||||
|
Premiums, reinsurance and other receivables (2)
|
$ | 3,150 | $ | 3,367 | $ | 3,752 | $ | 4,048 | ||||||||||||||||
|
Other assets (2)
|
$ | 1,614 | $ | 1,613 | $ | 466 | $ | 453 | ||||||||||||||||
|
Assets of subsidiaries held-for-sale (2)
|
$ | 3,156 | $ | 3,156 | $ | 3,068 | $ | 3,068 | ||||||||||||||||
|
Liabilities:
|
||||||||||||||||||||||||
|
Policyholder account balances (2)
|
$ | 149,747 | $ | 155,257 | $ | 146,822 | $ | 152,745 | ||||||||||||||||
|
Payables for collateral under securities loaned and other
transactions
|
$ | 28,625 | $ | 28,625 | $ | 27,272 | $ | 27,272 | ||||||||||||||||
|
Bank deposits
|
$ | 9,313 | $ | 9,364 | $ | 10,316 | $ | 10,371 | ||||||||||||||||
|
Short-term debt
|
$ | 572 | $ | 572 | $ | 306 | $ | 306 | ||||||||||||||||
|
Long-term debt (2),(4)
|
$ | 20,880 | $ | 22,046 | $ | 20,734 | $ | 21,892 | ||||||||||||||||
|
Collateral financing arrangements
|
$ | 5,297 | $ | 4,889 | $ | 5,297 | $ | 4,757 | ||||||||||||||||
|
Junior subordinated debt securities
|
$ | 3,191 | $ | 3,529 | $ | 3,191 | $ | 3,461 | ||||||||||||||||
|
Other liabilities (2)
|
$ | 3,560 | $ | 3,560 | $ | 2,777 | $ | 2,777 | ||||||||||||||||
|
Separate account liabilities (2)
|
$ | 46,796 | $ | 46,796 | $ | 42,160 | $ | 42,160 | ||||||||||||||||
|
Liabilities of subsidiaries held-for-sale (2)
|
$ | 117 | $ | 117 | $ | 105 | $ | 105 | ||||||||||||||||
|
Commitments:
(5)
|
||||||||||||||||||||||||
|
Mortgage loan commitments
|
$ | 4,051 | $ | — | $ | (2 | ) | $ | 3,754 | $ | — | $ | (17 | ) | ||||||||||
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
$ | 2,196 | $ | — | $ | 2 | $ | 2,437 | $ | — | $ | — | ||||||||||||
| (1) | Mortgage loans held-for-investment as presented in the table above differs from the amounts presented in the consolidated balance sheets because this table does not include commercial mortgage loans held by CSEs. Mortgage loans held-for-sale as presented in the table above differs from the amounts presented in the consolidated balance sheets because this table does not include residential mortgage loans held-for-sale that are accounted for under the FVO. | |
| (2) | Carrying values presented herein differ from those presented in the consolidated balance sheets because certain items within the respective financial statement caption are not considered financial instruments. Financial statement captions excluded from the table above are not considered financial instruments. |
82
| (3) | Short-term investments as presented in the table above differs from the amounts presented in the consolidated balance sheets because this table does not include short-term investments that meet the definition of a security, which are measured at estimated fair value on a recurring basis. | |
| (4) | Long-term debt as presented in the table above does not include long-term debt of CSEs, which are accounted for under the FVO. | |
| (5) | Commitments are off-balance sheet obligations. Negative estimated fair values represent off-balance sheet liabilities. |
83
84
85
86
| 6. | Closed Block |
87
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Closed Block Liabilities
|
||||||||
|
Future policy benefits
|
$ | 43,308 | $ | 43,456 | ||||
|
Other policy-related balances
|
306 | 316 | ||||||
|
Policyholder dividends payable
|
596 | 579 | ||||||
|
Policyholder dividend obligation
|
793 | 876 | ||||||
|
Current income tax payable
|
8 | 178 | ||||||
|
Other liabilities
|
708 | 627 | ||||||
|
Total closed block liabilities
|
45,719 | 46,032 | ||||||
|
Assets Designated to the Closed Block
|
||||||||
|
Investments:
|
||||||||
|
Fixed maturity securities
available-for-sale,
at estimated fair value (amortized cost: $26,966 and $27,067,
respectively)
|
28,581 | 28,768 | ||||||
|
Equity securities
available-for-sale,
at estimated fair value (cost: $111 and $110, respectively)
|
107 | 102 | ||||||
|
Mortgage loans
|
6,172 | 6,253 | ||||||
|
Policy loans
|
4,620 | 4,629 | ||||||
|
Real estate and real estate joint ventures
held-for-investment
|
340 | 328 | ||||||
|
Short-term investments
|
— | 1 | ||||||
|
Other invested assets
|
615 | 729 | ||||||
|
Total investments
|
40,435 | 40,810 | ||||||
|
Cash and cash equivalents
|
317 | 236 | ||||||
|
Accrued investment income
|
536 | 518 | ||||||
|
Premiums, reinsurance and other receivables
|
102 | 95 | ||||||
|
Deferred income tax assets
|
465 | 474 | ||||||
|
Total assets designated to the closed block
|
41,855 | 42,133 | ||||||
|
Excess of closed block liabilities over assets designated to the
closed block
|
3,864 | 3,899 | ||||||
|
Amounts included in accumulated other comprehensive income
(loss):
|
||||||||
|
Unrealized investment gains (losses), net of income tax of $565
and $594, respectively
|
1,050 | 1,101 | ||||||
|
Unrealized gains (losses) on derivative instruments, net of
income tax of $4 and $5, respectively
|
7 | 10 | ||||||
|
Allocated to policyholder dividend obligation, net of income tax
of ($277) and ($307), respectively
|
(516 | ) | (569 | ) | ||||
|
Total amounts included in accumulated other comprehensive income
(loss)
|
541 | 542 | ||||||
|
Maximum future earnings to be recognized from closed block
assets and liabilities
|
$ | 4,405 | $ | 4,441 | ||||
|
Three Months
|
Year
|
|||||||
|
Ended
|
Ended
|
|||||||
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Balance, beginning of period
|
$ | 876 | $ | — | ||||
|
Change in unrealized investment and derivative gains (losses)
|
(83 | ) | 876 | |||||
|
Balance, end of period
|
$ | 793 | $ | 876 | ||||
88
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Revenues
|
||||||||
|
Premiums
|
$ | 535 | $ | 575 | ||||
|
Net investment income
|
564 | 583 | ||||||
|
Net investment gains (losses):
|
||||||||
|
Other-than-temporary
impairments on fixed maturity securities
|
(1 | ) | — | |||||
|
Other-than-temporary
impairments on fixed maturity securities transferred to other
comprehensive income (loss)
|
— | — | ||||||
|
Other net investment gains (losses)
|
8 | 13 | ||||||
|
Total net investment gains (losses)
|
7 | 13 | ||||||
|
Net derivative gains (losses)
|
(18 | ) | (1 | ) | ||||
|
Total revenues
|
1,088 | 1,170 | ||||||
|
Expenses
|
||||||||
|
Policyholder benefits and claims
|
689 | 733 | ||||||
|
Policyholder dividends
|
297 | 321 | ||||||
|
Other expenses
|
49 | 50 | ||||||
|
Total expenses
|
1,035 | 1,104 | ||||||
|
Revenues, net of expenses before provision for income tax
expense (benefit)
|
53 | 66 | ||||||
|
Provision for income tax expense (benefit)
|
17 | 22 | ||||||
|
Revenues, net of expenses and provision for income tax expense
(benefit)
|
$ | 36 | $ | 44 | ||||
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Balance, end of period
|
$ | 4,405 | $ | 4,543 | ||||
|
Balance, beginning of period
|
4,441 | 4,587 | ||||||
|
Change during period
|
$ | (36 | ) | $ | (44 | ) | ||
| 7. | Long-term and Short-term Debt |
89
| 8. | Contingencies, Commitments and Guarantees |
90
91
92
93
94
95
96
| 9. | Employee Benefit Plans |
|
Other
|
||||||||||||||||
|
Pension
|
Postretirement
|
|||||||||||||||
| Benefits | Benefits | |||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||
| (In millions) | ||||||||||||||||
|
Service costs
|
$ | 63 | $ | 44 | $ | 5 | $ | 4 | ||||||||
|
Interest costs
|
105 | 99 | 27 | 28 | ||||||||||||
|
Expected return on plan assets
|
(114 | ) | (112 | ) | (20 | ) | (19 | ) | ||||||||
|
Amortization of net actuarial (gains) losses
|
49 | 49 | 11 | 9 | ||||||||||||
|
Amortization of prior service costs (credit)
|
1 | 2 | (27 | ) | (21 | ) | ||||||||||
|
Net periodic benefit costs
|
$ | 104 | $ | 82 | $ | (4 | ) | $ | 1 | |||||||
97
|
Other
|
||||||||||||||||
|
Pension
|
Postretirement
|
|||||||||||||||
| Benefits | Benefits | |||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||
| (In millions) | ||||||||||||||||
|
Amortization of net actuarial (gains) losses
|
$ | 49 | $ | 49 | $ | 11 | $ | 9 | ||||||||
|
Amortization of prior service costs (credit)
|
1 | 2 | (27 | ) | (21 | ) | ||||||||||
|
Subtotal
|
50 | 51 | (16 | ) | (12 | ) | ||||||||||
|
Deferred income tax expense (benefit)
|
(19 | ) | (18 | ) | 4 | (2 | ) | |||||||||
|
Components of net periodic benefit costs amortized from
accumulated other comprehensive income (loss), net of income tax
|
$ | 31 | $ | 33 | $ | (12 | ) | $ | (14 | ) | ||||||
| 10. | Equity |
98
| 11. | Other Expenses |
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Compensation
|
$ | 1,327 | $ | 844 | ||||
|
Pension, postretirement & postemployment benefit costs
|
95 | 91 | ||||||
|
Commissions
|
1,416 | 804 | ||||||
|
Volume-related costs
|
83 | 93 | ||||||
|
Interest credited to bank deposits
|
23 | 39 | ||||||
|
Capitalization of DAC
|
(1,569 | ) | (733 | ) | ||||
|
Amortization of DAC and VOBA
|
1,056 | 597 | ||||||
|
Amortization of negative VOBA
|
(183 | ) | — | |||||
|
Interest expense on debt and debt issue costs
|
415 | 370 | ||||||
|
Premium taxes, licenses & fees
|
135 | 117 | ||||||
|
Professional services
|
283 | 200 | ||||||
|
Rent, net of sublease income
|
107 | 75 | ||||||
|
Other
|
714 | 435 | ||||||
|
Total other expenses
|
$ | 3,902 | $ | 2,932 | ||||
99
| 12. | Earnings Per Common Share |
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions, except share and per share data) | ||||||||
|
Weighted Average Shares:
|
||||||||
|
Weighted average common stock outstanding for basic earnings per
common share
|
1,058,517,978 | 822,654,945 | ||||||
|
Incremental common shares from assumed:
|
||||||||
|
Stock purchase contracts underlying common equity units (1)
|
2,550,138 | — | ||||||
|
Exercise or issuance of stock-based awards
|
8,455,420 | 5,966,444 | ||||||
|
Weighted average common stock outstanding for diluted earnings
per common share
|
1,069,523,536 | 828,621,389 | ||||||
|
Income (Loss) from Continuing Operations:
|
||||||||
|
Income (loss) from continuing operations, net of income tax
|
$ | 1,055 | $ | 829 | ||||
|
Less: Income (loss) from continuing operations, net of income
tax, attributable to noncontrolling interests
|
7 | (1 | ) | |||||
|
Less: Preferred stock dividends
|
30 | 30 | ||||||
|
Preferred stock redemption premium
|
146 | — | ||||||
|
Income (loss) from continuing operations, net of income tax,
available to MetLife, Inc.’s common shareholders
|
$ | 872 | $ | 800 | ||||
|
Basic
|
$ | 0.82 | $ | 0.97 | ||||
|
Diluted
|
$ | 0.82 | $ | 0.96 | ||||
|
Income (Loss) from Discontinued Operations:
|
||||||||
|
Income (loss) from discontinued operations, net of income tax
|
$ | (42 | ) | $ | 5 | |||
|
Less: Income (loss) from discontinued operations, net of income
tax, attributable to noncontrolling interests
|
— | — | ||||||
|
Income (loss) from discontinued operations, net of income tax,
available to MetLife, Inc.’s common shareholders
|
$ | (42 | ) | $ | 5 | |||
|
Basic
|
$ | (0.04 | ) | $ | 0.01 | |||
|
Diluted
|
$ | (0.04 | ) | $ | 0.01 | |||
|
Net Income (Loss):
|
||||||||
|
Net income (loss)
|
$ | 1,013 | $ | 834 | ||||
|
Less: Net income (loss) attributable to noncontrolling interests
|
7 | (1 | ) | |||||
|
Less: Preferred stock dividends
|
30 | 30 | ||||||
|
Preferred stock redemption premium
|
146 | — | ||||||
|
Net income (loss) available to MetLife, Inc.’s common
shareholders
|
$ | 830 | $ | 805 | ||||
|
Basic
|
$ | 0.78 | $ | 0.98 | ||||
|
Diluted
|
$ | 0.78 | $ | 0.97 | ||||
| (1) | See Note 14 of the Notes to the Consolidated Financial Statements included in the 2010 Annual Report for a description of the Company’s common equity units. |
100
| 13. | Business Segment Information |
| • | Universal life and investment-type product policy fees exclude the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees (“GMIB Fees”); |
101
| • | Net investment income: (i) includes amounts for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of investments but do not qualify for hedge accounting treatment, (ii) includes income from discontinued real estate operations, (iii) excludes certain amounts related to contractholder-directed unit-linked investments, (iv) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, and (v) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and | |
| • | Other revenues are adjusted for settlements of foreign currency earnings hedges. |
| • | Policyholder benefits and claims and policyholder dividends exclude (i) changes in the policyholder dividend obligation related to net investment gains (losses) and net derivative gains (losses), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets, (iii) benefits and hedging costs related to GMIBs (“GMIB Costs”) and (iv) market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); | |
| • | Interest credited to policyholder account balances includes adjustments for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment and amounts related to net investment income earned on contractholder-directed unit-linked investments; | |
| • | Amortization of DAC and value of business acquired (“VOBA”) exclude amounts related to (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs, and (iii) Market Value Adjustments; | |
| • | Amortization of negative VOBA excludes amounts related to Market Value Adjustments; | |
| • | Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and | |
| • | Other expenses exclude costs related to (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements and (iii) business combinations. |
102
| Operating Earnings | ||||||||||||||||||||||||||||||||||||||||||||||||
| U.S. Business | International | |||||||||||||||||||||||||||||||||||||||||||||||
|
Corporate
|
Auto
|
Other
|
Banking,
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Insurance
|
Retirement
|
Benefit
|
&
|
International
|
Corporate
|
Total
|
||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, 2011 | Products | Products | Funding | Home | Total | Japan | Regions | Total | & Other | Total | Adjustments | Consolidated | ||||||||||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Revenues
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Premiums
|
$ | 4,192 | $ | 206 | $ | 291 | $ | 735 | $ | 5,424 | $ | 1,517 | $ | 1,611 | $ | 3,128 | $ | 2 | $ | 8,554 | $ | — | $ | 8,554 | ||||||||||||||||||||||||
|
Universal life and investment-type product policy fees
|
564 | 586 | 54 | — | 1,204 | 194 | 436 | 630 | — | 1,834 | 55 | 1,889 | ||||||||||||||||||||||||||||||||||||
|
Net investment income
|
1,529 | 786 | 1,311 | 53 | 3,679 | 439 | 421 | 860 | 330 | 4,869 | 448 | 5,317 | ||||||||||||||||||||||||||||||||||||
|
Other revenues
|
200 | 75 | 60 | 8 | 343 | 9 | 33 | 42 | 182 | 567 | (1 | ) | 566 | |||||||||||||||||||||||||||||||||||
|
Net investment gains (losses)
|
— | — | — | — | — | — | — | — | — | — | (99 | ) | (99 | ) | ||||||||||||||||||||||||||||||||||
|
Net derivative gains (losses)
|
— | — | — | — | — | — | — | — | — | — | (315 | ) | (315 | ) | ||||||||||||||||||||||||||||||||||
|
Total revenues
|
6,485 | 1,653 | 1,716 | 796 | 10,650 | 2,159 | 2,501 | 4,660 | 514 | 15,824 | 88 | 15,912 | ||||||||||||||||||||||||||||||||||||
|
Expenses
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
4,665 | 375 | 821 | 532 | 6,393 | 949 | 1,102 | 2,051 | 2 | 8,446 | 157 | 8,603 | ||||||||||||||||||||||||||||||||||||
|
Interest credited to policyholder account balances
|
241 | 393 | 335 | — | 969 | 369 | 143 | 512 | — | 1,481 | 443 | 1,924 | ||||||||||||||||||||||||||||||||||||
|
Interest credited to bank deposits
|
— | — | — | — | — | — | — | — | 23 | 23 | — | 23 | ||||||||||||||||||||||||||||||||||||
|
Capitalization of DAC
|
(216 | ) | (317 | ) | (12 | ) | (105 | ) | (650 | ) | (522 | ) | (397 | ) | (919 | ) | — | (1,569 | ) | — | (1,569 | ) | ||||||||||||||||||||||||||
|
Amortization of DAC and VOBA
|
231 | 198 | 5 | 109 | 543 | 292 | 288 | 580 | — | 1,123 | (67 | ) | 1,056 | |||||||||||||||||||||||||||||||||||
|
Amortization of negative VOBA
|
— | — | — | — | — | (146 | ) | (18 | ) | (164 | ) | — | (164 | ) | (19 | ) | (183 | ) | ||||||||||||||||||||||||||||||
|
Interest expense on debt
|
— | — | 2 | — | 2 | — | 2 | 2 | 319 | 323 | 92 | 415 | ||||||||||||||||||||||||||||||||||||
|
Other expenses
|
1,025 | 678 | 119 | 193 | 2,015 | 770 | 1,002 | 1,772 | 311 | 4,098 | 62 | 4,160 | ||||||||||||||||||||||||||||||||||||
|
Total expenses
|
5,946 | 1,327 | 1,270 | 729 | 9,272 | 1,712 | 2,122 | 3,834 | 655 | 13,761 | 668 | 14,429 | ||||||||||||||||||||||||||||||||||||
|
Provision for income tax expense (benefit)
|
189 | 114 | 157 | 10 | 470 | 157 | 102 | 259 | (114 | ) | 615 | (187 | ) | 428 | ||||||||||||||||||||||||||||||||||
|
Operating earnings
|
$ | 350 | $ | 212 | $ | 289 | $ | 57 | $ | 908 | $ | 290 | $ | 277 | $ | 567 | $ | (27 | ) | 1,448 | ||||||||||||||||||||||||||||
|
Adjustments to:
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Total revenues
|
88 | |||||||||||||||||||||||||||||||||||||||||||||||
|
Total expenses
|
(668 | ) | ||||||||||||||||||||||||||||||||||||||||||||||
|
Provision for income tax (expense) benefit
|
187 | |||||||||||||||||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations, net of income
tax
|
$ | 1,055 | $ | 1,055 | ||||||||||||||||||||||||||||||||||||||||||||
103
| Operating Earnings | ||||||||||||||||||||||||||||||||||||||||||||||||
| U.S. Business | International | |||||||||||||||||||||||||||||||||||||||||||||||
|
Corporate
|
Auto
|
Other
|
Banking,
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Insurance
|
Retirement
|
Benefit
|
&
|
International
|
Corporate
|
Total
|
||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, 2010 | Products | Products | Funding | Home | Total | Japan | Regions | Total | & Other | Total | Adjustments | Consolidated | ||||||||||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Revenues
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Premiums
|
$ | 4,323 | $ | 253 | $ | 671 | $ | 714 | $ | 5,961 | $ | — | $ | 827 | $ | 827 | $ | — | $ | 6,788 | $ | — | $ | 6,788 | ||||||||||||||||||||||||
|
Universal life and investment-type product policy fees
|
549 | 465 | 55 | — | 1,069 | — | 289 | 289 | — | 1,358 | 47 | 1,405 | ||||||||||||||||||||||||||||||||||||
|
Net investment income
|
1,504 | 852 | 1,191 | 53 | 3,600 | — | 428 | 428 | 243 | 4,271 | 50 | 4,321 | ||||||||||||||||||||||||||||||||||||
|
Other revenues
|
189 | 49 | 63 | (2 | ) | 299 | — | 1 | 1 | 213 | 513 | — | 513 | |||||||||||||||||||||||||||||||||||
|
Net investment gains (losses)
|
— | — | — | — | — | — | — | — | — | — | 32 | 32 | ||||||||||||||||||||||||||||||||||||
|
Net derivative gains (losses)
|
— | — | — | — | — | — | — | — | — | — | 41 | 41 | ||||||||||||||||||||||||||||||||||||
|
Total revenues
|
6,565 | 1,619 | 1,980 | 765 | 10,929 | — | 1,545 | 1,545 | 456 | 12,930 | 170 | 13,100 | ||||||||||||||||||||||||||||||||||||
|
Expenses
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
4,847 | 407 | 1,173 | 494 | 6,921 | — | 765 | 765 | (5 | ) | 7,681 | 160 | 7,841 | |||||||||||||||||||||||||||||||||||
|
Interest credited to policyholder account balances
|
234 | 406 | 355 | — | 995 | — | 150 | 150 | — | 1,145 | (3 | ) | 1,142 | |||||||||||||||||||||||||||||||||||
|
Interest credited to bank deposits
|
— | — | — | — | — | — | — | — | 39 | 39 | — | 39 | ||||||||||||||||||||||||||||||||||||
|
Capitalization of DAC
|
(206 | ) | (234 | ) | (8 | ) | (104 | ) | (552 | ) | — | (181 | ) | (181 | ) | — | (733 | ) | — | (733 | ) | |||||||||||||||||||||||||||
|
Amortization of DAC and VOBA
|
239 | 169 | 4 | 107 | 519 | — | 100 | 100 | — | 619 | (22 | ) | 597 | |||||||||||||||||||||||||||||||||||
|
Amortization of negative VOBA
|
— | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
|
Interest expense on debt
|
— | 1 | 1 | — | 2 | — | 1 | 1 | 261 | 264 | 106 | 370 | ||||||||||||||||||||||||||||||||||||
|
Other expenses
|
992 | 562 | 116 | 179 | 1,849 | — | 506 | 506 | 274 | 2,629 | 30 | 2,659 | ||||||||||||||||||||||||||||||||||||
|
Total expenses
|
6,106 | 1,311 | 1,641 | 676 | 9,734 | — | 1,341 | 1,341 | 569 | 11,644 | 271 | 11,915 | ||||||||||||||||||||||||||||||||||||
|
Provision for income tax expense (benefit)
|
161 | 107 | 119 | 17 | 404 | — | 57 | 57 | (69 | ) | 392 | (36 | ) | 356 | ||||||||||||||||||||||||||||||||||
|
Operating earnings
|
$ | 298 | $ | 201 | $ | 220 | $ | 72 | $ | 791 | $ | — | $ | 147 | $ | 147 | $ | (44 | ) | 894 | ||||||||||||||||||||||||||||
|
Adjustments to:
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Total revenues
|
170 | |||||||||||||||||||||||||||||||||||||||||||||||
|
Total expenses
|
(271 | ) | ||||||||||||||||||||||||||||||||||||||||||||||
|
Provision for income tax (expense) benefit
|
36 | |||||||||||||||||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations, net of income
tax
|
$ | 829 | $ | 829 | ||||||||||||||||||||||||||||||||||||||||||||
104
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
U.S. Business:
|
||||||||
|
Insurance Products
|
$ | 141,714 | $ | 141,366 | ||||
|
Retirement Products
|
183,918 | 177,045 | ||||||
|
Corporate Benefit Funding
|
183,569 | 172,929 | ||||||
|
Auto & Home
|
5,758 | 5,541 | ||||||
|
Total
|
514,959 | 496,881 | ||||||
|
International:
|
||||||||
|
Japan
|
95,615 | 87,416 | ||||||
|
Other International Regions
|
67,163 | 77,579 | ||||||
|
Total
|
162,778 | 164,995 | ||||||
|
Banking, Corporate & Other
|
73,604 | 69,030 | ||||||
|
Total
|
$ | 751,341 | $ | 730,906 | ||||
| 14. | Discontinued Operations |
105
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Total revenues
|
$ | 107 | $ | 89 | ||||
|
Total expenses
|
98 | 84 | ||||||
|
Income before provision for income tax
|
9 | 5 | ||||||
|
Provision for income tax expense
|
3 | 2 | ||||||
|
Income from operations of discontinued operations, net of income
tax
|
6 | 3 | ||||||
|
Net investment gain (loss), net of income tax
|
(67 | ) | — | |||||
|
Income (loss) from discontinued operations, net of income tax
|
$ | (61 | ) | $ | 3 | |||
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Total assets
held-for-sale
|
$ | 3,413 | $ | 3,331 | ||||
|
Total liabilities
held-for-sale
|
$ | 3,206 | $ | 3,043 | ||||
|
Major classes of assets and liabilities included above:
|
||||||||
|
Total investments
|
$ | 2,792 | $ | 2,726 | ||||
|
Total future policy benefits
|
$ | 2,495 | $ | 2,461 | ||||
| 15. | Intervening Event |
106
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
| • | Universal life and investment-type product policy fees exclude the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity guaranteed minimum income benefits (“GMIB”) fees (“GMIB Fees”); | |
| • | Net investment income: (i) includes amounts for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of investments but do not qualify for hedge accounting treatment, (ii) includes income from discontinued real estate operations, (iii) excludes certain amounts related to contractholder-directed unit-linked investments, (iv) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method and (v) excludes certain amounts related to securitization entities that are variable interest entities (“VIEs”) consolidated under GAAP; and | |
| • | Other revenues are adjusted for settlements of foreign currency earnings hedges. |
| • | Policyholder benefits and claims and policyholder dividends exclude (i) changes in the policyholder dividend obligation related to net investment gains (losses) and net derivative gains (losses), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets, (iii) benefits and hedging costs related to GMIBs (“GMIB Costs”) |
107
| and (iv) market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); |
| • | Interest credited to policyholder account balances includes adjustments for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment and amounts related to net investment income earned on contractholder-directed unit-linked investments; | |
| • | Amortization of deferred policy acquisition costs (“DAC”) and value of business acquired (“VOBA”) exclude amounts related to (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs, and (iii) Market Value Adjustments; | |
| • | Amortization of negative VOBA excludes amounts related to Market Value Adjustments; | |
| • | Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and | |
| • | Other expenses exclude costs related to (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements and (iii) business combinations. |
108
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Income (loss) from continuing operations, net of income tax
|
$ | 1,055 | $ | 829 | ||||
|
Less: Net investment gains (losses)
|
(99 | ) | 32 | |||||
|
Less: Net derivative gains (losses)
|
(315 | ) | 41 | |||||
|
Less: Other adjustments to continuing operations (1)
|
(166 | ) | (174 | ) | ||||
|
Less: Provision for income tax (expense) benefit
|
187 | 36 | ||||||
|
Operating earnings
|
1,448 | 894 | ||||||
|
Less: Preferred stock dividends
|
30 | 30 | ||||||
|
Operating earnings available to common shareholders
|
$ | 1,418 | $ | 864 | ||||
| (1) | See definitions of operating revenues and operating expenses for the components of such adjustments. |
109
| • | Premiums, fees and other revenues growth in 2011 of 29%, of which approximately 26% is directly attributable to the Acquisition. The remaining 3% increase is driven by: |
| • | Increases in our International businesses from continuing organic growth throughout our various geographic regions; and | |
| • | Higher fees earned on separate accounts, as the equity markets continue to improve, thereby increasing the value of those separate accounts. In addition, net flows of variable annuities are expected to remain strong in the remainder of 2011, which also increases the account values upon which these fees are earned. |
| • | Focus on disciplined underwriting. We see no significant changes to the underlying trends that drive underwriting results and continue to anticipate solid results in 2011. | |
| • | Focus on expense management. We continue to focus on expense control throughout the Company, specifically managing the costs associated with the integration of ALICO. We also continue to expect to begin realizing cost synergies later in 2011. | |
| • | Performance of the investment portfolio. Although the market environment remains challenging, we expect the performance on our investment portfolio in 2011 with respect to both income and realized gains and losses will generally be higher than the results achieved in 2010. |
110
111
112
| (i) | the estimated fair value of investments in the absence of quoted market values; | |
| (ii) | investment impairments; | |
| (iii) | the recognition of income on certain investment entities and the application of the consolidation rules to certain investments; | |
| (iv) | the estimated fair value of and accounting for freestanding derivatives and the existence and estimated fair value of embedded derivatives requiring bifurcation; | |
| (v) | the capitalization and amortization of DAC and the establishment and amortization of VOBA; | |
| (vi) | the measurement of goodwill and related impairment, if any; | |
| (vii) | the liability for future policyholder benefits and the accounting for reinsurance contracts; | |
| (viii) | accounting for income taxes and the valuation of deferred tax assets; | |
| (ix) | accounting for employee benefit plans; and | |
| (x) | the liability for litigation and regulatory matters. |
113
114
|
Three Months
|
||||||||||||||||
|
Ended
|
||||||||||||||||
| March 31, | ||||||||||||||||
| 2011 | 2010 | Change | % Change | |||||||||||||
| (In millions) | ||||||||||||||||
|
Revenues
|
||||||||||||||||
|
Premiums
|
$ | 8,554 | $ | 6,788 | $ | 1,766 | 26.0 | % | ||||||||
|
Universal life and investment-type product policy fees
|
1,889 | 1,405 | 484 | 34.4 | % | |||||||||||
|
Net investment income
|
5,317 | 4,321 | 996 | 23.1 | % | |||||||||||
|
Other revenues
|
566 | 513 | 53 | 10.3 | % | |||||||||||
|
Net investment gains (losses)
|
(99 | ) | 32 | (131 | ) | (409.4 | )% | |||||||||
|
Net derivative gains (losses)
|
(315 | ) | 41 | (356 | ) | (868.3 | )% | |||||||||
|
Total revenues
|
15,912 | 13,100 | 2,812 | 21.5 | % | |||||||||||
|
Expenses
|
||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
8,603 | 7,841 | 762 | 9.7 | % | |||||||||||
|
Interest credited to policyholder account balances
|
1,924 | 1,142 | 782 | 68.5 | % | |||||||||||
|
Interest credited to bank deposits
|
23 | 39 | (16 | ) | (41.0 | )% | ||||||||||
|
Capitalization of DAC
|
(1,569 | ) | (733 | ) | (836 | ) | (114.1 | )% | ||||||||
|
Amortization of DAC and VOBA
|
1,056 | 597 | 459 | 76.9 | % | |||||||||||
|
Amortization of negative VOBA
|
(183 | ) | — | (183 | ) | |||||||||||
|
Interest expense on debt
|
415 | 370 | 45 | 12.2 | % | |||||||||||
|
Other expenses
|
4,160 | 2,659 | 1,501 | 56.4 | % | |||||||||||
|
Total expenses
|
14,429 | 11,915 | 2,514 | 21.1 | % | |||||||||||
|
Income (loss) from continuing operations before provision for
income tax
|
1,483 | 1,185 | 298 | 25.1 | % | |||||||||||
|
Provision for income tax expense (benefit)
|
428 | 356 | 72 | 20.2 | % | |||||||||||
|
Income (loss) from continuing operations, net of income tax
|
1,055 | 829 | 226 | 27.3 | % | |||||||||||
|
Income (loss) from discontinued operations, net of income tax
|
(42 | ) | 5 | (47 | ) | (940.0 | )% | |||||||||
|
Net income (loss)
|
1,013 | 834 | 179 | 21.5 | % | |||||||||||
|
Less: Net income (loss) attributable to noncontrolling interests
|
7 | (1 | ) | 8 | 800.0 | % | ||||||||||
|
Net income (loss) attributable to MetLife, Inc.
|
1,006 | 835 | 171 | 20.5 | % | |||||||||||
|
Less: Preferred stock dividends
|
30 | 30 | — | — | % | |||||||||||
|
Preferred stock redemption premium
|
146 | — | 146 | |||||||||||||
|
Net income (loss) available to MetLife, Inc.’s common
shareholders
|
$ | 830 | $ | 805 | $ | 25 | 3.1 | % | ||||||||
115
116
|
Corporate
|
Other
|
Banking,
|
||||||||||||||||||||||||||||||
|
Insurance
|
Retirement
|
Benefit
|
Auto &
|
International
|
Corporate
|
|||||||||||||||||||||||||||
| Products | Products | Funding | Home | Japan | Regions | & Other | Total | |||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations, net of income tax
|
$ | 232 | $ | 174 | $ | 243 | $ | 57 | $ | 262 | $ | 205 | $ | (118 | ) | $ | 1,055 | |||||||||||||||
|
Less: Net investment gains (losses)
|
37 | 9 | 12 | — | (47 | ) | (112 | ) | 2 | (99 | ) | |||||||||||||||||||||
|
Less: Net derivative gains (losses)
|
(169 | ) | (7 | ) | (127 | ) | — | (8 | ) | 76 | (80 | ) | (315 | ) | ||||||||||||||||||
|
Less: Other adjustments to continuing operations (1)
|
(51 | ) | (60 | ) | 44 | — | 11 | (53 | ) | (57 | ) | (166 | ) | |||||||||||||||||||
|
Less: Provision for income tax (expense) benefit
|
65 | 20 | 25 | — | 16 | 17 | 44 | 187 | ||||||||||||||||||||||||
|
Operating earnings
|
$ | 350 | $ | 212 | $ | 289 | $ | 57 | $ | 290 | $ | 277 | (27 | ) | 1,448 | |||||||||||||||||
|
Less: Preferred stock dividends
|
30 | 30 | ||||||||||||||||||||||||||||||
|
Operating earnings available to common shareholders
|
$ | (57 | ) | $ | 1,418 | |||||||||||||||||||||||||||
117
|
Corporate
|
Other
|
Banking,
|
||||||||||||||||||||||||||||||
|
Insurance
|
Retirement
|
Benefit
|
Auto &
|
International
|
Corporate
|
|||||||||||||||||||||||||||
| Products | Products | Funding | Home | Japan | Regions | & Other | Total | |||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
|
Income (loss) from continuing operations, net of income tax
|
$ | 288 | $ | 196 | $ | 240 | $ | 71 | $ | — | $ | 108 | $ | (74 | ) | $ | 829 | |||||||||||||||
|
Less: Net investment gains (losses)
|
13 | 21 | 41 | (1 | ) | — | (34 | ) | (8 | ) | 32 | |||||||||||||||||||||
|
Less: Net derivative gains (losses)
|
20 | 93 | (59 | ) | — | — | 6 | (19 | ) | 41 | ||||||||||||||||||||||
|
Less: Other adjustments to continuing operations (1)
|
(48 | ) | (123 | ) | 52 | — | — | (35 | ) | (20 | ) | (174 | ) | |||||||||||||||||||
|
Less: Provision for income tax (expense) benefit
|
5 | 4 | (14 | ) | — | — | 24 | 17 | 36 | |||||||||||||||||||||||
|
Operating earnings
|
$ | 298 | $ | 201 | $ | 220 | $ | 72 | $ | — | $ | 147 | (44 | ) | 894 | |||||||||||||||||
|
Less: Preferred stock dividends
|
30 | 30 | ||||||||||||||||||||||||||||||
|
Operating earnings available to common shareholders
|
$ | (74 | ) | $ | 864 | |||||||||||||||||||||||||||
| (1) | See definitions of operating revenues and operating expenses for the components of such adjustments. |
|
Corporate
|
Other
|
Banking,
|
||||||||||||||||||||||||||||||
|
Insurance
|
Retirement
|
Benefit
|
Auto &
|
International
|
Corporate
|
|||||||||||||||||||||||||||
| Products | Products | Funding | Home | Japan | Regions | & Other | Total | |||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
|
Total revenues
|
$ | 6,302 | $ | 1,675 | $ | 1,645 | $ | 796 | $ | 2,363 | $ | 2,597 | $ | 534 | $ | 15,912 | ||||||||||||||||
|
Less: Net investment gains (losses)
|
37 | 9 | 12 | — | (47 | ) | (112 | ) | 2 | (99 | ) | |||||||||||||||||||||
|
Less: Net derivative gains (losses)
|
(169 | ) | (7 | ) | (127 | ) | — | (8 | ) | 76 | (80 | ) | (315 | ) | ||||||||||||||||||
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
(3 | ) | — | — | — | — | — | — | (3 | ) | ||||||||||||||||||||||
|
Less: Other adjustments to revenues (1)
|
(48 | ) | 20 | 44 | — | 259 | 132 | 98 | 505 | |||||||||||||||||||||||
|
Total operating revenues
|
$ | 6,485 | $ | 1,653 | $ | 1,716 | $ | 796 | $ | 2,159 | $ | 2,501 | $ | 514 | $ | 15,824 | ||||||||||||||||
|
Total expenses
|
$ | 5,946 | $ | 1,407 | $ | 1,270 | $ | 729 | $ | 1,960 | $ | 2,307 | $ | 810 | $ | 14,429 | ||||||||||||||||
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
— | (30 | ) | — | — | — | — | — | (30 | ) | ||||||||||||||||||||||
|
Less: Other adjustments to expenses (1)
|
— | 110 | — | — | 248 | 185 | 155 | 698 | ||||||||||||||||||||||||
|
Total operating expenses
|
$ | 5,946 | $ | 1,327 | $ | 1,270 | $ | 729 | $ | 1,712 | $ | 2,122 | $ | 655 | $ | 13,761 | ||||||||||||||||
118
|
Corporate
|
Other
|
Banking,
|
||||||||||||||||||||||||||||||
|
Insurance
|
Retirement
|
Benefit
|
Auto &
|
International
|
Corporate
|
|||||||||||||||||||||||||||
| Products | Products | Funding | Home | Japan | Regions | & Other | Total | |||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
|
Total revenues
|
$ | 6,561 | $ | 1,714 | $ | 2,014 | $ | 764 | $ | — | $ | 1,504 | $ | 543 | $ | 13,100 | ||||||||||||||||
|
Less: Net investment gains (losses)
|
13 | 21 | 41 | (1 | ) | — | (34 | ) | (8 | ) | 32 | |||||||||||||||||||||
|
Less: Net derivative gains (losses)
|
20 | 93 | (59 | ) | — | — | 6 | (19 | ) | 41 | ||||||||||||||||||||||
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
(1 | ) | — | — | — | — | — | — | (1 | ) | ||||||||||||||||||||||
|
Less: Other adjustments to revenues (1)
|
(36 | ) | (19 | ) | 52 | — | — | (13 | ) | 114 | 98 | |||||||||||||||||||||
|
Total operating revenues
|
$ | 6,565 | $ | 1,619 | $ | 1,980 | $ | 765 | $ | — | $ | 1,545 | $ | 456 | $ | 12,930 | ||||||||||||||||
|
Total expenses
|
$ | 6,117 | $ | 1,415 | $ | 1,641 | $ | 676 | $ | — | $ | 1,363 | $ | 703 | $ | 11,915 | ||||||||||||||||
|
Less: Adjustments related to net investment gains (losses) and
net derivative gains (losses)
|
10 | 4 | — | — | — | — | — | 14 | ||||||||||||||||||||||||
|
Less: Other adjustments to expenses (1)
|
1 | 100 | — | — | — | 22 | 134 | 257 | ||||||||||||||||||||||||
|
Total operating expenses
|
$ | 6,106 | $ | 1,311 | $ | 1,641 | $ | 676 | $ | — | $ | 1,341 | $ | 569 | $ | 11,644 | ||||||||||||||||
119
120
|
Three Months
|
||||||||||||||||
|
Ended
|
||||||||||||||||
| March 31, | ||||||||||||||||
| 2011 | 2010 | Change | % Change | |||||||||||||
| (In millions) | ||||||||||||||||
|
OPERATING REVENUES
|
||||||||||||||||
|
Premiums
|
$ | 4,192 | $ | 4,323 | $ | (131 | ) | (3.0 | )% | |||||||
|
Universal life and investment-type product policy fees
|
564 | 549 | 15 | 2.7 | % | |||||||||||
|
Net investment income
|
1,529 | 1,504 | 25 | 1.7 | % | |||||||||||
|
Other revenues
|
200 | 189 | 11 | 5.8 | % | |||||||||||
|
Total operating revenues
|
6,485 | 6,565 | (80 | ) | (1.2 | )% | ||||||||||
|
OPERATING EXPENSES
|
||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
4,665 | 4,847 | (182 | ) | (3.8 | )% | ||||||||||
|
Interest credited to policyholder account balances
|
241 | 234 | 7 | 3.0 | % | |||||||||||
|
Capitalization of DAC
|
(216 | ) | (206 | ) | (10 | ) | (4.9 | )% | ||||||||
|
Amortization of DAC and VOBA
|
231 | 239 | (8 | ) | (3.3 | )% | ||||||||||
|
Other expenses
|
1,025 | 992 | 33 | 3.3 | % | |||||||||||
|
Total operating expenses
|
5,946 | 6,106 | (160 | ) | (2.6 | )% | ||||||||||
|
Provision for income tax expense (benefit)
|
189 | 161 | 28 | 17.4 | % | |||||||||||
|
Operating earnings
|
$ | 350 | $ | 298 | $ | 52 | 17.4 | % | ||||||||
121
|
Three Months
|
||||||||||||||||
|
Ended
|
||||||||||||||||
| March 31, | ||||||||||||||||
| 2011 | 2010 | Change | % Change | |||||||||||||
| (In millions) | ||||||||||||||||
|
OPERATING REVENUES
|
||||||||||||||||
|
Premiums
|
$ | 206 | $ | 253 | $ | (47 | ) | (18.6 | )% | |||||||
|
Universal life and investment-type product policy fees
|
586 | 465 | 121 | 26.0 | % | |||||||||||
|
Net investment income
|
786 | 852 | (66 | ) | (7.7 | )% | ||||||||||
|
Other revenues
|
75 | 49 | 26 | 53.1 | % | |||||||||||
|
Total operating revenues
|
1,653 | 1,619 | 34 | 2.1 | % | |||||||||||
|
OPERATING EXPENSES
|
||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
375 | 407 | (32 | ) | (7.9 | )% | ||||||||||
|
Interest credited to policyholder account balances
|
393 | 406 | (13 | ) | (3.2 | )% | ||||||||||
|
Capitalization of DAC
|
(317 | ) | (234 | ) | (83 | ) | (35.5 | )% | ||||||||
|
Amortization of DAC and VOBA
|
198 | 169 | 29 | 17.2 | % | |||||||||||
|
Interest expense on debt
|
— | 1 | (1 | ) | (100.0 | )% | ||||||||||
|
Other expenses
|
678 | 562 | 116 | 20.6 | % | |||||||||||
|
Total operating expenses
|
1,327 | 1,311 | 16 | 1.2 | % | |||||||||||
|
Provision for income tax expense (benefit)
|
114 | 107 | 7 | 6.5 | % | |||||||||||
|
Operating earnings
|
$ | 212 | $ | 201 | $ | 11 | 5.5 | % | ||||||||
122
|
Three Months
|
||||||||||||||||
|
Ended
|
||||||||||||||||
| March 31, | ||||||||||||||||
| 2011 | 2010 | Change | % Change | |||||||||||||
| (In millions) | ||||||||||||||||
|
OPERATING REVENUES
|
||||||||||||||||
|
Premiums
|
$ | 291 | $ | 671 | $ | (380 | ) | (56.6 | )% | |||||||
|
Universal life and investment-type product policy fees
|
54 | 55 | (1 | ) | (1.8 | )% | ||||||||||
|
Net investment income
|
1,311 | 1,191 | 120 | 10.1 | % | |||||||||||
|
Other revenues
|
60 | 63 | (3 | ) | (4.8 | )% | ||||||||||
|
Total operating revenues
|
1,716 | 1,980 | (264 | ) | (13.3 | )% | ||||||||||
|
OPERATING EXPENSES
|
||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
821 | 1,173 | (352 | ) | (30.0 | )% | ||||||||||
|
Interest credited to policyholder account balances
|
335 | 355 | (20 | ) | (5.6 | )% | ||||||||||
|
Capitalization of DAC
|
(12 | ) | (8 | ) | (4 | ) | (50.0 | )% | ||||||||
|
Amortization of DAC and VOBA
|
5 | 4 | 1 | 25.0 | % | |||||||||||
|
Interest expense on debt
|
2 | 1 | 1 | 100.0 | % | |||||||||||
|
Other expenses
|
119 | 116 | 3 | 2.6 | % | |||||||||||
|
Total operating expenses
|
1,270 | 1,641 | (371 | ) | (22.6 | )% | ||||||||||
|
Provision for income tax expense (benefit)
|
157 | 119 | 38 | 31.9 | % | |||||||||||
|
Operating earnings
|
$ | 289 | $ | 220 | $ | 69 | 31.4 | % | ||||||||
123
|
Three Months
|
||||||||||||||||
|
Ended
|
||||||||||||||||
| March 31, | ||||||||||||||||
| 2011 | 2010 | Change | % Change | |||||||||||||
| (In millions) | ||||||||||||||||
|
OPERATING REVENUES
|
||||||||||||||||
|
Premiums
|
$ | 735 | $ | 714 | $ | 21 | 2.9 | % | ||||||||
|
Net investment income
|
53 | 53 | — | — | % | |||||||||||
|
Other revenues
|
8 | (2 | ) | 10 | 500.0 | % | ||||||||||
|
Total operating revenues
|
796 | 765 | 31 | 4.1 | % | |||||||||||
|
OPERATING EXPENSES
|
||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
532 | 494 | 38 | 7.7 | % | |||||||||||
|
Capitalization of DAC
|
(105 | ) | (104 | ) | (1 | ) | (1.0 | )% | ||||||||
|
Amortization of DAC and VOBA
|
109 | 107 | 2 | 1.9 | % | |||||||||||
|
Other expenses
|
193 | 179 | 14 | 7.8 | % | |||||||||||
|
Total operating expenses
|
729 | 676 | 53 | 7.8 | % | |||||||||||
|
Provision for income tax expense (benefit)
|
10 | 17 | (7 | ) | (41.2 | )% | ||||||||||
|
Operating earnings
|
$ | 57 | $ | 72 | $ | (15 | ) | (20.8 | )% | |||||||
124
|
Three Months
|
||||||||||||
|
Ended
|
||||||||||||
| March 31, | ||||||||||||
| 2011 | 2010 | Change | ||||||||||
| (In millions) | ||||||||||||
|
OPERATING REVENUES
|
||||||||||||
|
Premiums
|
$ | 1,517 | $ | — | $ | 1,517 | ||||||
|
Universal life and investment-type product policy fees
|
194 | — | 194 | |||||||||
|
Net investment income
|
439 | — | 439 | |||||||||
|
Other revenues
|
9 | — | 9 | |||||||||
|
Total operating revenues
|
2,159 | — | 2,159 | |||||||||
|
OPERATING EXPENSES
|
||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
949 | — | 949 | |||||||||
|
Interest credited to policyholder account balances
|
369 | — | 369 | |||||||||
|
Capitalization of DAC
|
(522 | ) | — | (522 | ) | |||||||
|
Amortization of DAC and VOBA
|
292 | — | 292 | |||||||||
|
Amortization of negative VOBA
|
(146 | ) | — | (146 | ) | |||||||
|
Other expenses
|
770 | — | 770 | |||||||||
|
Total operating expenses
|
1,712 | — | 1,712 | |||||||||
|
Provision for income tax expense (benefit)
|
157 | — | 157 | |||||||||
|
Operating earnings
|
$ | 290 | $ | — | $ | 290 | ||||||
125
|
Three Months
|
||||||||||||||||
|
Ended
|
||||||||||||||||
| March 31, | ||||||||||||||||
| 2011 | 2010 | Change | % Change | |||||||||||||
| (In millions) | ||||||||||||||||
|
OPERATING REVENUES
|
||||||||||||||||
|
Premiums
|
$ | 1,611 | $ | 827 | $ | 784 | 94.8 | % | ||||||||
|
Universal life and investment-type product policy fees
|
436 | 289 | 147 | 50.9 | % | |||||||||||
|
Net investment income
|
421 | 428 | (7 | ) | (1.6 | )% | ||||||||||
|
Other revenues
|
33 | 1 | 32 | 3200.0 | % | |||||||||||
|
Total operating revenues
|
2,501 | 1,545 | 956 | 61.9 | % | |||||||||||
|
OPERATING EXPENSES
|
||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
1,102 | 765 | 337 | 44.1 | % | |||||||||||
|
Interest credited to policyholder account balances
|
143 | 150 | (7 | ) | (4.7 | )% | ||||||||||
|
Capitalization of DAC
|
(397 | ) | (181 | ) | (216 | ) | (119.3 | )% | ||||||||
|
Amortization of DAC and VOBA
|
288 | 100 | 188 | 188.0 | % | |||||||||||
|
Amortization of negative VOBA
|
(18 | ) | — | (18 | ) | |||||||||||
|
Interest expense on debt
|
2 | 1 | 1 | 100.0 | % | |||||||||||
|
Other expenses
|
1,002 | 506 | 496 | 98.0 | % | |||||||||||
|
Total operating expenses
|
2,122 | 1,341 | 781 | 58.2 | % | |||||||||||
|
Provision for income tax expense (benefit)
|
102 | 57 | 45 | 78.9 | % | |||||||||||
|
Operating earnings
|
$ | 277 | $ | 147 | $ | 130 | 88.4 | % | ||||||||
126
|
Three Months
|
||||||||||||||||
|
Ended
|
||||||||||||||||
| March 31, | ||||||||||||||||
| 2011 | 2010 | Change | % Change | |||||||||||||
| (In millions) | ||||||||||||||||
|
OPERATING REVENUES
|
||||||||||||||||
|
Premiums
|
$ | 2 | $ | — | $ | 2 | ||||||||||
|
Net investment income
|
330 | 243 | 87 | 35.8 | % | |||||||||||
|
Other revenues
|
182 | 213 | (31 | ) | (14.6 | )% | ||||||||||
|
Total operating revenues
|
514 | 456 | 58 | 12.7 | % | |||||||||||
|
OPERATING EXPENSES
|
||||||||||||||||
|
Policyholder benefits and claims and policyholder dividends
|
2 | (5 | ) | 7 | 140.0 | % | ||||||||||
|
Interest credited to bank deposits
|
23 | 39 | (16 | ) | (41.0 | )% | ||||||||||
|
Interest expense on debt
|
319 | 261 | 58 | 22.2 | % | |||||||||||
|
Other expenses
|
311 | 274 | 37 | 13.5 | % | |||||||||||
|
Total operating expenses
|
655 | 569 | 86 | 15.1 | % | |||||||||||
|
Provision for income tax expense (benefit)
|
(114 | ) | (69 | ) | (45 | ) | (65.2 | )% | ||||||||
|
Operating earnings
|
(27 | ) | (44 | ) | 17 | 38.6 | % | |||||||||
|
Less: Preferred stock dividends
|
30 | 30 | — | — | % | |||||||||||
|
Operating earnings available to common shareholders
|
$ | (57 | ) | $ | (74 | ) | $ | 17 | 23.0 | % | ||||||
127
| • | credit risk, relating to the uncertainty associated with the continued ability of a given obligor to make timely payments of principal and interest; |
128
| • | interest rate risk, relating to the market price and cash flow variability associated with changes in market interest rates; | |
| • | liquidity risk, relating to the diminished ability to sell certain investments in times of strained market conditions; and | |
| • | market valuation risk, relating to the variability in the estimated fair value of investments associated with changes in market factors such as credit spreads. |
129
|
At or For the
|
||||||||
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Fixed Maturity Securities:
|
||||||||
|
Yield (1)
|
4.91 | % | 5.74 | % | ||||
|
Investment income (2), (3)
|
$ | 3,693 | $ | 3,114 | ||||
|
Investment gains (losses) (3)
|
$ | (163 | ) | $ | (66 | ) | ||
|
Ending carrying value (2), (3)
|
$ | 334,409 | $ | 240,314 | ||||
|
Mortgage Loans:
|
||||||||
|
Yield (1)
|
5.54 | % | 5.40 | % | ||||
|
Investment income (3), (4)
|
$ | 759 | $ | 672 | ||||
|
Investment gains (losses) (3)
|
$ | 47 | $ | (28 | ) | |||
|
Ending carrying value (3)
|
$ | 55,061 | $ | 50,291 | ||||
|
Real Estate and Real Estate Joint Ventures:
|
||||||||
|
Yield (1)
|
2.83 | % | (2.11 | )% | ||||
|
Investment income
|
$ | 57 | $ | (36 | ) | |||
|
Investment gains (losses)
|
$ | 29 | $ | (22 | ) | |||
|
Ending carrying value
|
$ | 8,042 | $ | 6,866 | ||||
|
Policy Loans:
|
||||||||
|
Yield (1)
|
5.42 | % | 7.05 | % | ||||
|
Investment income
|
$ | 160 | $ | 176 | ||||
|
Ending carrying value
|
$ | 11,872 | $ | 10,015 | ||||
|
Equity Securities:
|
||||||||
|
Yield (1)
|
3.45 | % | 3.39 | % | ||||
|
Investment income
|
$ | 30 | $ | 25 | ||||
|
Investment gains (losses)
|
$ | 36 | $ | 27 | ||||
|
Ending carrying value
|
$ | 3,584 | $ | 3,062 | ||||
|
Other Limited Partnership Interests:
|
||||||||
|
Yield (1)
|
15.14 | % | 18.85 | % | ||||
|
Investment income
|
$ | 243 | $ | 265 | ||||
|
Investment gains (losses)
|
$ | 3 | $ | (1 | ) | |||
|
Ending carrying value
|
$ | 6,409 | $ | 5,753 | ||||
|
Cash and Short-Term Investments:
|
||||||||
|
Yield (1)
|
0.94 | % | 0.38 | % | ||||
|
Investment income
|
$ | 43 | $ | 13 | ||||
|
Investment gains (losses)
|
$ | — | $ | 1 | ||||
|
Ending carrying value (3)
|
$ | 19,455 | $ | 17,066 | ||||
|
Other Invested Assets: (5)
|
||||||||
|
Investment income
|
$ | 12 | $ | 154 | ||||
|
Investment gains (losses)
|
$ | 4 | $ | 58 | ||||
|
Ending carrying value
|
$ | 13,693 | $ | 12,314 | ||||
|
Total Investments:
|
||||||||
|
Gross investment income yield (1)
|
4.81 | % | 5.54 | % | ||||
|
Investment fees and expenses yield
|
(0.12 | ) | (0.14 | ) | ||||
|
Investment Income Yield (3)
|
4.69 | % | 5.40 | % | ||||
|
Gross investment income
|
$ | 4,997 | $ | 4,383 | ||||
|
Investment fees and expenses
|
(128 | ) | (112 | ) | ||||
|
Investment Income (3), (6)
|
$ | 4,869 | $ | 4,271 | ||||
|
Ending Carrying Value (3)
|
$ | 452,525 | $ | 345,681 | ||||
|
Gross investment gains (3)
|
$ | 290 | $ | 274 | ||||
|
Gross investment losses (3)
|
(243 | ) | (156 | ) | ||||
|
Writedowns
|
(91 | ) | (149 | ) | ||||
|
Investment Portfolio Gains (Losses) (3), (6)
|
$ | (44 | ) | $ | (31 | ) | ||
|
Investment portfolio gains (losses) income tax (expense) benefit
|
15 | 8 | ||||||
|
Investment Portfolio Gains (Losses), Net of Income Tax
|
$ | (29 | ) | $ | (23 | ) | ||
|
Derivative Net Gains (Losses)
(6)
|
$ | (386 | ) | $ | (10 | ) | ||
|
Derivative net gains (losses) income tax (expense) benefit
|
132 | 11 | ||||||
|
Derivative Net Gains (Losses), Net of Income Tax
|
$ | (254 | ) | $ | 1 | |||
130
| (1) | Yields are based on average of quarterly average asset carrying values, excluding recognized and unrealized investment gains (losses), collateral received from counterparties associated with our securities lending program, the effects of consolidating certain VIEs that are treated as CSEs, and effective October 1, 2010 contractholder-directed unit-linked investments. Yields also exclude investment income recognized on mortgage loans and securities held by CSEs and, effective October 1, 2010, contractholder-directed unit-linked investments. | |
| (2) | Fixed maturity securities include $745 million and $2,765 million at estimated fair value of trading and other securities at March 31, 2011 and 2010, respectively. Fixed maturity securities include $28 million and $79 million of investment income related to trading and other securities for the three months ended March 31, 2011 and 2010, respectively. | |
| (3) | (a) Fixed maturity securities ending carrying values as presented herein, exclude (i) contractholder-directed unit-linked investments — reported within trading and other securities of $18,459 million at March 31, 2011, and (ii) securities held by CSEs— reported within trading and other securities of $161 million and $274 million at March 31, 2011 and 2010, respectively. Net investment income as presented herein, excludes investment income on contractholder-directed unit-linked investments — reported within trading and other securities effective October 1, 2010 as shown in footnote (6) to this yield table. | |
| (b) Ending carrying values, investment income, and investment gains (losses) as presented herein, exclude the effects of consolidating certain VIEs that are treated as CSEs. The adjustments to investment income and investment gains (losses) in the aggregate are as shown in footnote (6) to this yield table. The adjustments to ending carrying value, investment income and investment gains (losses) by invested asset class are presented below. Both the invested assets and long-term debt of the CSEs are accounted for under the fair value option (“FVO”). The adjustment to investment gains (losses) presented below and in footnote (6) to this yield table includes the effects of remeasuring both the invested assets and long-term debt in accordance with the FVO. |
| At or For the Three Months Ended March 31, 2011 | ||||||||||||
|
Impact of Excluding
|
Total — With all
|
|||||||||||
|
As Reported in the
|
Trading and Other
|
Trading and Other
|
||||||||||
| Yield Table | Securities and CSEs | Securities and CSEs | ||||||||||
| (In millions) | ||||||||||||
|
Trading and Other Securities (included within Fixed Maturity
Securities):
|
||||||||||||
|
Ending carrying value
|
$ | 745 | $ | 18,620 | $ | 19,365 | ||||||
|
Investment income
|
$ | 28 | $ | 420 | $ | 448 | ||||||
|
Investment gains (losses)
|
$ | — | $ | 7 | $ | 7 | ||||||
|
Mortgage Loans:
|
||||||||||||
|
Ending carrying value
|
$ | 55,061 | $ | 6,771 | $ | 61,832 | ||||||
|
Investment income
|
$ | 759 | $ | 95 | $ | 854 | ||||||
|
Investment gains (losses)
|
$ | 47 | $ | 18 | $ | 65 | ||||||
|
Cash and Short-Term Investments:
|
||||||||||||
|
Ending carrying value
|
$ | 19,455 | $ | 59 | $ | 19,514 | ||||||
|
Total Investments:
|
||||||||||||
|
Ending carrying value
|
$ | 452,525 | $ | 25,450 | $ | 477,975 | ||||||
131
| (4) | Investment income from fixed maturity securities and mortgage loans includes prepayment fees. | |
| (5) | Other invested assets are principally comprised of freestanding derivatives with positive estimated fair values and leveraged leases. Freestanding derivatives with negative estimated fair values are included within other liabilities. However, the accruals of settlement payments in other liabilities are included in net investment income as shown in Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements. As yield is not considered a meaningful measure of performance for other invested assets, it has been excluded from the yield table. | |
| (6) | Investment income (loss), investment portfolio gains (losses) and derivative gains (losses) presented in this yield table vary from the most directly comparable measures presented in the GAAP interim condensed consolidated statements of operations due to certain reclassifications affecting net investment income, net investment gains (losses), net derivative gains (losses), and interest credited to policyholder account balances and to exclude the effects of consolidating under GAAP certain VIEs that are treated as CSEs. Such reclassifications are presented in the tables below. |
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Investment income — in the above yield table
|
$ | 4,869 | $ | 4,271 | ||||
|
Real estate discontinued operations — deduct from net
investment income
|
(1 | ) | (2 | ) | ||||
|
Scheduled periodic settlement payments on derivatives not
qualifying for hedge accounting — deduct from net
investment income, add to net derivative gains (losses)
|
(39 | ) | (49 | ) | ||||
|
Equity method operating joint ventures — add to net
investment income, deduct from net derivative gains (losses)
|
(23 | ) | (5 | ) | ||||
|
Net investment income on contractholder-directed unit-linked
investments — reported within trading and other
securities — add to net investment income
|
419 | — | ||||||
|
Incremental net investment income from CSEs — add to
net investment income
|
92 | 106 | ||||||
|
Net investment income — GAAP consolidated statements
of operations
|
$ | 5,317 | $ | 4,321 | ||||
|
Investment portfolio gains (losses) — in the above
yield table
|
$ | (44 | ) | $ | (31 | ) | ||
|
Real estate discontinued operations — deduct from net
investment gains (losses)
|
(28 | ) | — | |||||
|
Investment gains (losses) related to CSEs — add to net
investment gains (losses)
|
25 | 10 | ||||||
|
Other gains (losses) — add to net investment gains
(losses)
|
(52 | ) | 53 | |||||
|
Net investment gains (losses) — GAAP consolidated
statements of operations
|
$ | (99 | ) | $ | 32 | |||
|
Derivative gains (losses) — in the above yield table
|
$ | (386 | ) | $ | (10 | ) | ||
|
Scheduled periodic settlement payments on derivatives not
qualifying for hedge accounting — add to net
derivative gains (losses), deduct from net investment income
|
39 | 49 | ||||||
|
Scheduled periodic settlement payments on derivatives not
qualifying for hedge accounting — add to net
derivative gains (losses), deduct from interest credited to PABs
|
8 | (3 | ) | |||||
|
Settlement of foreign currency earnings — add to net
derivative gains (losses), deduct from other revenues
|
1 | — | ||||||
|
Equity method operating joint ventures— add to net
investment income, deduct from net derivative gains (losses)
|
23 | 5 | ||||||
|
Net derivative gains (losses) — GAAP consolidated
statements of operations
|
$ | (315 | ) | $ | 41 | |||
132
| March 31, 2011 | ||||||||||||||||
|
Fixed Maturity
|
Equity
|
|||||||||||||||
| Securities | Securities | |||||||||||||||
| (In millions) | ||||||||||||||||
|
Level 1:
|
||||||||||||||||
|
Quoted prices in active markets for identical assets
|
$ | 16,668 | 5.0 | % | $ | 632 | 17.6 | % | ||||||||
|
Level 2:
|
||||||||||||||||
|
Independent pricing source
|
259,851 | 77.8 | 655 | 18.3 | ||||||||||||
|
Internal matrix pricing or discounted cash flow techniques
|
35,870 | 10.8 | 992 | 27.7 | ||||||||||||
|
Significant other observable inputs
|
295,721 | 88.6 | 1,647 | 46.0 | ||||||||||||
|
Level 3:
|
||||||||||||||||
|
Independent pricing source
|
9,267 | 2.8 | 1,078 | 30.1 | ||||||||||||
|
Internal matrix pricing or discounted cash flow techniques
|
10,479 | 3.1 | 207 | 5.8 | ||||||||||||
|
Independent broker quotations
|
1,529 | 0.5 | 20 | 0.5 | ||||||||||||
|
Significant unobservable inputs
|
21,275 | 6.4 | 1,305 | 36.4 | ||||||||||||
|
Total estimated fair value
|
$ | 333,664 | 100.0 | % | $ | 3,584 | 100.0 | % | ||||||||
133
| March 31, 2011 | ||||||||||||||||
| Fair Value Measurements Using | ||||||||||||||||
|
Quoted Prices
|
Significant
|
|||||||||||||||
|
in Active
|
Other
|
Significant
|
||||||||||||||
|
Markets for
|
Observable
|
Unobservable
|
Total
|
|||||||||||||
|
Identical Assets
|
Inputs
|
Inputs
|
Estimated
|
|||||||||||||
| (Level 1) | (Level 2) | (Level 3) | Fair Value | |||||||||||||
| (In millions) | ||||||||||||||||
|
Fixed Maturity Securities:
|
||||||||||||||||
|
U.S. corporate securities
|
$ | — | $ | 86,688 | $ | 6,861 | $ | 93,549 | ||||||||
|
Foreign corporate securities
|
— | 63,163 | 5,534 | 68,697 | ||||||||||||
|
Foreign government securities
|
87 | 41,916 | 3,186 | 45,189 | ||||||||||||
|
Residential mortgage-backed securities (“RMBS”)
|
— | 44,736 | 271 | 45,007 | ||||||||||||
|
U.S. Treasury and agency securities
|
16,581 | 18,822 | 76 | 35,479 | ||||||||||||
|
Commercial mortgage-backed securities (“CMBS”)
|
— | 18,994 | 791 | 19,785 | ||||||||||||
|
Asset-backed securities (“ABS”)
|
— | 10,484 | 4,506 | 14,990 | ||||||||||||
|
State and political subdivision securities
|
— | 10,915 | 46 | 10,961 | ||||||||||||
|
Other fixed maturity securities
|
— | 3 | 4 | 7 | ||||||||||||
|
Total fixed maturity securities
|
$ | 16,668 | $ | 295,721 | $ | 21,275 | $ | 333,664 | ||||||||
|
Equity Securities:
|
||||||||||||||||
|
Common stock
|
$ | 632 | $ | 1,121 | $ | 359 | $ | 2,112 | ||||||||
|
Non-redeemable preferred stock
|
— | 526 | 946 | 1,472 | ||||||||||||
|
Total equity securities
|
$ | 632 | $ | 1,647 | $ | 1,305 | $ | 3,584 | ||||||||
| • | The majority of the Level 3 fixed maturity and equity securities (89%, as presented above) were concentrated in four sectors: U.S. and foreign corporate securities, ABS and foreign government securities. | |
| • | Level 3 fixed maturity securities are priced principally through market standard valuation methodologies, independent pricing services and independent non-binding broker quotations using inputs that are not market observable or cannot be derived principally from or corroborated by observable market data. Level 3 fixed maturity securities consists of less liquid fixed maturity securities with very limited trading activity or where less price transparency exists around the inputs to the valuation methodologies including alternative residential mortgage loan RMBS and less liquid prime RMBS, certain below investment grade private placements and less liquid investment grade corporate securities (included in U.S. and foreign corporate securities) and less liquid ABS including securities supported by sub-prime mortgage loans (included in ABS). | |
| • | During the three months ended March 31, 2011, Level 3 fixed maturity securities decreased by $1,441 million, or 6%. The decrease was driven by transfers out of Level 3, partially offset by net purchases in excess of sales and an increase in estimated fair value recognized in other comprehensive income (loss). See analysis of transfers into and/or out of Level 3 below. Net purchases in excess of sales of fixed maturity securities were concentrated in ABS, U.S. corporate and foreign government securities. The increase in estimated fair value recognized in accumulated other comprehensive income (loss) for fixed maturity securities was concentrated in RMBS, U.S. and foreign corporate securities and ABS (including RMBS backed by sub-prime mortgage loans) due to improving market conditions including an improvement in liquidity. |
134
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, 2011 | ||||||||
|
Fixed Maturity
|
Equity
|
|||||||
| Securities | Securities | |||||||
| (In millions) | ||||||||
|
Balance, beginning of period
|
$ | 22,716 | $ | 1,173 | ||||
|
Total realized/unrealized gains (losses) included in:
|
||||||||
|
Earnings
|
53 | 3 | ||||||
|
Other comprehensive income (loss)
|
422 | 55 | ||||||
|
Purchases
|
2,446 | 42 | ||||||
|
Sales
|
(1,915 | ) | (43 | ) | ||||
|
Transfers into and/or out of Level 3
|
(2,447 | ) | 75 | |||||
|
Balance, end of period
|
$ | 21,275 | $ | 1,305 | ||||
| • | Total gains and losses in earnings and other comprehensive income (loss) are calculated assuming transfers into or out of Level 3 occurred at the beginning of the period. Items transferred into and out for the same period are excluded from the rollforward. | |
| • | Total gains (losses) for fixed maturity securities included in earnings of ($1) million and other comprehensive income (loss) of $56 million, respectively, were incurred for transfers subsequent to their transfer to Level 3, for the three months ended March 31, 2011. | |
| • | Net transfers into and/or out of Level 3 for fixed maturity securities were ($2,447) million for the three months ended March 31, 2011, and were comprised of transfers into of $196 million and transfers out of ($2,643) million, respectively. |
| • | During the three months ended March 31, 2011, fixed maturity securities transfers into Level 3 of $196 million resulted primarily from current market conditions characterized by a lack of trading activity, decreased liquidity and credit ratings downgrades (e.g., from investment grade to below investment grade). These current market conditions have resulted in decreased transparency of valuations and an increased use of broker quotations and unobservable inputs to determine estimated fair value principally for certain CMBS and U.S. and foreign corporate securities. | |
| • | During the three months ended March 31, 2011, fixed maturity securities transfers out of Level 3 of ($2,643) million resulted primarily from increased transparency of both new issuances that subsequent to issuance and establishment of trading activity, became priced by independent pricing services and existing issuances that, over time, the Company was able to obtain pricing from, or corroborate pricing received from independent pricing services with observable inputs, or there were increases in market activity and upgraded credit ratings primarily for certain U.S. and foreign corporate securities, ABS and RMBS. |
135
136
| March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||||||||||||||
|
NAIC
|
Amortized
|
Fair
|
% of
|
Amortized
|
Fair
|
% of
|
||||||||||||||||||||||
| Rating | Rating Agency Designation: | Cost | Value | Total | Cost | Value | Total | |||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||
| 1 | Aaa/Aa/A | $ | 233,177 | $ | 236,943 | 71.0 | % | $ | 226,639 | $ | 231,198 | 71.2 | % | |||||||||||||||
| 2 | Baa | 68,518 | 71,582 | 21.5 | 65,412 | 68,729 | 21.2 | |||||||||||||||||||||
| 3 | Ba | 15,259 | 15,428 | 4.6 | 15,331 | 15,290 | 4.7 | |||||||||||||||||||||
| 4 | B | 8,616 | 8,391 | 2.5 | 8,742 | 8,308 | 2.6 | |||||||||||||||||||||
| 5 | Caa and lower | 1,314 | 1,172 | 0.4 | 1,340 | 1,142 | 0.3 | |||||||||||||||||||||
| 6 | In or near default | 168 | 148 | — | 153 | 130 | — | |||||||||||||||||||||
| Total fixed maturity securities | $ | 327,052 | $ | 333,664 | 100.0 | % | $ | 317,617 | $ | 324,797 | 100.0 | % | ||||||||||||||||
| Fixed Maturity Securities — by Sector & Credit Quality Rating at March 31, 2011 | ||||||||||||||||||||||||||||
| NAIC Rating | 1 | 2 | 3 | 4 | 5 | 6 |
Total
|
|||||||||||||||||||||
|
Caa and
|
In or Near
|
Estimated
|
||||||||||||||||||||||||||
| Rating Agency Designation: | Aaa/Aa/A | Baa | Ba | B | Lower | Default | Fair Value | |||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||
|
U.S. corporate securities
|
$ | 46,121 | $ | 35,271 | $ | 7,986 | $ | 3,784 | $ | 363 | $ | 24 | $ | 93,549 | ||||||||||||||
|
Foreign corporate securities
|
39,207 | 25,239 | 2,559 | 1,509 | 174 | 9 | 68,697 | |||||||||||||||||||||
|
Foreign government securities
|
34,114 | 7,912 | 1,963 | 1,191 | 9 | — | 45,189 | |||||||||||||||||||||
|
RMBS (1)
|
39,482 | 1,102 | 2,433 | 1,589 | 317 | 84 | 45,007 | |||||||||||||||||||||
|
U.S. Treasury and agency securities
|
35,479 | — | — | — | — | — | 35,479 | |||||||||||||||||||||
|
CMBS (1)
|
18,574 | 649 | 285 | 213 | 64 | — | 19,785 | |||||||||||||||||||||
|
ABS (1)
|
13,805 | 645 | 171 | 101 | 237 | 31 | 14,990 | |||||||||||||||||||||
|
State and political subdivision securities
|
10,161 | 761 | 31 | — | 8 | — | 10,961 | |||||||||||||||||||||
|
Other fixed maturity securities
|
— | 3 | — | 4 | — | — | 7 | |||||||||||||||||||||
|
Total fixed maturity securities
|
$ | 236,943 | $ | 71,582 | $ | 15,428 | $ | 8,391 | $ | 1,172 | $ | 148 | $ | 333,664 | ||||||||||||||
|
Percentage of total
|
71.0 | % | 21.5 | % | 4.6 | % | 2.5 | % | 0.4 | % | — | % | 100.0 | % | ||||||||||||||
| Fixed Maturity Securities — by Sector & Credit Quality Rating at December 31, 2010 | ||||||||||||||||||||||||||||
| NAIC Rating | 1 | 2 | 3 | 4 | 5 | 6 |
Total
|
|||||||||||||||||||||
|
Caa and
|
In or Near
|
Estimated
|
||||||||||||||||||||||||||
| Rating Agency Designation: | Aaa/Aa/A | Baa | Ba | B | Lower | Default | Fair Value | |||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||
|
U.S. corporate securities
|
$ | 46,035 | $ | 34,259 | $ | 7,633 | $ | 3,452 | $ | 353 | $ | 40 | $ | 91,772 | ||||||||||||||
|
Foreign corporate securities
|
39,430 | 24,352 | 2,474 | 1,454 | 169 | 9 | 67,888 | |||||||||||||||||||||
|
Foreign government securities
|
31,559 | 7,184 | 2,179 | 1,080 | — | — | 42,002 | |||||||||||||||||||||
|
RMBS (1)
|
38,984 | 1,109 | 2,271 | 1,993 | 331 | 45 | 44,733 | |||||||||||||||||||||
|
U.S. Treasury and agency securities
|
33,304 | — | — | — | — | — | 33,304 | |||||||||||||||||||||
|
CMBS (1)
|
19,385 | 665 | 363 | 205 | 56 | 1 | 20,675 | |||||||||||||||||||||
|
ABS (1)
|
13,133 | 435 | 338 | 120 | 226 | 35 | 14,287 | |||||||||||||||||||||
|
State and political subdivision securities
|
9,368 | 722 | 32 | — | 7 | — | 10,129 | |||||||||||||||||||||
|
Other fixed maturity securities
|
— | 3 | — | 4 | — | — | 7 | |||||||||||||||||||||
|
Total fixed maturity securities
|
$ | 231,198 | $ | 68,729 | $ | 15,290 | $ | 8,308 | $ | 1,142 | $ | 130 | $ | 324,797 | ||||||||||||||
|
Percentage of total
|
71.2 | % | 21.2 | % | 4.7 | % | 2.6 | % | 0.3 | % | — | % | 100.0 | % | ||||||||||||||
137
| • | Fixed maturity and equity securities on a sector basis and the related cost or amortized cost, gross unrealized gains and losses, including noncredit loss component of OTTI loss, and estimated fair value of such securities at March 31, 2011 and December 31, 2010. | |
| • | Estimated fair value and unrealized gains (losses) on below investment grade or non-rated, non-income producing, fixed maturity securities at March 31, 2011 and December 31, 2010. | |
| • | Government and agency securities holdings in excess of 10% of the Company’s equity. | |
| • | U.S. and foreign corporate fixed maturity securities — the composition by industry and sector and related concentrations of credit risk at March 31, 2011 and December 31, 2010. |
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Estimated
|
Estimated
|
|||||||||||||||
|
Fair
|
% of
|
Fair
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
RMBS
|
$ | 45,007 | 56.4 | % | $ | 44,733 | 56.1 | % | ||||||||
|
CMBS
|
19,785 | 24.8 | 20,675 | 26.0 | ||||||||||||
|
ABS
|
14,990 | 18.8 | 14,287 | 17.9 | ||||||||||||
|
Total structured securities
|
$ | 79,782 | 100.0 | % | $ | 79,695 | 100.0 | % | ||||||||
|
Ratings profile:
|
||||||||||||||||
|
RMBS rated Aaa/AAA
|
$ | 36,550 | 81.2 | % | $ | 36,085 | 80.7 | % | ||||||||
|
RMBS rated NAIC 1
|
$ | 39,482 | 87.7 | % | $ | 38,984 | 87.1 | % | ||||||||
|
CMBS rated Aaa/AAA
|
$ | 16,064 | 81.2 | % | $ | 16,901 | 81.7 | % | ||||||||
|
CMBS rated NAIC 1
|
$ | 18,574 | 93.9 | % | $ | 19,385 | 93.7 | % | ||||||||
|
ABS rated Aaa/AAA
|
$ | 10,486 | 70.0 | % | $ | 10,411 | 72.9 | % | ||||||||
|
ABS rated NAIC 1
|
$ | 13,805 | 92.1 | % | $ | 13,133 | 91.9 | % | ||||||||
| • | RMBS holdings by security type and risk profile at March 31, 2011 and December 31, 2010. | |
| • | Alt-A RMBS holdings by vintage year and selected other information at March 31, 2011 and December 31, 2010. | |
| • | CMBS holdings by rating agency designation and by vintage year as well as NAIC rating at March 31, 2011 and December 31, 2010. | |
| • | ABS holdings by collateral type and selected other information at March 31, 2011 and December 31, 2010. |
138
139
| • | Evaluating Available-for-Sale Securities for Other-Than-Temporary Impairment | |
| • | Net Unrealized Investment Gains (Losses) | |
| • | Continuous Gross Unrealized Losses and OTTI Losses for Fixed Maturity and Equity Securities Available-for-Sale by Sector | |
| • | Aging of Gross Unrealized Losses and OTTI Losses for Fixed Maturity and Equity Securities Available-for-Sale | |
| • | Concentration of Gross Unrealized Losses and OTTI Losses for Fixed Maturity and Equity Securities Available-for-Sale | |
| • | Evaluating Temporarily Impaired Available-for-Sale Securities |
| • | The components of net investment gains (losses) for the three months ended March 31, 2011 and 2010. | |
| • | Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) for the three months ended March 31, 2011 and 2010. | |
| • | Fixed maturity security OTTI losses recognized in earnings by sector and by industry within the U.S. and foreign corporate securities sector for the three months ended March 31, 2011 and 2010. | |
| • | Equity security OTTI losses recognized in earnings by sector and industry for the three months ended March 31, 2011 and 2010. |
140
| • | Securities on loan, aging of cash collateral liability, security collateral on deposit from counterparties and the estimated fair value of the reinvestment portfolio at March 31, 2011 and December 31, 2010. | |
| • | Estimated fair value of the securities on loan related to the cash collateral on open at March 31, 2011 and portion consisting of U.S. Treasury and agency securities at March 31, 2011 and composition of the remaining securities on loan and the composition of the reinvestment portfolio at March 31, 2011. |
141
| March 31, 2011 | ||||||||||||||||
|
Trading and Other
|
Trading
|
|||||||||||||||
| Securities | Liabilities | |||||||||||||||
| (In millions) | ||||||||||||||||
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
$ | 7,085 | 36.6 | % | $ | 47 | 100.0 | % | ||||||||
|
Significant other observable inputs (Level 2)
|
11,612 | 60.0 | — | — | ||||||||||||
|
Significant unobservable inputs (Level 3)
|
668 | 3.4 | — | — | ||||||||||||
|
Total estimated fair value
|
$ | 19,365 | 100.0 | % | $ | 47 | 100.0 | % | ||||||||
|
Three Months
|
||||
|
Ended
|
||||
| March 31, 2011 | ||||
| (millions) | ||||
|
Balance, beginning of period
|
$ | 822 | ||
|
Total realized/unrealized gains (losses) included in:
|
||||
|
Earnings
|
36 | |||
|
Purchases
|
84 | |||
|
Sales
|
(268 | ) | ||
|
Transfer into and/or out of Level 3
|
(6 | ) | ||
|
Balance, end of period
|
$ | 668 | ||
142
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
% of
|
% of
|
|||||||||||||||
| Amount | Total | Amount | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Region:
|
||||||||||||||||
|
Pacific
|
$ | 8,329 | 21.9 | % | $ | 8,974 | 23.7 | % | ||||||||
|
South Atlantic
|
8,035 | 21.1 | 8,016 | 21.2 | ||||||||||||
|
Middle Atlantic
|
6,674 | 17.5 | 6,484 | 17.1 | ||||||||||||
|
International
|
4,773 | 12.5 | 4,214 | 11.2 | ||||||||||||
|
West South Central
|
3,336 | 8.8 | 3,266 | 8.6 | ||||||||||||
|
East North Central
|
2,926 | 7.7 | 3,066 | 8.1 | ||||||||||||
|
New England
|
1,730 | 4.5 | 1,531 | 4.1 | ||||||||||||
|
Mountain
|
915 | 2.4 | 884 | 2.3 | ||||||||||||
|
West North Central
|
654 | 1.7 | 666 | 1.8 | ||||||||||||
|
East South Central
|
460 | 1.2 | 461 | 1.2 | ||||||||||||
|
Other
|
255 | 0.7 | 256 | 0.7 | ||||||||||||
|
Total recorded investment
|
38,087 | 100.0 | % | 37,818 | 100.0 | % | ||||||||||
|
Less: valuation allowances
|
532 | 562 | ||||||||||||||
|
Carrying value, net of valuation allowances
|
$ | 37,555 | $ | 37,256 | ||||||||||||
|
Property Type:
|
||||||||||||||||
|
Office
|
$ | 16,728 | 43.9 | % | $ | 16,857 | 44.6 | % | ||||||||
|
Retail
|
9,217 | 24.2 | 9,215 | 24.3 | ||||||||||||
|
Apartments
|
3,536 | 9.3 | 3,630 | 9.6 | ||||||||||||
|
Hotels
|
3,223 | 8.5 | 3,089 | 8.2 | ||||||||||||
|
Industrial
|
3,138 | 8.2 | 2,910 | 7.7 | ||||||||||||
|
Other
|
2,245 | 5.9 | 2,117 | 5.6 | ||||||||||||
|
Total recorded investment
|
38,087 | 100.0 | % | 37,818 | 100.0 | % | ||||||||||
|
Less: valuation allowances
|
532 | 562 | ||||||||||||||
|
Carrying value, net of valuation allowances
|
$ | 37,555 | $ | 37,256 | ||||||||||||
143
| March 31, 2011 | December 31, 2010 | |||||||||||||||||||||||||||||||
|
% of
|
% of
|
|||||||||||||||||||||||||||||||
|
Recorded
|
% of
|
Valuation
|
Recorded
|
Recorded
|
% of
|
Valuation
|
Recorded
|
|||||||||||||||||||||||||
| Investment | Total | Allowance | Investment | Investment | Total | Allowance | Investment | |||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
|
Commercial:
|
||||||||||||||||||||||||||||||||
|
Performing
|
$ | 37,723 | 99.0 | % | $ | 491 | 1.3 | % | $ | 37,487 | 99.1 | % | $ | 528 | 1.4 | % | ||||||||||||||||
|
Restructured
|
149 | 0.4 | 8 | 5.4 | % | 93 | 0.2 | 6 | 6.5 | % | ||||||||||||||||||||||
|
Potentially delinquent
|
214 | 0.6 | 33 | 15.4 | % | 180 | 0.5 | 28 | 15.6 | % | ||||||||||||||||||||||
|
Delinquent or under foreclosure
|
1 | — | — | — | % | 58 | 0.2 | — | — | % | ||||||||||||||||||||||
|
Total
|
$ | 38,087 | 100.0 | % | $ | 532 | 1.4 | % | $ | 37,818 | 100.0 | % | $ | 562 | 1.5 | % | ||||||||||||||||
|
Agricultural
(1):
|
||||||||||||||||||||||||||||||||
|
Performing
|
$ | 12,493 | 97.9 | % | $ | 42 | 0.3 | % | $ | 12,486 | 97.9 | % | $ | 35 | 0.3 | % | ||||||||||||||||
|
Restructured
|
38 | 0.3 | 8 | 21.1 | % | 33 | 0.3 | 8 | 24.2 | % | ||||||||||||||||||||||
|
Potentially delinquent
|
68 | 0.5 | — | — | % | 62 | 0.5 | 11 | 17.7 | % | ||||||||||||||||||||||
|
Delinquent or under foreclosure
|
162 | 1.3 | 26 | 16.0 | % | 170 | 1.3 | 34 | 20.0 | % | ||||||||||||||||||||||
|
Total
|
$ | 12,761 | 100.0 | % | $ | 76 | 0.6 | % | $ | 12,751 | 100.0 | % | $ | 88 | 0.7 | % | ||||||||||||||||
|
Residential
(2):
|
||||||||||||||||||||||||||||||||
|
Performing
|
$ | 2,356 | 98.2 | % | $ | 12 | 0.5 | % | $ | 2,145 | 96.1 | % | $ | 12 | 0.6 | % | ||||||||||||||||
|
Restructured
|
3 | 0.1 | — | — | % | 4 | 0.2 | — | — | % | ||||||||||||||||||||||
|
Potentially delinquent
|
4 | 0.2 | — | — | % | 4 | 0.2 | — | — | % | ||||||||||||||||||||||
|
Delinquent or under foreclosure
|
36 | 1.5 | 1 | 2.8 | % | 78 | 3.5 | 2 | 2.6 | % | ||||||||||||||||||||||
|
Total
|
$ | 2,399 | 100.0 | % | $ | 13 | 0.5 | % | $ | 2,231 | 100.0 | % | $ | 14 | 0.6 | % | ||||||||||||||||
| (1) | Of the $12.8 billion of agricultural mortgage loans outstanding at March 31, 2011, 52% were subject to rate resets prior to maturity. A substantial portion of these mortgage loans have been successfully reset, refinanced or extended at market terms. | |
| (2) | Residential mortgage loans held-for-investment consist primarily of first lien residential mortgage loans, and to a much lesser extent, second lien residential mortgage loans and home equity lines of credit. |
144
145
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Carrying
|
% of
|
Carrying
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Traditional
|
$ | 5,610 | 69.8 | % | $ | 5,136 | 64.0 | % | ||||||||
|
Real estate joint ventures and funds
|
2,266 | 28.2 | 2,707 | 33.7 | ||||||||||||
|
Real estate and real estate joint ventures
|
7,876 | 98.0 | 7,843 | 97.7 | ||||||||||||
|
Foreclosed (commercial, agricultural and residential)
|
165 | 2.0 | 152 | 1.9 | ||||||||||||
|
Real estate
held-for-investment
|
8,041 | 100.0 | 7,995 | 99.6 | ||||||||||||
|
Real estate
held-for-sale
|
1 | — | 35 | 0.4 | ||||||||||||
|
Total real estate and real estate joint ventures
|
$ | 8,042 | 100.0 | % | $ | 8,030 | 100.0 | % | ||||||||
146
| March 31, 2011 | December 31, 2010 | |||||||||||||||
|
Carrying
|
% of
|
Carrying
|
% of
|
|||||||||||||
| Value | Total | Value | Total | |||||||||||||
| (In millions) | ||||||||||||||||
|
Freestanding derivatives with positive estimated fair values
|
$ | 6,344 | 46.3 | % | $ | 7,777 | 50.4 | % | ||||||||
|
Leveraged leases, net of non-recourse debt
|
2,201 | 16.1 | 2,191 | 14.2 | ||||||||||||
|
MSRs
|
1,029 | 7.5 | 950 | 6.2 | ||||||||||||
|
Tax credit partnerships
|
974 | 7.1 | 976 | 6.3 | ||||||||||||
|
Joint venture investments
|
717 | 5.2 | 694 | 4.5 | ||||||||||||
|
Funds withheld
|
550 | 4.0 | 551 | 3.6 | ||||||||||||
|
Other
|
1,878 | 13.8 | 2,291 | 14.8 | ||||||||||||
|
Total
|
$ | 13,693 | 100.0 | % | $ | 15,430 | 100.0 | % | ||||||||
| • | A comprehensive description of the nature of the Company’s derivative instruments, including the strategies for which derivatives are used in managing various risks. | |
| • | Information about the notional amount, estimated fair value, and primary underlying risk exposure of the Company’s derivative financial instruments, excluding embedded derivatives held at March 31, 2011 and December 31, 2010. |
| • | The notional amount and estimated fair value of derivatives and non-derivative instruments designated as hedging instruments by type of hedge designation at March 31, 2011 and December 31, 2010. | |
| • | The notional amount and estimated fair value of derivatives that are not designated or do not qualify as hedging instruments by derivative type at March 31, 2011 and December 31, 2010. | |
| • | The statement of operations effects of derivatives in cash flow, fair value, or non-qualifying hedge relationships for the three months ended March 31, 2011 and 2010. |
147
| March 31, 2011 | ||||||||||||||||
| Derivative Assets | Derivative Liabilities | |||||||||||||||
| (In millions) | ||||||||||||||||
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
$ | 17 | — | % | $ | 62 | 2 | % | ||||||||
|
Significant other observable inputs (Level 2)
|
6,028 | 95 | 3,583 | 90 | ||||||||||||
|
Significant unobservable inputs (Level 3)
|
299 | 5 | 322 | 8 | ||||||||||||
|
Total estimated fair value
|
$ | 6,344 | 100 | % | $ | 3,967 | 100 | % | ||||||||
|
Three Months
|
||||
|
Ended
|
||||
| March 31, 2011 | ||||
| (In millions) | ||||
|
Balance, beginning of period
|
$ | 173 | ||
|
Total realized/unrealized gains (losses) included in:
|
||||
|
Earnings
|
(80 | ) | ||
|
Other comprehensive income (loss)
|
(17 | ) | ||
|
Purchases, sales, issuances and settlements
|
9 | |||
|
Transfer in and/or out of Level 3
|
(108 | ) | ||
|
Balance, end of period
|
$ | (23 | ) | |
148
| March 31, 2011 | ||||||||||||||||
| Net Embedded Derivatives Within | ||||||||||||||||
|
Asset Host
|
Liability Host
|
|||||||||||||||
| Contracts | Contracts | |||||||||||||||
| (In millions) | ||||||||||||||||
|
Quoted prices in active markets for identical assets and
liabilities (Level 1)
|
$ | — | — | % | $ | — | — | % | ||||||||
|
Significant other observable inputs (Level 2)
|
— | — | 11 | 1 | ||||||||||||
|
Significant unobservable inputs (Level 3)
|
162 | 100 | 1,700 | 99 | ||||||||||||
|
Total estimated fair value
|
$ | 162 | 100 | % | $ | 1,711 | 100 | % | ||||||||
|
Three Months
|
||||
|
Ended
|
||||
| March 31, 2011 | ||||
| (In millions) | ||||
|
Balance, beginning of period
|
$ | (2,438 | ) | |
|
Total realized/unrealized gains (losses) included in:
|
||||
|
Earnings
|
957 | |||
|
Other comprehensive income (loss)
|
48 | |||
|
Purchases, sales, issuances and settlements
|
(105 | ) | ||
|
Transfer in and/or out of Level 3
|
— | |||
|
Balance, end of period
|
$ | (1,538 | ) | |
| • | Commitments to Fund Partnership Investments |
149
| • | Mortgage Loan Commitments | |
| • | Commitments to Fund Bank Credit Facilities, Bridge Loans and Private Corporate Bond Investments | |
| • | Guarantees |
150
151
|
Three Months
|
||||||||
|
Ended
|
||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
| (In millions) | ||||||||
|
Sources:
|
||||||||
|
Net cash provided by operating activities
|
$ | 3,501 | $ | 2,871 | ||||
|
Net cash provided by changes in policyholder account balances
|
1,679 | 3,127 | ||||||
|
Net cash provided by changes in payables for collateral under
securities loaned and other transactions
|
1,353 | 1,786 | ||||||
|
Net cash provided by short-term debt issuances
|
266 | — | ||||||
|
Long-term debt issued, net of issuance costs
|
280 | 163 | ||||||
|
Common stock issued, net of issuance costs
|
2,997 | — | ||||||
|
Cash provided by the effect of change in foreign currency
exchange rates
|
93 | — | ||||||
|
Total sources
|
10,169 | 7,947 | ||||||
|
Uses:
|
||||||||
|
Net cash used in investing activities
|
8,094 | 7,598 | ||||||
|
Net cash used for changes in bank deposits
|
1,027 | 218 | ||||||
|
Net cash used for short-term debt repayments
|
— | 594 | ||||||
|
Long-term debt repaid
|
249 | 322 | ||||||
|
Redemption of convertible preferred stock
|
2,805 | — | ||||||
|
Preferred stock redemption premium
|
146 | — | ||||||
|
Dividends on preferred stock
|
30 | 30 | ||||||
|
Net cash used in other, net
|
56 | 67 | ||||||
|
Cash used in the effect of change in foreign currency exchange
rates
|
— | 28 | ||||||
|
Total uses
|
12,407 | 8,857 | ||||||
|
Net decrease in cash and cash equivalents
|
$ | 2,238 | $ | 910 | ||||
152
| • | The Holding Company and MetLife Funding, Inc. (“MetLife Funding”) each have commercial paper programs supported by $4.0 billion in general corporate credit facilities. MetLife Funding, a subsidiary of Metropolitan Life Insurance Company (“MLIC”), serves as a centralized finance unit for the Company. MetLife Funding raises cash from its commercial paper program and uses the proceeds to extend loans, through MetLife Credit Corp., another subsidiary of MLIC, to the Holding Company, MLIC and other affiliates in order to enhance the financial flexibility and liquidity of these companies. Outstanding balances for the commercial paper program fluctuate in line with changes to affiliates’ financing arrangements. Pursuant to a support agreement, MLIC has agreed to cause MetLife Funding to have a tangible net worth of at least one dollar. At both March 31, 2011 and December 31, 2010, MetLife Funding had a tangible net worth of $12 million. At both March 31, 2011 and December 31, 2010, MetLife Funding had total outstanding liabilities for its commercial paper program, including accrued interest payable, of $102 million. | |
| • | MetLife Bank is a depository institution that is approved to use the Federal Reserve Bank of New York Discount Window borrowing privileges. To utilize these privileges, MetLife Bank has pledged qualifying loans and investment securities to the Federal Reserve Bank of New York as collateral. At both March 31, 2011 and December 31, 2010, MetLife Bank had no liability for advances from the Federal Reserve Bank of New York under this facility. | |
| • | MetLife Bank has a cash need to fund residential mortgage loans that it originates and generally holds for a relatively short period before selling them to one of the government-sponsored enterprises such as FNMA or FHLMC. The outstanding volume of residential mortgage originations varies from month to month and is cyclical within a month. To meet the variable funding requirements from this mortgage activity, as well as to increase overall liquidity from time to time, MetLife Bank takes advantage of short-term collateralized borrowing opportunities with the Federal Home Loan Bank of New York (“FHLB of NY”). MetLife Bank has entered into advances agreements with the FHLB of NY whereby MetLife Bank has received cash advances and under which the FHLB of NY has been granted a blanket lien on certain of MetLife Bank’s residential mortgage loans, mortgage loans held-for-sale, commercial mortgage loans and mortgage-backed securities to collateralize MetLife Bank’s repayment obligations. Upon any event of default by MetLife Bank, the FHLB of NY’s recovery is limited to the amount of MetLife Bank’s liability under the advances agreements. MetLife Bank has received advances from the FHLB of NY on both short-term and long-term bases, with a total liability of $4.3 billion and $3.8 billion at March 31, 2011 and December 31, 2010, respectively. | |
| • | The Company also had obligations under funding agreements with the FHLB of NY of $12.2 billion and $12.6 billion at March 31, 2011 and December 31, 2010, respectively, for MLIC, and with the Federal Home Loan Bank of Boston (“FHLB of Boston”) of $400 million and $100 million at March 31, 2011 and December 31, 2010, respectively, for MetLife Insurance Company of Connecticut (“MICC”). See Note 8 of the Notes to the Consolidated Financial Statements included in the 2010 Annual Report. In September 2010, MetLife Investors Insurance Company (“MLIIC”) and General American Life Insurance Company (“GALIC”), subsidiaries of MetLife, Inc., each became a member of the Federal Home Loan Bank of Des Moines (“FHLB of Des Moines”), and each purchased $10 million of FHLB of Des Moines common stock. Membership in the FHLB of Des Moines provides an additional source of contingent liquidity for the Company. The Company had obligations under funding agreements with the FHLB of Des Moines of $175 million for MLIIC and $425 million for GALIC at March 31, 2011. There were no funding agreements with the FHLB of Des Moines at December 31, 2010. | |
| • | The Company issues fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities (“SPEs”) that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding |
153
| agreements. At March 31, 2011 and December 31, 2010, funding agreements outstanding, which are included in policyholder account balances, were $28.6 billion and $27.2 billion, respectively. See Note 8 of the Notes to the Consolidated Financial Statements included in the 2010 Annual Report. |
| • | MLIC and MICC have each issued funding agreements to certain SPEs that have issued debt securities for which payment of interest and principal is secured by such funding agreements, and such debt securities are also guaranteed as to payment of interest and principal by the Federal Agricultural Mortgage Corporation, a federally chartered instrumentality of the U.S. The obligations under these funding agreements are secured by a pledge of certain eligible agricultural real estate mortgage loans and may, under certain circumstances, be secured by other qualified collateral. The amount of the Company’s liability for funding agreements issued to such SPEs was $2.8 billion at both March 31, 2011 and December 31, 2010, which is included in policyholder account balances. The obligations under these funding agreements are collateralized by designated agricultural real estate mortgage loans with carrying values of $3.2 billion at both March 31, 2011 and December 31, 2010. See Note 8 of the Notes to the Consolidated Financial Statements included in the 2010 Annual Report. |
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Short-term debt
|
$ | 572 | $ | 306 | ||||
|
Long-term debt (1)
|
$ | 20,920 | $ | 20,766 | ||||
|
Collateral financing arrangements
|
$ | 5,297 | $ | 5,297 | ||||
|
Junior subordinated debt securities
|
$ | 3,191 | $ | 3,191 | ||||
| (1) | Excludes $6,684 million and $6,820 million at March 31, 2011 and December 31, 2010, respectively, of long-term debt relating to CSEs. See Note 3 of the Notes to the Interim Condensed Consolidated Financial Statements. |
154
155
| Dividend | ||||||||||||||||||||
|
Series A
|
Series A
|
Series B
|
Series B
|
|||||||||||||||||
| Declaration Date | Record Date | Payment Date | Per Share | Aggregate | Per Share | Aggregate | ||||||||||||||
| (In millions, except per share data) | ||||||||||||||||||||
|
March 7, 2011
|
February 28, 2011 | March 15, 2011 | $ | 0.2500000 | $ | 6 | $ | 0.4062500 | $ | 24 | ||||||||||
156
157
| 2011 | ||||
|
Permitted w/o
|
||||
| Company | Approval (1) | |||
| (In millions) | ||||
|
Metropolitan Life Insurance Company
|
$ | 1,321 | ||
|
American Life Insurance Company
|
$ | 661 | ||
|
MetLife Insurance Company of Connecticut
|
$ | 517 | ||
|
Metropolitan Property and Casualty Insurance Company
|
$ | — | ||
|
Metropolitan Tower Life Insurance Company
|
$ | 80 | ||
| (1) | Reflects dividend amounts that may be paid during 2011 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2011, some or all of such dividends may require regulatory approval. None of these available amounts have been paid as of March 31, 2011. On April 29, 2011, MLIC paid as a dividend $183 million of its available amount to the Holding Company. During the three months ended March 31, 2011, the Holding Company did not receive any dividends from other subsidiaries. |
158
| March 31, 2011 | December 31, 2010 | |||||||
| (In millions) | ||||||||
|
Long-term debt — unaffiliated
|
$ | 16,287 | $ | 16,258 | ||||
|
Long-term debt — affiliated (1)
|
$ | 664 | $ | 665 | ||||
|
Collateral financing arrangements
|
$ | 2,797 | $ | 2,797 | ||||
|
Junior subordinated debt securities
|
$ | 1,748 | $ | 1,748 | ||||
| (1) | Includes $164 million and $165 million of affiliated senior notes associated with bonds held by ALICO at March 31, 2011 and December 31, 2010, respectively. |
| Subsidiaries | Interest Rate | Maturity Date | March 31, 2011 | December 31, 2010 | ||||||||
| (In millions) | ||||||||||||
|
Metropolitan Life Insurance Company (1)
|
6-month LIBOR + 1.80% | December 31, 2011 | $ | 775 | $ | 775 | ||||||
|
Metropolitan Life Insurance Company
|
7.13% | December 15, 2032 | 400 | 400 | ||||||||
|
Metropolitan Life Insurance Company
|
7.13% | January 15, 2033 | 100 | 100 | ||||||||
|
Total
|
$ | 1,275 | $ | 1,275 | ||||||||
| (1) | On April 25, 2011, MLIC repaid in cash the $775 million surplus note issued to the Holding Company in December 2009. The early redemption was approved by the New York Superintendent of Insurance. |
159
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
| • | implementing a corporate risk framework, which outlines the Company’s approach for managing risk on an enterprise-wide basis; | |
| • | developing policies and procedures for managing, measuring, monitoring and controlling those risks identified in the corporate risk framework; | |
| • | establishing appropriate corporate risk tolerance levels; | |
| • | deploying capital on an economic capital basis; and |
160
| • | reporting on a periodic basis to the Finance and Risk Committee of the Company’s Board of Directors; with respect to credit risk, to the Investment Committee of the Company’s Board of Directors; and, reporting on various aspects of risk, to financial and non-financial senior management committees. |
161
| • | The Company’s Treasury Department is responsible for managing the exposure to investments in foreign subsidiaries. Limits to exposures are established and monitored by the Treasury Department and managed by the Investment Department. | |
| • | The Investment Department is responsible for managing the exposure to foreign currency investments. Exposure limits to unhedged foreign currency investments are incorporated into the standing authorizations granted to management by the Board of Directors and are reported to the Board of Directors on a periodic basis. | |
| • | The lines of business are responsible for establishing limits and managing any foreign exchange rate exposure caused by the sale or issuance of insurance products. |
162
| • | Risks Related to Living Guarantee Benefits — The Company uses a wide range of derivative contracts to hedge the risk associated with variable annuity living guarantee benefits. These hedges include equity and interest rate futures, interest rate swaps, currency futures/forwards, equity indexed options and interest rate option contracts and equity variance swaps. | |
| • | Minimum Interest Rate Guarantees — For certain Company liability contracts, the Company provides the contractholder a guaranteed minimum interest rate. These contracts include certain fixed annuities and other insurance liabilities. The Company purchases interest rate floors to reduce risk associated with these liability guarantees. | |
| • | Reinvestment Risk in Long Duration Liability Contracts — Derivatives are used to hedge interest rate risk related to certain long duration liability contracts, such as deferred annuities. Hedges include zero coupon interest rate swaps and swaptions. | |
| • | Foreign Currency Risk — The Company uses currency swaps and forwards to hedge foreign currency risk. These hedges primarily swap foreign currency denominated bonds, investments in foreign subsidiaries or equity exposures to U.S. dollars. | |
| • | General ALM Hedging Strategies — In the ordinary course of managing the Company’s asset/liability risks, the Company uses interest rate futures, interest rate swaps, interest rate caps, interest rate floors and inflation swaps. These hedges are designed to reduce interest rate risk or inflation risk related to the existing assets or liabilities or related to expected future cash flows. |
| • | the net present values of its interest rate sensitive exposures resulting from a 10% change (increase or decrease) in interest rates; | |
| • | the U.S. dollar equivalent estimated fair values of the Company’s foreign currency exposures due to a 10% change (increase or decrease) in foreign currency exchange rates; and | |
| • | the estimated fair value of its equity positions due to a 10% change (increase or decrease) in equity market prices. |
163
| • | the market risk information is limited by the assumptions and parameters established in creating the related sensitivity analysis, including the impact of prepayment rates on mortgages; | |
| • | for the derivatives that qualify as hedges, the impact on reported earnings may be materially different from the change in market values; | |
| • | the analysis excludes other significant real estate holdings and liabilities pursuant to insurance contracts; and | |
| • | the model assumes that the composition of assets and liabilities remains unchanged throughout the period. |
| March 31, 2011 | ||||
| (In millions) | ||||
|
Non-trading:
|
||||
|
Interest rate risk
|
$ | 5,749 | ||
|
Foreign currency exchange rate risk
|
$ | 4,080 | ||
|
Equity market risk
|
$ | 18 | ||
|
Trading:
|
||||
|
Interest rate risk
|
$ | 40 | ||
|
Foreign currency exchange rate risk
|
$ | 389 | ||
164
| March 31, 2011 | ||||||||||||
|
Assuming a
|
||||||||||||
|
Estimated
|
10% Increase
|
|||||||||||
|
Notional
|
Fair
|
in the Yield
|
||||||||||
| Amount | Value (3) | Curve | ||||||||||
| (In millions) | ||||||||||||
|
Assets:
|
||||||||||||
|
Fixed maturity securities
|
$ | 333,664 | $ | (6,182 | ) | |||||||
|
Equity securities
|
3,584 | — | ||||||||||
|
Trading and other securities
|
19,365 | (42 | ) | |||||||||
|
Mortgage loans:
|
||||||||||||
|
Held-for-investment
|
61,387 | (402 | ) | |||||||||
|
Held-for-sale
|
2,435 | (10 | ) | |||||||||
|
Mortgage loans, net
|
63,822 | (412 | ) | |||||||||
|
Policy loans
|
13,247 | (180 | ) | |||||||||
|
Real estate joint ventures (1)
|
489 | — | ||||||||||
|
Other limited partnership interests (1)
|
1,658 | — | ||||||||||
|
Short-term investments
|
8,822 | (2 | ) | |||||||||
|
Other invested assets:
|
||||||||||||
|
Mortgage servicing rights
|
1,029 | 65 | ||||||||||
|
Other
|
1,509 | — | ||||||||||
|
Cash and cash equivalents
|
10,692 | — | ||||||||||
|
Accrued investment income
|
4,478 | — | ||||||||||
|
Premiums, reinsurance and other receivables
|
3,367 | (199 | ) | |||||||||
|
Other assets
|
1,613 | (7 | ) | |||||||||
|
Net embedded derivatives within asset host contracts (2)
|
162 | (16 | ) | |||||||||
|
Mortgage loan commitments
|
$ | 4,051 | (2 | ) | 15 | |||||||
|
Commitments to fund bank credit facilities, bridge loans and
private corporate bond investments
|
$ | 2,196 | 2 | — | ||||||||
|
Total Assets
|
$ | (6,960 | ) | |||||||||
|
Liabilities:
|
||||||||||||
|
Policyholder account balances
|
$ | 155,257 | $ | 792 | ||||||||
|
Payables for collateral under securities loaned and other
transactions
|
28,625 | — | ||||||||||
|
Bank deposits
|
9,364 | 6 | ||||||||||
|
Short-term debt
|
572 | — | ||||||||||
|
Long-term debt
|
22,046 | 366 | ||||||||||
|
Collateral financing arrangements
|
4,889 | — | ||||||||||
|
Junior subordinated debt securities
|
3,529 | 170 | ||||||||||
|
Other liabilities:
|
||||||||||||
|
Trading liabilities
|
47 | 2 | ||||||||||
|
Other
|
3,560 | — | ||||||||||
|
Net embedded derivatives within liability host contracts (2)
|
1,711 | 1,290 | ||||||||||
|
Total Liabilities
|
$ | 2,626 | ||||||||||
|
Derivative Instruments:
|
||||||||||||
|
Interest rate swaps
|
$ | 60,526 | $ | 730 | $ | (1,286 | ) | |||||
|
Interest rate floors
|
$ | 23,866 | 438 | (57 | ) | |||||||
|
Interest rate caps
|
$ | 36,726 | 232 | 75 | ||||||||
|
Interest rate futures
|
$ | 10,697 | 3 | — | ||||||||
|
Interest rate options
|
$ | 8,391 | 93 | (16 | ) | |||||||
|
Interest rate forwards
|
$ | 7,742 | (120 | ) | (71 | ) | ||||||
|
Synthetic GICs
|
$ | 4,365 | — | — | ||||||||
|
Foreign currency swaps
|
$ | 17,194 | 7 | (6 | ) | |||||||
|
Foreign currency forwards
|
$ | 10,830 | (112 | ) | 1 | |||||||
|
Currency futures
|
$ | 476 | — | — | ||||||||
|
Currency options
|
$ | 2,346 | 28 | 1 | ||||||||
|
Non-derivative hedging instruments
|
$ | — | — | — | ||||||||
|
Credit default swaps
|
$ | 12,013 | 30 | — | ||||||||
|
Credit forwards
|
$ | 120 | (5 | ) | — | |||||||
|
Equity futures
|
$ | 5,761 | (34 | ) | — | |||||||
|
Equity options
|
$ | 14,920 | 1,095 | (89 | ) | |||||||
|
Variance swaps
|
$ | 17,635 | (5 | ) | (7 | ) | ||||||
|
Total rate of return swaps
|
$ | 1,694 | (3 | ) | — | |||||||
|
Total Derivative Instruments
|
$ | (1,455 | ) | |||||||||
|
Net Change
|
$ | (5,789 | ) | |||||||||
| (1) | Represents only those investments accounted for using the cost method. | |
| (2) | Embedded derivatives are recognized in the consolidated balance sheet in the same caption as the host contract. |
165
| (3) | Separate account assets and liabilities which are interest rate sensitive are not included herein as any interest rate risk is borne by the holder of the separate account. |
| March 31, 2011 | ||||||||||||
|
Assuming a
|
||||||||||||
|
Estimated
|
10% Increase
|
|||||||||||
|
Notional
|
Fair
|
in the Foreign
|
||||||||||
| Amount | Value (1) | Exchange Rate | ||||||||||
| (In millions) | ||||||||||||
|
Assets:
|
||||||||||||
|
Fixed maturity securities
|
$ | 333,664 | $ | (7,101 | ) | |||||||
|
Equity securities
|
3,584 | (123 | ) | |||||||||
|
Trading and other securities
|
19,365 | (389 | ) | |||||||||
|
Mortgage loans:
|
||||||||||||
|
Held-for-investment
|
61,387 | (433 | ) | |||||||||
|
Held-for-sale
|
2,435 | — | ||||||||||
|
Mortgage loans, net
|
63,822 | (433 | ) | |||||||||
|
Policy loans
|
13,247 | (205 | ) | |||||||||
|
Other limited partnership interest
|
1,658 | (12 | ) | |||||||||
|
Short-term investments
|
8,822 | (199 | ) | |||||||||
|
Other invested assets:
|
||||||||||||
|
Mortgage servicing rights
|
1,029 | — | ||||||||||
|
Other
|
1,509 | (126 | ) | |||||||||
|
Cash and cash equivalents
|
10,692 | (133 | ) | |||||||||
|
Accrued investment income
|
4,478 | (13 | ) | |||||||||
|
Other Assets
|
1,613 | (19 | ) | |||||||||
|
Premiums, reinsurance and other receivables
|
3,367 | (5 | ) | |||||||||
|
Total Assets
|
$ | (8,758 | ) | |||||||||
|
Liabilities:
|
||||||||||||
|
Policyholder account balances
|
$ | 155,257 | $ | 3,280 | ||||||||
|
Bank deposits
|
9,364 | — | ||||||||||
|
Long-term debt
|
22,046 | 115 | ||||||||||
|
Payable for collateral under securities loaned and other
transactions
|
28,625 | 2 | ||||||||||
|
Other liabilities
|
3,560 | 29 | ||||||||||
|
Net embedded derivatives within liability host contracts (2)
|
1,711 | 361 | ||||||||||
|
Total Liabilities
|
$ | 3,787 | ||||||||||
|
Derivative Instruments:
|
||||||||||||
|
Interest rate swaps
|
$ | 60,526 | $ | 730 | $ | 2 | ||||||
|
Interest rate floors
|
$ | 23,866 | 438 | — | ||||||||
|
Interest rate caps
|
$ | 36,726 | 232 | — | ||||||||
|
Interest rate futures
|
$ | 10,697 | 3 | (3 | ) | |||||||
|
Interest rate options
|
$ | 8,391 | 93 | — | ||||||||
|
Interest rate forwards
|
$ | 7,742 | (120 | ) | — | |||||||
|
Synthetic GICs
|
$ | 4,365 | — | — | ||||||||
|
Foreign currency swaps
|
$ | 17,194 | 7 | 531 | ||||||||
|
Foreign currency forwards
|
$ | 10,830 | (112 | ) | 92 | |||||||
|
Currency futures
|
$ | 476 | — | (49 | ) | |||||||
|
Currency options
|
$ | 2,346 | 28 | — | ||||||||
|
Non-derivative hedging instruments
|
$ | — | — | — | ||||||||
|
Credit default swaps
|
$ | 12,013 | 30 | — | ||||||||
|
Credit forwards
|
$ | 120 | (5 | ) | — | |||||||
|
Equity futures
|
$ | 5,761 | (34 | ) | (7 | ) | ||||||
|
Equity options
|
$ | 14,920 | 1,095 | (64 | ) | |||||||
|
Variance swaps
|
$ | 17,635 | (5 | ) | — | |||||||
|
Total rate of return swaps
|
$ | 1,694 | (3 | ) | — | |||||||
|
Total Derivative Instruments
|
$ | 502 | ||||||||||
|
Net Change
|
$ | (4,469 | ) | |||||||||
| (1) | Estimated fair value presented in the table above represents the estimated fair value of all financial instruments within this financial statement caption, not necessarily those solely subject to foreign exchange risk. |
166
| (2) | Embedded derivatives are recognized in the consolidated balance sheet in the same caption as the host contract. |
| March 31, 2011 | ||||||||||||
|
Assuming a
|
||||||||||||
|
Estimated
|
10% Decrease
|
|||||||||||
|
Notional
|
Fair
|
in Equity
|
||||||||||
| Amount | Value (1) | Prices | ||||||||||
| (In millions) | ||||||||||||
|
Assets:
|
||||||||||||
|
Equity securities
|
$ | 3,584 | $ | (350 | ) | |||||||
|
Other invested assets:
|
||||||||||||
|
Net embedded derivatives within asset host contracts (2)
|
162 | 10 | ||||||||||
|
Total Assets
|
$ | (340 | ) | |||||||||
|
Liabilities:
|
||||||||||||
|
Policyholder account balances
|
$ | 155,257 | — | |||||||||
|
Bank deposits
|
9,364 | — | ||||||||||
|
Other liabilities:
|
||||||||||||
|
Net embedded derivatives within liability host contracts (2)
|
1,711 | (428 | ) | |||||||||
|
Total Liabilities
|
$ | (428 | ) | |||||||||
|
Derivative Instruments:
|
||||||||||||
|
Interest rate swaps
|
$ | 60,526 | $ | 730 | — | |||||||
|
Interest rate floors
|
$ | 23,866 | 438 | — | ||||||||
|
Interest rate caps
|
$ | 36,726 | 232 | — | ||||||||
|
Interest rate futures
|
$ | 10,697 | 3 | — | ||||||||
|
Interest rate options
|
$ | 8,391 | 93 | — | ||||||||
|
Interest rate forwards
|
$ | 7,742 | (120 | ) | — | |||||||
|
Synthetic GICs
|
$ | 4,365 | — | — | ||||||||
|
Foreign currency swaps
|
$ | 17,194 | 7 | — | ||||||||
|
Foreign currency forwards
|
$ | 10,830 | (112 | ) | — | |||||||
|
Currency futures
|
$ | 476 | — | — | ||||||||
|
Currency options
|
$ | 2,346 | 28 | — | ||||||||
|
Non-derivative hedging instruments
|
$ | — | — | — | ||||||||
|
Credit default swaps
|
$ | 12,013 | 30 | — | ||||||||
|
Credit forwards
|
$ | 120 | (5 | ) | — | |||||||
|
Equity futures
|
$ | 5,761 | (34 | ) | 329 | |||||||
|
Equity options
|
$ | 14,920 | 1,095 | 261 | ||||||||
|
Variance swaps
|
$ | 17,635 | (5 | ) | — | |||||||
|
Total rate of return swaps
|
$ | 1,694 | (3 | ) | 160 | |||||||
|
Total Derivative Instruments
|
$ | 750 | ||||||||||
|
Net Change
|
$ | (18 | ) | |||||||||
167
| (1) | Estimated fair value presented in the table above represents the estimated fair value of all financial instruments within this financial statement caption, not necessarily those solely subject to equity price risk. | |
| (2) | Embedded derivatives are recognized in the consolidated balance sheet in the same caption as the host contract. |
| Item 4. | Controls and Procedures |
| Item 1. | Legal Proceedings |
168
169
| Item 1A. | Risk Factors |
170
171
| • | licensing companies and agents to transact business; | |
| • | calculating the value of assets to determine compliance with statutory requirements; | |
| • | mandating certain insurance benefits; | |
| • | regulating certain premium rates; | |
| • | reviewing and approving policy forms; | |
| • | regulating unfair trade and claims practices, including through the imposition of restrictions on marketing and sales practices, distribution arrangements and payment of inducements; | |
| • | regulating advertising; | |
| • | protecting privacy; | |
| • | establishing statutory capital and reserve requirements and solvency standards; | |
| • | fixing maximum interest rates on insurance policy loans and minimum rates for guaranteed crediting rates on life insurance policies and annuity contracts; | |
| • | approving changes in control of insurance companies; | |
| • | restricting the payment of dividends and other transactions between affiliates; and | |
| • | regulating the types, amounts and valuation of investments. |
172
| • | chartering to carry on business as a bank; | |
| • | the permissibility of certain activities; | |
| • | maintaining minimum capital ratios; | |
| • | capital management in relation to the bank’s assets; | |
| • | dividend payments; | |
| • | safety and soundness standards; | |
| • | loan loss and other related liabilities; | |
| • | liquidity; | |
| • | financial reporting and disclosure standards; | |
| • | counterparty credit concentration; | |
| • | restrictions on related party and affiliate transactions; | |
| • | lending limits (and, in addition, Dodd-Frank includes the credit exposures arising from securities lending by MetLife Bank within lending limits otherwise applicable to loans); | |
| • | payment of interest; | |
| • | unfair or deceptive acts or practices; | |
| • | privacy; and | |
| • | relationships with MetLife, Inc. in its capacity as a bank holding company and potentially with other investors in connection with a change in control of MetLife Bank. |
173
174
175
176
177
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
|
(c) Total Number
|
(d) Maximum Number
|
|||||||||||||||
|
of Shares
|
(or Approximate
|
|||||||||||||||
|
Purchased as Part
|
Dollar Value) of
|
|||||||||||||||
|
(a) Total Number
|
of Publicly
|
Shares that May Yet
|
||||||||||||||
|
of Shares
|
(b) Average Price
|
Announced Plans
|
Be Purchased Under the
|
|||||||||||||
| Period | Purchased (1) | Paid per Share | or Programs | Plans or Programs (2) | ||||||||||||
|
January 1 — January 31, 2011
|
1,860 | $ | 45.64 | — | $ | 1,260,735,127 | ||||||||||
|
February 1 — February 28, 2011
|
— | $ | — | — | $ | 1,260,735,127 | ||||||||||
|
March 1 — March 31, 2011
|
42,643 | $ | 45.10 | — | $ | 1,260,735,127 | ||||||||||
| (1) | During the periods January 1 through January 31, 2011 and March 1 through March 31, 2011, separate account affiliates of the Company purchased 1,860 shares and 42,643 shares, respectively, of common stock on the open market in nondiscretionary transactions to rebalance index funds. Except as disclosed above, there were no shares of common stock which were repurchased by the Company. | |
| (2) | At March 31, 2011, the Company had $1,261 million remaining under its common stock repurchase program authorizations. In April 2008, the Company’s Board of Directors authorized an additional $1.0 billion common stock repurchase program, which will begin after the completion of the January 2008 $1.0 billion common stock repurchase program, of which $261 million remained outstanding at March 31, 2011. Under these authorizations, the Company may purchase its common stock from the MetLife Policyholder Trust, in the open market (including pursuant to the terms of a pre-set trading plan meeting the requirements of Rule 10b5-1 under the Exchange Act) and in privately negotiated transactions. Any future common stock repurchases will be dependent upon several factors, including the Company’s capital position, its liquidity, its financial strength and credit ratings, general market conditions and the market price of MetLife, Inc.’s common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory, legal and accounting factors. |
178
| Item 6. | Exhibits |
|
Exhibit
|
||||
| No. | Description | |||
| 3 | .1 | Amended and Restated Certificate of Incorporation of MetLife, Inc. (Incorporated by reference to Exhibit 3.1 to MetLife, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006 (the “2006 Annual Report”)). | ||
| 3 | .2 | Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock of MetLife, Inc., filed with the Secretary of State of Delaware on April 7, 2000 (Incorporated by reference to Exhibit 3.2 to the 2006 Annual Report). | ||
| 3 | .3 | Certificate of Designations of Floating Rate Non-Cumulative Preferred Stock, Series A, of MetLife, Inc., filed with the Secretary of State of Delaware on June 10, 2005 (Incorporated by reference to Exhibit 99.5 to MetLife, Inc.’s Registration Statement on Form 8-A filed on June 10, 2005). | ||
| 3 | .4 | Certificate of Designations of 6.50% Non-Cumulative Preferred Stock, Series B, of MetLife, Inc., filed with the Secretary of State of Delaware on June 14, 2005 (Incorporated by reference to Exhibit 99.5 to MetLife, Inc.’s Registration Statement on Form 8-A filed on June 15, 2005). | ||
| 3 | .5 | Certificate of Designations of Series B Contingent Convertible Junior Participating Non-Cumulative Perpetual Preferred Stock, filed with the Secretary of State of Delaware on October 27, 2010 (Incorporated by reference to Exhibit 3.1 to MetLife, Inc.’s Current Report on Form 8-K dated November 2, 2010). | ||
| 3 | .6 | Certificate of Amendment of Amended and Restated Certificate of Incorporation of MetLife, Inc., dated April 29, 2011. | ||
| 4 | .1 | Coordination Agreement dated as of March 1, 2011 among MetLife, Inc., AM Holdings LLC (formerly known as ALICO Holdings LLC) and American International Group, Inc. (Incorporated by reference to Exhibit 4.1 to MetLife, Inc.’s Current Report on Form 8-K dated March 2, 2011). | ||
| 4 | .2 | Amended and Restated Indemnification Collateral Account Security and Control Agreement dated as of March 8, 2011 among MetLife, Inc., AM Holdings LLC (formerly known as ALICO Holdings LLC), Deutsche Bank Trust Company Americas, as Securities Intermediary, Pledge Collateral Agent and Stock Purchase Contract Agent, and American International Group, Inc. | ||
| 31 | .1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
| 31 | .2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
| 32 | .1 | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
| 32 | .2 | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
| 101 | .INS | XBRL Instance Document. | ||
| 101 | .SCH | XBRL Taxonomy Extension Schema Document. | ||
| 101 | .CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | ||
| 101 | .LAB | XBRL Taxonomy Extension Label Linkbase Document. | ||
| 101 | .PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | ||
| 101 | .DEF | XBRL Taxonomy Extension Definition Linkbase Document. | ||
179
| By |
/s/ PETER
M. CARLSON
|
| Title: | Executive Vice President, Finance |
180
|
Exhibit
|
||||
| No. | Description | |||
| 3 | .1 | Amended and Restated Certificate of Incorporation of MetLife, Inc. (Incorporated by reference to Exhibit 3.1 to MetLife, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006 (the “2006 Annual Report”)). | ||
| 3 | .2 | Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock of MetLife, Inc., filed with the Secretary of State of Delaware on April 7, 2000 (Incorporated by reference to Exhibit 3.2 to the 2006 Annual Report). | ||
| 3 | .3 | Certificate of Designations of Floating Rate Non-Cumulative Preferred Stock, Series A, of MetLife, Inc., filed with the Secretary of State of Delaware on June 10, 2005 (Incorporated by reference to Exhibit 99.5 to MetLife, Inc.’s Registration Statement on Form 8-A filed on June 10, 2005). | ||
| 3 | .4 | Certificate of Designations of 6.50% Non-Cumulative Preferred Stock, Series B, of MetLife, Inc., filed with the Secretary of State of Delaware on June 14, 2005 (Incorporated by reference to Exhibit 99.5 to MetLife, Inc.’s Registration Statement on Form 8-A filed on June 15, 2005). | ||
| 3 | .5 | Certificate of Designations of Series B Contingent Convertible Junior Participating Non-Cumulative Perpetual Preferred Stock, filed with the Secretary of State of Delaware on October 27, 2010 (Incorporated by reference to Exhibit 3.1 to MetLife, Inc.’s Current Report on Form 8-K dated November 2, 2010). | ||
| 3 | .6 | Certificate of Amendment of Amended and Restated Certificate of Incorporation of MetLife, Inc., dated April 29, 2011. | ||
| 4 | .1 | Coordination Agreement dated as of March 1, 2011 among MetLife, Inc., AM Holdings LLC (formerly known as ALICO Holdings LLC) and American International Group, Inc. (Incorporated by reference to Exhibit 4.1 to MetLife, Inc.’s Current Report on Form 8-K dated March 2, 2011). | ||
| 4 | .2 | Amended and Restated Indemnification Collateral Account Security and Control Agreement dated as of March 8, 2011 among MetLife, Inc., AM Holdings LLC (formerly known as ALICO Holdings LLC), Deutsche Bank Trust Company Americas, as Securities Intermediary, Pledge Collateral Agent and Stock Purchase Contract Agent, and American International Group, Inc. | ||
| 31 | .1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
| 31 | .2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
| 32 | .1 | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
| 32 | .2 | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
| 101 | .INS | XBRL Instance Document. | ||
| 101 | .SCH | XBRL Taxonomy Extension Schema Document. | ||
| 101 | .CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | ||
| 101 | .LAB | XBRL Taxonomy Extension Label Linkbase Document. | ||
| 101 | .PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | ||
| 101 | .DEF | XBRL Taxonomy Extension Definition Linkbase Document. | ||
E-1
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| American Axle & Manufacturing Holdings, Inc. | AXL |
| Aon Plc | AON |
| Marsh & McLennan Companies, Inc. | MMC |
| Unum Group | UNM |
Suppliers
| Supplier name | Ticker |
|---|---|
| Johnson & Johnson | JNJ |
| Toyota Motor Corporation | TM |
| Abbott Laboratories | ABT |
| Tesla, Inc. | TSLA |
| AbbVie Inc. | ABBV |
| The Blackstone Group Inc. | BX |
| Merck & Co., Inc. | MRK |
| Pfizer Inc. | PFE |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|